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Abstract 
 Accurate medication adherence and the self-efficacy to properly adhere are essential for 
breast cancer survivors. Not only are these patients often continuing their treatment with 
adjuvant therapies, they are frequently taking medications for other medical, or comorbid, issues 
such as diabetes, asthma, high blood pressure, arthritis, and congestive heart failure. With the 
increasing number of breast cancer survivors (ACS, 2009), there is a growing need for empirical 
research of their medication usage and the influence that health literacy has on proper adherence.  
Inadequate medication adherence, lack of perceived self-efficacy in proper adherence, 
and low health literacy are factors that have received minimal attention with respect to breast 
cancer survivors, particularly those who are underserved with comorbid health issues. It would 
be beneficial to address these issues within a collaborative framework that addresses the multiple 
factors affecting them. The merits of the collaborative model of healthcare are in stark contrast to 
the medical model, indicating the need to use the former with breast cancer survivors.  
An underlying assumption of this dissertation is that traditional medical treatment of 
breast cancer is the preferred and primary course of action chosen by breast cancer patients. This 
course is not globally accepted, and even those choosing a traditional medical route are adding 
complementary and alternative medicine to their treatment (Boon et al, 2000; Lee, Lin, Wrensch, 
Adler, & Eisenberg, 2000; Richardson, Sanders, Palmer, Greisinger, & Singletary, 2000).  For 
the purposes of this paper, however, it is assumed that the majority of those diagnosed with 
breast cancer choose traditional medical courses of treatment. 
This dissertation reports the exploration of the impact of a skills development 
intervention on medication adherence and self-efficacy. Chapter 1 provides a statement of the 
problem that was examined, the purpose of the study, and the objectives of the research. 
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Chapters 2 through 5 present a review of the literature that relates to the multiple components of 
the study’s framework. Chapter 6 contains methodology, chapter 7 reports the results chapter 8 
provides discussion of the findings, and Chapter 9 offers the conclusion and personal thoughts of 
the researcher.  
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Chapter 1 
Statement of the Problem 
Louise is a 58-year-old African American woman who was diagnosed with breast 
cancer four years ago. Upon diagnosis, she had a lumpectomy, chemotherapy, and radiation. She 
is in her third year of taking the oral medication tamoxifen. In addition, she takes eight 
medications for comorbid conditions, or other health issues, which include diabetes, 
hypertension, and asthma. Louise has four children and is the primary caretaker of her two 
grandchildren. She is insured through Tenncare, the state healthcare coverage, which pays for 
only five of her medications. Although her children are able to help her when they are not 
working, she often does not have transportation to doctor appointments and the pharmacy. She 
receives diabetes counseling at the clinic where she is treated, but has difficulty understanding 
her rigid schedule of blood glucose monitoring and insulin injections. She also experiences flu-
like symptoms that could be due to tamoxifen. In addition to her physician, the oncology clinic 
has a nurse practitioner and social worker on staff to monitor progress with her breast cancer 
survival, but Louise does not want to “bother them” with questions about treatment and coping. 
Her retail pharmacist explained her medications to her when she first had them filled, but she 
cannot remember the oral instructions and has difficulty reading the prescription labels and 
patient leaflets. Louise reports having her medications in a pill box partitioned by days of the 
week but comments that she only takes her oral medications when she is feeling run down in 
order to make them last longer. 
Louise’s story reflects many of the barriers that breast cancer survivors face in 
achieving optimal health and quality of life after breast cancer treatment. Her story also 
emphasizes the need for a healthcare approach that addresses the biopsychosocial issues of the 
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patient, among them health literacy, medication adherence, and self-efficacy. The purpose of this 
study is to 1) provide an empirical foundation for examining the link between medication 
adherence, self-efficacy and health literacy within a collaborative model of health care, 2) 
examine the psychosocial barriers to proper medication adherence, 3) provide evidence that 
research on these issues is lacking among underserved breast cancer survivors and 4) provide 
results of a study that will evaluate hypotheses that have been formulated to address these issues. 
 Former United States Surgeon General C. Everett Koop once said, “Drugs don’t work in 
patients who don’t take them” (Osterberg & Blaschke, 2005). This simplistic yet accurate 
statement summarizes the dilemma faced by healthcare providers and patients in the quest for 
optimum health care. Such is the case for all patients, but perhaps none more so than the growing 
population of female breast cancer survivors (ACS, 2009), particularly those who are 
underserved. As illustrated by the case above, there are numerous factors that need to be 
addressed when examining the lack of proper medication usage with this particular group of 
women.  
  Women who have survived breast cancer are valiant warriors of a disease that strives to 
rob them of their lives, hope, and dignity. As if that is not enough, there are untold numbers of 
women who have to face the added burden of navigating the complex systems that are designed 
to help them. These psychosocial aspects of survival can be extremely challenging for women 
who are underserved. Survival for many women means adding another disease state to those that 
they are already dealing with. Comorbid issues are not only more challenging to treat for 
survivors but can impede chances of optimum survival. In a cohort study of 906 breast cancer 
patients, Tammemagi and colleagues found a total of 77 comorbid health issues associated with 
decreased survival. In addition, at least one comorbidity was found in 86.0% of the African-
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American patients (n=221) and 64.7% (n=407) of the white patients (Tammemagi, Nerenz; 
Neslund-Dudas; Feldkamp & Nathanson, 2005).  
 Coping with multiple diseases compounds the psychosocial issues that survivors face 
with respect to medication.  For example, Louise is faced with the hardship of inadequate 
resources for acquiring her medication, such as transportation to pick up medications and attend 
appointments to obtain prescriptions. She also faces the burden of juggling the Tenncare 
restriction of five prescriptions when filling her eight medications. Prescription costs are an 
added stress to her situation. In addition to costs are the multiple drug regimens she must follow 
on a daily basis. Checking blood sugar and blood pressure and maintaining proper asthma 
control are difficult problems without the added onus of breast cancer survival. For patients like 
Louise, the cognitive and psychological burdens of breast cancer treatment can impede the 
medical outcome. The patient is often presented with an overwhelming amount of information 
about treatment that he or she is unable to comprehend. 
 The inability to properly understand health information produces a formidable barrier to 
receiving optimum health care (Jeppesen, Coyle & Misser, 2009). Wallace (2006) asserts that 
health literacy needs to be a key demographic variable studied in empirical research. The 
rationale for investigating the link between health literacy and medication adherence is the 
importance of patient understanding when taking medication. Health literacy is a component of 
the cognitive and functional skills needed for adequate medication adherence (Ngoh 2009), and 
patients with inadequate health literacy are more likely to take medications incorrectly (Georges, 
Bolton & Bennett, 2004). Although empirical inroads have been made in the evaluation and 
measurement of health literacy, more research needs to be done in order to ascertain the ability 
of patients to receive and process health information (Chew, Bradley, & Boyko, 2004).   
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 It is necessary to address medication adherence, self-efficacy, and health literacy  with 
the main focus on the patient. For patients like Louise, resources are available to provide 
education, information and means to cope with her survival issues. However, she is not able to 
utilize these resources for several reasons. First, she is faced with transportation issues due to 
lack of physical support from family and friends. This may be due to unwillingness to ask for 
help or a lack of knowledge of available resources. Second, Louise’s lack of understanding about 
her treatments and medication could be improved if she took advantage of the resources that she 
is already aware of. She lacks the confidence to speak up for herself and ask for help. She may 
also be intimidated by the overwhelming amount of information that is presented to her in a 
manner that she cannot understand. Further, she may be at the mercy of a system that functions 
within a model of healthcare that does not consider the person in the environment. 
 It is insufficient to only examine the link between medication adherence, self-efficacy, 
and health literacy. This methodology is reflective of a medical model of health care, which is 
not an inclusive approach (Fang, Machtinger, Wang & Schillinger, 2006). Lindau and colleagues 
find that the resistance to a transition from the medical model to a more collaborative approach is 
twofold: 1) medical and research scientists and healthcare providers continue to utilize a linear 
progressive approach of disease from etiology to health outcome, and 2) research continues to do 
the same (Lindau, Laumann, Levinson & Waite, 2003). The link between health literacy and 
medication adherence needs to be examined within an integrative, biopsychosocial structure, and 
research pertaining to these issues needs to reflect this approach. 
The medical model of healthcare does not incorporate considerations of the psychosocial 
aspects of treatment (Andrist, 1997; Bird & Reiker, 1999). This deficiency is important when 
considering the behavioral aspects of patients and the collective, relational, social systems in 
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which they live. Furthermore, the use of the medical model challenges the social work code of 
ethics concerning social justice (Thyer, Sowers & Dulmas, 2008). A biopsychosocial approach to 
health care encompasses the whole person, thereby recognizing strengths and limitations as well 
as the social and environmental aspects of the patient’s life. 
It is the position of this paper that collaboration and consideration of psychosocial issues 
must include recognition of where the individual is with respect to beliefs regarding health and 
the individual’s self-efficacy to cope. This is a critical component when considering a patient’s 
identification of the need to change behavior, such as adherence to medication, and the 
willingness and ability to do it. Empowerment of an individual to self-determine benefits and 
risks of action or behavior are crucial to change.  
Merely recognizing that a problem exists and having the research to support it may be 
noble and noteworthy, but the problem will remain unless corrective action is taken. Exploring 
the issue of inadequate medication adherence and low health literacy among underserved breast 
cancer survivors will not improve these issues until research ascertains the impact of intervention 
on them. From the perspective of this study, there are three presenting problems that need to be 
addressed. First, there is a gap in research regarding medication adherence, self-efficacy in 
proper medication adherence, and health literacy among underserved breast cancer survivors. 
Second, this population is at risk for inadequate self-efficacy for coping, lower health literacy, 
and improper medication adherence. Gaining access to services and support throughout 
treatment, recovery, and survival is crucial in improving quality of life for breast cancer patients 
and their family systems (Freeman, 2006; Hiatt, et al., 2001; Till, 2003). There is little if any 
research regarding these issues with respect to the impact that the psychosocial environment has 
on self-efficacy. Third, these gaps in research include the lack of use of interventions 
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implemented with the purpose to improve medication adherence and health literacy in this 
population.  
Purpose of the Study 
             The purpose of the study is to contribute to the body of knowledge addressing 
medication adherence, self-efficacy, and health literacy among African American breast cancer 
survivors. The following questions were posed for this study:  
1. What is the level of medication adherence among breast cancer survivors?  
2.  What is the level of self-efficacy in taking medications among African American breast 
cancer survivors?  
3. What is the level of and role of health literacy in medication adherence among African 
American breast cancer survivors?  
4. What impact would skills intervention have on medication adherence, health literacy, and 
self-efficacy among African American breast cancer survivors? 
Objectives  
         There are three primary objectives and two secondary objectives of the study. 
         Primary Objectives: 
         Objective 1:  To evaluate the efficacy of a medication adherence skills intervention alone 
compared to a medication adherence skills intervention in conjunction with a cancer skills 
psychoeducational program in increasing medication adherence for African American breast 
cancer survivors. 
          Objective 2: To evaluate the efficacy of a medication adherence skills intervention alone 
compared to a medication adherence skills intervention in conjunction with a cancer skills 
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psychoeducational program in increasing self-efficacy in medication adherence for African 
American breast cancer survivors. 
            Secondary Objectives: 
            Objective 1: To conduct analyses to determine the role of health literacy in medication 
adherence and self-efficacy. 
            Objective 2: To collect data for future analysis to be conducted on the psychosocial 
factors (e.g. depression, quality of life) impacting medication adherence. 
                
 8 
 
Chapter 2 
Overview of Breast Cancer 
Breast Cancer  Facts and Figures  
Breast cancer is an insidious disease that affects not only those diagnosed but the people 
who are closely connected to them (Davis, 2009). New cases of diagnosed breast cancer are 
increasing at an alarming rate.  Based on breast cancer incidence rates reported to the North 
American Association of Central Cancer Registries (NAACCR, 2009), 192,370 new cases of 
invasive breast cancer and 62,280 new cases of in situ breast cancer in women in the United 
States were projected for 2009 (ACS, 2009; Copeland et al., 2009). Even so, breast cancer is no 
longer a death sentence. Early detection and improvements in treatment have resulted in 
increased survival rates. According to collected U.S. cancer incidence data by the National 
Cancer Institute, approximately 2.4 million women with a history of breast cancer were alive in 
January 2006, and most were determined to be cancer free (ACS, 2007; Horner et al., 2009). As 
a result, the population of breast cancer survivors is growing into a body of women with distinct 
strengths, limitations, and issues that need to be addressed. The following section will look at the 
survival phase of breast cancer. Because breast cancer in men accounts for 1% of cases in the 
United States, it is considered rare among males (ACS, 2009). For the purpose of this 
dissertation, references to breast cancer and breast cancer survival will apply to women. 
Survival Phase of Breast Cancer 
The term survivor carries many meanings and can refer to a patient who is recently 
diagnosed with cancer or one who is in the post treatment phase. Mullan (1985) conceptualized 
cancer as three seasons of experience: diagnosis and treatment (acute stage), remission (extended 
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stage), and permanent or end-of-life stage (Mullan, 1985). The Centers for Disease Control 
(CDC, 2009) consider survivorship to mean the time of diagnosis through remaining years of life 
(DHHS, 2009). The American Cancer Society (2009) asserts that each individual patient has the 
right to his or her personal definition of survivorship. For the purposes of this paper, use of the 
term survivor will be in accordance to the definition of the CDC to include all patients who have 
received a diagnosis of cancer. 
 The survival phase of breast cancer is receiving increased attention in the literature as 
well as the media (Abel & Subramanian, 2008; Davis, 2009; Mayer, 2003).  Earlier detection and 
use of adjuvant therapy have been instrumental in increasing survival rates, but have also created 
a phase of cancer in which the needs of the patient are often neglected. Accordingly, 
psychosocial care and treatment in the post treatment phase of survival need increased attention.  
The conveyor belt of care that begins with a diagnosis of breast cancer and continues through 
treatment often ends abruptly with the last chemotherapy or the final radiation visit or the five-
year checkup where the patient is sent on her way cancer free.  A longitudinal study of 558 
treated breast cancer patients illuminated the fact that although treatments have become more 
sophisticated and patient friendly, quality of care often diminishes or disappears once 
chemotherapy and radiation end (Ganz, et al., 2004). This dilemma is compounded by the 
existing identifiable factors that affect breast cancer survival.  
Factors affecting breast cancer survival. The American Cancer Society reports the 
most recent relative survival rates for women diagnosed with breast cancer as: 89% at five years 
after diagnosis, 82% ten years after diagnosis, and 77% fifteen years after diagnosis (ACS, 
20011). There are several factors that influence the survival rate of breast cancer. Among these 
are  1) stage at diagnosis, 2) age, 3)race/ethnicity, and 4) socioeconomic factors (ACS, 20011). 
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These factors will be discussed below and followed by an examination of underserved breast 
cancer survivors. 
 Stage at diagnosis. Women diagnosed at a more advanced stage and women with larger 
tumor size have lower five-year survival rates (ACS, 20011). When all races are considered, the 
five-year relative survival rate is 98% for localized tumors, 84% for regionalized cancer, and 
23% for distant stage disease (Horner, et al., 2008). When controlling for race in women with 
regionalized disease, the 5-year relative survival rate is 95% for tumors less than or equal to 2.0 
centimeters, 82% for tumors 2.1-5.0 centimeters, and 66% for tumors greater than 5.0 
centimeters (Horner et al., 2008).  
Age. Women who receive a diagnosis of breast cancer before the age of 40 have an 83% 
5-year survival rate, and women diagnosed at age 40 or older have a 90% 5-year survival rate. 
Tumors diagnosed at younger ages tend to be more aggressive and less responsive to treatment 
(Anders et al., 2008; Goldhirsch et al., 2001). In 2006, 250,000 women in the United States 
under the age of 40 were living with a diagnosis of breast cancer (ACS, 2007; Davis, 2009).  
 Race/ethnicity. African American women have a 78% 5-year survival rate compared to 
white women who have a 90% survival rate (Horner et al., 2008). The discrepancy has been 
attributed to delay in detection, which results in more advanced stages of breast cancer at 
diagnosis (ACS, 2009). Aggressive tumor characteristics with poorer prognosis are more 
common in African American women (Carey et al., 2006; Morris & Carey, 2007). African 
American women have the lowest cause-specific survival rate, which is the probability of not 
dying of breast cancer within 5 years of diagnosis, of any ethnic or racial group. This indicates 
that African American women have the highest probability of dying of breast cancer (ACS, 
2009; Horner et al., 2008). In 2007, death rates among African American women were 41% 
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higher than white women even though death rates for African American women had declined 
1.6% annually between 1998 and 2007 (ACS, 2011). A recent study by Christiansen and 
associates (2012) reported that African American patients with nonmetastatic triple negative 
breast cancer had significantly lower 5-year disease free survival and significantly higher 5-year 
recurrence rate (Christiansen et al., 2012) Additionally, while investigating risk factors for 
disparities in breast cancer mortality among African American and Hispanic women in Texas, 
Tian and associates discovered that patients in the studied population with higher poverty status 
were more likely to exhibit significant racial disparities in breast cancer mortality for both racial 
groups (Tien et al., 2012). 
Underserved breast cancer survivors. Lower survival rates of breast cancer are 
associated with lack of health insurance (Halpern, Bian, Ward, Schrag, & Chen, 2007) and lower 
income (Singh, Miller, Hankdy, & Edwards, 2003). Comorbidity, inequality of access to care, 
and treatment disparities between lower and higher income patients and African American and 
white women affect the survival rates of underserved breast cancer survivors (Baquet, Mishra, 
Commiskey, Ellison, & DeShields, 2008; Curtis, Quale, Haggstrom & Smith-Bindman, 2008; 
Newman et al., 2006; Tammemagi et al., 2005; Smedley, Stith & Nelson, 2003).    
Longitudinal analysis of hospital discharge data reveals that minority women insured by 
Medicaid are undertreated for breast cancer (Ayanian, Kohler, Abe & Epstein, 1993). Some 
researchers assert that, regardless of insurance status, medically underserved patients are less 
likely to receive quality medical services throughout the continuum of cancer care (Kressin, 
2005; Smedley et al., 2003). In contrast, federal screening programs report findings through the 
National Breast and Cervical Cancer Early Detection Program that low-income women received 
similar standards of care comparable to that of all women studied (Liu et al., 2005). This 
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discrepancy in results might be attributed to the type of methods used by the studies as well as 
the source of the data. The former studies deals with care post diagnosis and the latter study 
focuses on early detection and screening. 
Adjusting to survival. Adjustment to living with a diagnosis of cancer has been 
described as being burdensome and lengthy, with deterioration of quality of life affecting 
biological processes and health outcomes (Alfano & Rowland, 2006; Anderson, Kiecolt-Glaser, 
& Glaser, 1994). Health related quality of life is an important component of the survival phase of 
breast cancer patients. Surveying nearly one thousand breast cancer survivors allowed Engel and 
colleagues (2003) to report that demographic and clinical factors, such as comorbid conditions, 
body image, education, and physical difficulties, affect quality of life (Engel, et al., 2003). 
Exploratory studies employing patient interviews reveal that post treatment transition into 
survivorship can result in decreased physical functioning (Dow, Ferrell, Leigh, Ly & 
Gulasekaram; 1996; Ganz, et al., 2004; Schag, et al., 1993), mood disturbances, psychosocial 
problems, and poorer quality of life (Cappiello, Cunningham, Knobf, & Erdos, 2007; Dow et al., 
1996 Schag, et al., 1993; Shimozuma, Ganz, Petersen, & Hirji, 1999).  
Multiple interrelated factors can minimize the ability of survivors to lead full and 
complete lives. Treatment of breast cancer survivors needs to be provided in a manner that will 
address the biopsychosocial needs of the patients. Such treatment is difficult if not impossible 
within the medical model of healthcare. The following section will support the premise that 
collaborative care is the most effective framework of treatment for breast cancer survivors. 
Medical Model vs. Collaborative Model in treatment of Breast Cancer Survivors 
  This paper assumes that use of the medical model of healthcare does not adequately 
address the psychosocial needs of patients (Andrist, 1997; Bird & Reiker, 1999). In this section, 
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the medical model will be contrasted with the collaborative approach. This will provide evidence 
that use of the collaborative model in breast cancer treatment provides a biopsychosocial structure 
in which to address health literacy and medication adherence among breast cancer survivors. First, 
the medical model will be defined and examined with respect to its limitations in the treatment of 
breast cancer survivors. This will be followed by an examination of collaborative care, as the 
goodness of fit of this model for treating breast cancer survivors, particularly when addressing 
medication adherence and health literacy.  
Medical Model  
  Definition and overview. The paradigm of practice known as the medical model has been 
the gold standard of healthcare for centuries with little historical competition or empirical 
challenges until recent decades. The medical model of healthcare has been described as an 
individualistic concept of healthcare (Engel, 1977; Weick, 1983), progressing from a recognition 
of symptoms and characterization of etiology to rational, specific treatment (Engel, 1977).  It is a 
method of service delivery and medical care that focuses on the biological causes of disease 
(Gehlert & Browne, 2006).   
Analyses of gender specific treatment and healthcare inequality resulted in the assertion 
that the approach of the medical model treats the biological issues of the patient but does not 
address the psychosocial needs. (Bird & Reiker, 1999; Calnan & Johnson, 1985). This neglect of 
the whole person and the environment in which the person lives limits the ability of the medical 
model to be an effective framework in which to treat patients, particularly breast cancer 
survivors. 
For example, as illustrated in the introduction’s case study, a female breast cancer patient 
is often the primary caretaker of her family. Decisions made concerning her treatment would 
 14 
 
most likely be based on what needs to be done for the entire family system. She would consider 
her economic situation in light of her family responsibilities and engage her social support 
system in her decision-making (Andrist, 1997; Holmes-Rovner & Charles, 2003).  
Limitations of the medical model in the treatment of breast cancer survivors. There 
are several limitations to the use of the medical model in treating breast cancer survivors. First, 
lack of attention to the person-in-environment does not allow providers to address the impact of 
economic barriers, such as healthcare coverage, transportation to appointments and treatment, 
and access to prescriptions (Gehlert & Browne, 2006).  In a controlled trial of multi-site 
community breast cancer screenings of 1599 low income underserved women, findings showed 
that economic considerations such as access to care and availability of insurance are often 
neglected. Results reveal that the strongest predictor of mammogram screening behavior is a 
woman having private health insurance and regular medical services (Hiatt, et al., 2001).  
Second, the disruption of family homeostasis is not addressed within the medical model 
(Andrist, 1997; Gehlert & Browne, 2006). As with Louise, the inability to carry out her role as 
babysitter would affect her grandchildren, her children and their jobs, and her children’s 
employers. There are several additional healthcare issues that could disrupt the family. For 
example, shorter hospital stays have mandated that recuperation from certain surgeries and acute 
medical episodes is conducted in outpatient facilities and at home. These issues may put added 
burden on already unstable home situations (Gehlert & Browne, 2006). In addition, breast cancer 
is a disease that follows a continuum of phases that require particular psychosocial demands and 
developmental tasks for the survivor and the family (Gehlert & Brown, 2006; Rolland, 1994). 
Third, family, social and spiritual support systems are not recognized and utilized within 
the medical model (Doherty & McCubbin, 1985; Gehlert & Browne, 2006; Webb& Koch, 1997).  
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The literature supports the assertion that female breast cancer patients desire the input and 
support of their friends, family, and outside medical resources to make informed decisions 
concerning treatment (Andrist, 1997; Holmes-Rovner & Charles, 2003; Webb & Koch, 1997).  
Fourth, lack of consideration and recognition of the patient as an active participant in the 
decision making process disempowers patients (Andrist, 1997).  Empowerment, as shown 
through qualitative research, enables the patient to have a sense of self-efficacy, encourages the 
ability to take action through informed decisions, and provides a sense of connectedness 
throughout the treatment process (Davis, Darby, Likes & Bell, 2009; Sharf, 1997; Shields, 1995). 
Historically, the medical model has embraced a patriarchal dichotomy of expert doctor to 
subordinate patient with little consideration for the patient and her needs, desires, cultural 
background, and locus of control (Engel, 1977). The medical model of care is lacking in 
providing supportive care for women and their families, especially in the recovery phase of 
treatment (Freeman, 2006). Even so, the medical model has not been stagnant through the years 
but has evolved to become more inclusive in its approach.  
Collaborative Model 
Recognition of the whole person is the primary component of the biopsychosocial 
approach to health care. According to Engel (1977), this approach addresses the biological as 
well as the social, environmental, psychological, and behavioral components of illness and 
disease. Thus, the nonmedical components of health are regarded in conjunction with medical or 
biological components such as physical examinations, laboratory results, and medical tests 
(Gehlert & Browne, 2006). This interactive biopsychosocial model relies on interdisciplinary 
collaboration among medical and social scientists to achieve positive health outcomes (Gehlert & 
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Browne, 2006; Lindau, Laumann, Levinson, & Waite, 2003). This is the theoretical basis for 
collaborative model of healthcare. 
Collaborative care is a team approach to delivering evidence-based care (Hedrick, et al., 
2003) that provides an environment in which healthcare professionals can teach one another and 
share resources (Sorrells-Jones & Weaver, 1999). Meta-analyses of long term collaborative 
treatments reveal that collaborative care is emerging as an effective model of treatment (Gilbody, 
Bower, Fletcher, Richards & Sutton, 2006), providing a structure in which to address the 
psychosocial needs of the patient, improve health outcomes, reduce costs, and increase access to 
available resources and services (Wagner, 2000).  
 Sommers and associates (2000) investigated the effect of a collaborative approach to care 
through an 18-site, controlled cohort study of 543 patients that illustrates the positive financial, 
medical, and psychosocial effects of a collaborative approach to healthcare. The intervention 
groups received care from a team comprised of primary care, nursing, and social work while the 
control groups received usual primary care. The intervention group had significantly lower rates 
of hospitalization (0.36 compared to 0.52), fewer primary care follow-ups (decrease of 1.5 
compared to 0.5), and increased social activity. There was also a cost savings of $90 per patient 
due to the decrease in primary care visits (Gehlert & Browne, 2006; Sommers, Marton, 
Barbaccia, & Randolph, 2000).  
The fields of medicine, pharmacy, social work, and nursing are key components of 
successful collaborative teams (Cott, 1997). These teams may also include physician assistants, 
residents, nurse practitioners, dietitians, psychologists, chaplains, administrators and physical, 
occupational and speech therapists (Gehlert & Browne, 2006). Meta-analysis of empirical 
research as well as individual clinical trials validate the positive aspects of collaborative care in 
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the treatment of mental disorders  (Chang-Quan  et al. 2009; Davies, McBride & Sajatovic,  
2008; Katon, et al., 1999), heart disease (Brush, et al. 2009), critical care (Carr, 2009), and 
diabetes (McElmurray, et al., 2009; Phelps, et al., 2009).  
Collaborative care has evolved to result in three types of healthcare teams. 
Multidisciplinary team members represent separate areas of healthcare that are included in the 
collaboration yet work autonomously with individual disciplinary languages. Team members of 
an interdisciplinary collaboration are more inclusive in that they share their individual 
disciplinary languages and bodies of knowledge.  Finally, transdisciplinary teams develop a 
common shared language based on individual disciplines and compile bodies of knowledge and 
theories to jointly achieve new methods and techniques (Gehlert & Browne, 2006; Zerhouni, 
2003).  
Collaborative care and breast cancer. Helping patients and their families gain access to 
services and support throughout treatment and recovery is crucial in improving quality of life for 
breast cancer patients and their family systems (Freeman, 2006; Hiatt et al., 2001; Till, 2003). 
Medical professionals are often not trained or skilled at identifying or discussing psychosocial 
concerns of cancer patients and often assume these problems are a normal component of the 
cancer experience (APOS, 2000; Fallowfield, Ratclliffe, Jenkins & Saul, 2001). Fallowfield and 
colleagues surveyed 143 physicians to assess their ability to accurately identify cancer patients' 
psychological status. Results revealed low sensitivity, high specificity, and high misclassification 
(Fallowfield et al., 2001). Sollner and associates had similar findings when evaluating the ability 
of eight oncologists to identify psychosocial distress in 298 consecutive patients, where 11 of the 
30 patients who were diagnosed to be severely depressed were positively identified by the 
practitioners (Sollner et al., 2001).   
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A review of patient perceptions and survivor perspectives reflect a lack of provider 
attention to the psychosocial needs of breast cancer survivors. In one recent study, screening of 
150 consecutive cancer patients identified as having major depressive disorder were assessed to 
determine if those patients received evidence-based treatment for depression. Results showed 
that half of the patients had discussed symptoms with the healthcare provider, one-third had been 
prescribed medication and 15% had received evidence-based therapy, which indicates that 
treatment needs for depression were unmet by medical providers (Sharpe et al, 2004). In another 
study, sixty women diagnosed with localized or regional breast cancer were interviewed and 
assessed via telephone to examine the relationship between perception of diagnostic consultation 
and long-term outcomes of psychological adjustment. It was found that physician interpersonal 
skills at the diagnostic consultation were associated with later psychological adjustment (Mager 
& Andrykowski, 2002).  
The medical model’s lack of recognition of psychosocial distress and coping, among 
breast cancer survivors  reflected in the studies above, hinders the treatment, recovery, and 
survival processes of survivors because it hinders patient access to services and supports. The 
collaborative model helps medical professionals to achieve desired outcomes because it offers 
better attention to patient needs than the medical model. The following chapter will discuss 
coping with breast cancer survival among the underserved populations. 
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Chapter 3 
Coping with Breast Cancer Survival Among the Underserved 
Survival phase for the underserved 
As previously mentioned, comorbidity, inequality of access to care and discrepancies in 
treatment affect the survival rates of underserved breast cancer survivors (Baquet et al., 2008; 
Curtis et al., 2008; Newman et al., 2006;  Smedley et al., 2003; Tammemagi et al., 2005). 
According to review studies (Blackman, & Masi, 2006; Dohan & Schrag, 2005), there are 
numerous factors that contribute to health disparities. Among these factors are lower income 
(Singh et al., 2003), lack of health insurance (Aziz & Rowland, 2002; Breen, Kessler & Brown, 
1996; Lannin et al., 1998; Lannin, Mathews, Mitchell, & Swanson, 2002; Wolff et al., 2003) 
irregular source of care (Madnelblatt et al., 1999), low levels of health literacy (Aziz & Rowland, 
2002; Davis, Emerson & Husaini, 2005; Husaini et al., 2001; Wolff et al., 2003), cultural beliefs 
(Lantz, Dupuis,Reding, Krsuska & Lappe, 1994; Lantz & Reding, 1994; Madnelblatt, Gold, & 
O’Malley, 1999; Wolff et al., 2003), and logistic barriers such as transportation, childcare, and 
work schedule (Davis, Emerson & Husaini, 2005; Lannin et al., 1998 Lantz et al., 1994; Rojas et 
al., 1996; Vernon et al., 1992; Wolff et al., 2003).  These factors can affect the ability of 
survivors to navigate the continuum of care, cope with a diagnosis of breast cancer and manage 
their quality of life during survivorship. 
Health related quality of life is an important component of the survival phase of breast 
cancer patients, and increased survival rates have peaked interest in this issue (Ashing-Giwa et 
al., 2004). Biological, psychological, and social issues that often inhibit optimum quality of life 
often mark the transition into the survivorship phase of breast cancer (Kantsiper, et al., 2009). As 
a result, the survivor’s quality of life diminishes. The added burden of navigating a system of 
treatment that is not meeting the needs of the patient on multiple levels can compound feelings of 
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inadequacy in coping and lead to distress (Hewitt, Herdman, & Holland, 2004; O’Hair, et al., 
2003; Rowland, 1990; Rowland, 2006). 
Survival Phase Distress  
It is estimated that one-third of breast cancer patients experience significant distress 
and/or impairment of functioning in their lives (Andrykowski et al., 2002; Coyne, Palmer, 
Shapiro, Thompson, & DeMichele, 2004; Hegel et al., 2006). Literature suggests that a diagnosis 
of cancer has the potential to result in significant psychological distress (Carver et al., 1993; 
Hegel et al., 2006; Hewitt et al., 2006; Michael, Kawaci, Berkman, Holmes, & Colditz, 2000; 
Mitchell, 2007; Sanson-Fisher et al., 2000; Stanton, 2006; Stanton & Snider, 1993; Zabora, 
BrintzenhofeSzoc, Curboe, Hooker & Piantadosi, 2002). Lack of recognition of psychosocial 
distress hinders the treatment, recovery, and survival processes of survivors due to lack of access 
to services and support (Sharpe et al., 2004).   
Distress is also a factor of quality of life. A descriptive study of 294 breast cancer 
survivors that studied quality of life for long term survivors demonstrated that, along with 
positive benefits of hopefulness and life purpose, psychological distress, physical issues and 
uncertainty of the future were reported (Dow et al., 1996). The effect of decline in cognition can 
also have a monumental impact on quality of life (Jansen, 2005; Taillibert et al., 2007). These 
women are often caretakers of children and parents as well as full time workers (Abel & 
Subramanian, 2008; Staat & Segatore, 2005). Because of the multiple roles that these women 
have in their lives, alterations in quality of life affect those around them as well. 
Many studies report that distress is related to a woman’s physical and psychological 
adjustment to breast cancer and that this distress can be detrimental to decision making, 
treatment compliance and outcomes (Allen et al., 2002; Blake-Mortimer, Gore-Felton, 
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Kimerling, Turner-Cobb & Spiegel, 1999; Ganz et al., 1993; Ganz et al., 2004; Graves, 2003; 
Heim, Valach & Schaffner, 1997; McCaul et al.,1999; Patrick-Miller, Broccoli, Much & Levine, 
2004; Schnoll, Harlow, Stolbach & Brandt, 1998; Stanton, 2006; Stanton et al., 2000). The 
decision making process is highly stressful as patients are asked to consider an enormous amount 
of information, learn a new language and make life-changing decisions. Herein lies the potential 
for “information overload” for both the patient and their family, which can set the stage for 
maladaptive coping and communication skills.  
Merely providing information in the diagnostic stage is insufficient. Survivors react 
emotionally to the information and may not be able to fully process what they hear or read 
(Walsh-Burke & Marcusen, 1999; Hewitt, Herdman & Holland, 2004). Poor understanding and 
communication of information between patient and health care providers creates a barrier to 
well-being and increases distress (Blake-Mortimer, Gore-Felton, Kimerling, Turner-Cobb & 
Spiegel, 1999; Foley, 1995; Hewitt, Herdman & Holland, 2004; Lerman et al., 1993; Northouse 
& Northouse, 1987; Stovall, 2006;).   
Evidence suggests that survivors who experience isolation in the early stages of their 
decision making are at higher risk of developing and maintaining poor coping skills and 
experiencing increased distress throughout their cancer experience (Rowland, 1990; Rowland, 
2006). Being able to cope with a diagnosis of breast cancer and the challenges that survival 
brings to a patient is an area of breast cancer care that needs investigation, particularly with 
regard to whether or not particular underserved populations possess the skills necessary to cope. 
Survivor Phase Coping 
Coping with diagnosis, treatment and survival of breast cancer is complicated by feelings 
of vulnerability (Fredette, 1995), depression and anxiety (Karakoyun-Celik et al., 2009). 
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Communication with health professionals and dealing with the diagnosis of breast cancer 
prompts information-seeking behavior as a means of coping (Ransom, Jacobsen et al., 2005). In 
order to investigate methods of coping through communication, Reaby (1998) studied the 
decision making processes of mastectomy patients and reported four coping patterns of decision 
making among participants: vigilance (active searching for information), satisficing (being 
satisfied with first solution), complacency (acceptance without question or full comprehension), 
and defensive avoidance (rationalization and avoidance of discussion) (Reaby, 1998).  
The use of social support is a coping mechanism directly associated with health related 
quality of life (Danhauer et al.,2009; Filazoglu & Griva, 2008).  This method of support can be 
adversely affected by misconceptions and negative cultural beliefs held by the support system 
(Hamilton, Moore, Powe, Agarwal & Martin, 2010). Even so, social support can benefit from 
humor (Johnson, 2002) and spirituality (Ashing-Giwa, 2004; Choumanova, Wanat et al., 2006; 
Fredette, 1995; Johnson, 2002; Morgan et al., 2006) when they are used as coping skills to 
address physical, emotional, and functional stressors of breast cancer. 
Depression and anxiety levels influence the ability of breast cancer survivors to cope with 
diagnosis and treatment and affects quality of life (Karakoyun-Celik et al, 2009). In addition, 
survivors often face an inefficient health care system, which further compromises survivors’ 
abilities to make decisions and understand and weigh treatment recommendations (Hewitt, 
Herdman, & Holland, 2004; O’Hair, et al., 2003; Rowland, 1990; Rowland, 2006). As previously 
mentioned, lacks recognition of patients as an active participant in the decision making process 
disempowers them (Andrist, 1997). Empowerment promotes self-efficacy and the ability to make 
informed decisions (Davis, Darby, Likes & Bell, 2009; Sharf, 1997; Shields, 1995). 
Empowerment allows individuals to manage their lives (Clark & Stovall, 1996; Gray, Doan & 
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Church, 1991; Henderson & Thomas, 1987) and emphasizes the fact that individuals understand 
their own needs and should be engaged in the various aspects of their health care (Clark & 
Stovall, 1996; Clark & Stovall, 2004; Stecher, DeVillis, Becker & Rowenstack, 1986; Walsh-
Burke & Marcusenn, 1999).   
Coping Of African American Survivors 
African American survivors face unique barriers to successful survival such as cultural 
issues revolving around the taboos of discussion of cancer and concerns about access to care 
(Kantsiper, 2009). Coping by African American women has been shown to be affected by 
perceptions and fears of family and friends and the desire to lessen the burden of loved ones. 
These factors can cause women to withdrawal from support due to fear of being ostracized 
(Hamilton et al., 2010). Moore (2001) interviewed 23 African American survivors and found that 
they lacked both social support and understanding of their unique experiences by those around 
them.  Studies with African American survivors have also found a lack of culturally–specific 
resources for social support, appearance, childcare, financial support, and navigation of the 
health care system (Darby, Davis, Likes & Bell, 2009; Davis, Darby, Likes & Bell, 2009; Davis, 
Emerson, & Husaini, 2005; Mosavel and Sanders, 2010). 
Royak-Schaler and colleagues (2008) investigated patient perception of communication 
with providers regarding survivorship care with 39 African American breast cancer survivors. 
Their findings included reported gaps in information provided about diagnosis, treatment, and 
guidelines for follow-up care despite  patient reports of a strong interest in self-care practices and 
the receiving of evidence-based information and guidelines (Royak-Schaler, 2008). Davey and 
colleagues (2010) conducted focus group interviews of nine breast cancer survivors. Their 
findings reveal that patient concerns regarding delivery of care from oncology staff revolved 
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around interaction with physicians, power and authority of physicians, family involvement in 
treatment and navigation of the medical system (Davey, Kissil, Nino & Tubbs, 2010). 
Summary 
Over the last two decades, it has been shown that ongoing assessments are beneficial to 
identify at-risk breast cancer patients as well as promote self-care that maximizes 
biopsychosocial functioning during and after the acute phases of cancer treatment (Bowen et al., 
2007; Ganz, 1995; Ganz et al., 1993; Ganz et al., 1996; Ganz et al., 2004; Ganz, Polinsky, Schag 
& Heinrich, 1989; Ganz, Schag, Polinsky, Heinrich & Flack, 1987; Polinsky, Fred & Ganz, 
1991; Pollack, Greer, Rowland et al., 2007; Zebrack, Yi, Perersen & Ganz, 2007). Although 
research exists regarding the unique barriers that African American women face regarding 
coping with issues of breast cancer survival, there is little information regarding whether or not 
this particular population possesses the skills necessary to cope with these issues. Two areas 
where self-efficacy and coping skills are crucial are health literacy medication adherence.  
 Barriers to accessing health information and inadequate health care can impede proper 
medication usage (Atkins & Fallowfield, 2006; Barber, 2002). Social and environmental barriers 
such as a lack of access to help or inadequate knowledge about where to go to receive help 
contribute to this dilemma. Empowering  breast cancer survivors and their families to gain access 
to services and support throughout treatment and recovery is crucial if quality of life for breast 
cancer patients and their families is to improve (Freeman. 2006; Hiatt et al., 2003; Till, 2001).  
This dissertation posits that methods of empowerment include improving patient understanding 
of the merits of proper medication adherence and providing skills to overcome barriers to 
achieving medication adherence. 
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  Intervention methods that favorably influence psychological and social functioning 
through enhanced coping skills need to be evaluated and incorporated into practice (Burke & 
Kissane, 1998; Clark & Stovall, 2004; Clark & Stovall, 1996; Hewitt, Greenfield & Stovall, 
2006; Hoffman & Stovall, 2006; Stovall, 2006; Stanton & Reed, 2006). It is proposedhat such is 
the case with providing the skills necessary to cope with the burden of proper medication usage 
and adherence, particularly with respect to self-efficacy and level of health literacy.  
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Chapter 4 
Medication Adherence, Self-Efficacy, and the Role of Health Literacy 
Medication Adherence 
Description and overview. Medication adherence, or compliance, is the extent to which 
patients follow the medication regimens prescribed by healthcare providers. Adherence is the 
preferred term because compliance suggests passivity on the part of the patient and a lack of a 
therapeutic alliance between patient and provider (Osterberg & Blaschke, 2005; Steiner & 
Earnest, 2000). A retrospective analysis of insurance claims confirm the earlier findings that 
poor medication adherence is a common problem across most chronic conditions (Their et al., 
2008). Data analysis reveals that poor medication adherence, accounts for 33%-69% of all 
hospital admissions, and improper drug therapy accounts for an estimated cost of over $100 
billion dollars per year (Osterberg, & Blaschke, 2005).  An online survey conducted by Harris 
Interactive and The Boston Consulting Group that queried nearly ten thousand adults with 
chronic medical conditions revealed that prescriptions were not filled or were taken incorrectly 
by respondents due to forgetting (24%), side effects (20%), cost (17%), not thinking the 
medication is needed (14%), and inconvenience (10%) (Boston Consulting Group, 2003). These 
results are corroborated by the empirical findings discussed below. 
Comorbidity and the associated burden of taking multiple medications compound the 
problems of proper medication usage. Recognizing the risk of increased drug related problems 
among patients being treated for cancer, Puts and colleagues (2009) investigated this issue in a 
prospective pilot study of 112 predominately female and newly diagnosed cancer patients 
(breast, colorectal, lung, lymphoma, and myeloma) aged 65 and older. Of the participants 
screened for participation through medical chart review at a Canadian cancer center, 103 (92%) 
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were taking medications. The pharmacy records of 96 patients and self-reports of 12 patients 
provided information regarding active prescribed medication. The 18-item Functional 
Comorbidity Index was administered to the participants to gather information regarding 
additional health issues including arthritis, cardiovascular disease, diabetes, gastrointestinal 
disease, vision and hearing impairment, depression, anxiety, and obesity. The median number of 
medications per patient was 5 (range 3-9). Potential drug-drug and drug-disease problems were 
categorized via computer software, drug monographs, Beers criteria, and published studies. 
Computer analysis revealed a total of 247 potential drug problems. Classifications were based on 
implications to clinical management: level 1 (most severe) – medication should be avoided, level 
2 – medication should be avoided or adjusted to avoid potential problems, and level 3 (least 
severe) – evaluate risk. Moderate to severe drug problems were identified in 49 patients (47.6%). 
Factors associated with having moderate to severe drug problems were taking 5 or more drugs 
and being 76 years of age or older (Puts, et al., 2009). 
In order to explore the effects of a client centered approach to medication usage, 
Chewning and Sleath (1996) examined the literature with regard to client participation in setting 
treatment goals, choosing and evaluating medication regimens, and self care with 
nonprescription medications. Their study of the literature led to the conclusion that these tasks 
should be the shared responsibility of the patient and the provider, which stands in contrast to the 
medical model’s characteristic passive patient and assertive provider paradigm (Chewning & 
Sleath, 1996). If patients are to take an active role in the management of their medications, it is 
imperative that they have an understanding of the information they are given. These findings 
support the use of the collaborative approach to medication management. 
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Collaborative care involving a working relationship between physicians and pharmacists 
has been shown, through chart review of patient outcomes and patient case study, to improve 
patient care and reduce medication errors (Kuo, Buckley, Fitzsimmons, & Steinbauer, 2004). A 
meta-analysis of 37 randomized studies of 12,355 patients diagnosed with depression reported 
that collaborative methods to improve medication adherence were more effective than standard 
care for improving both short and long term outcomes related to depression (Gilbody et al., 
2006). Collaborative care is beneficial in addressing the psychosocial factors that can affect 
medication adherence. The following section provides empirical evidence of such factors.  
Measurement of Medication Adherence. Determination of patient adherence to 
medication regimens is conducted either directly or indirectly. Direct assessment can involve 
direct observation of the patient taking a medication,  blood and urine assays, or drug markers 
(Andrade, Kahler, Frech & Chan, 2005; Farmer, 1999). Indirect methods include patient or 
caregiver self-report through questionnaire, diary or interview, pill counts, electronic monitoring 
devices, pharmacy refill records, and insurance claims (Andrade, Kahler, Frech & Chan, 2005; 
Farmer, 1999; Garber, Nau, Erickson, Aikens, & Lawrence, 2004; Steiner & Prochazka, 1996). 
Although the more sophisticated methods of indirect measure such as electronic records and 
electronic monitoring devices are becoming more available and more trusted, they are often not 
accessible to small studies and small populations (Steiner & Prochazka, 1996). Questionnaires, 
which are the method of measurement for the study, have moderate to high concordance with 
other methods. Garber and colleagues (2004) conducted 86 comparisons of self-report to non-
self electronic reports of assessments and concluded that questionnaires and diary methods are 
preferable to interviews. 
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Factors affecting medication adherence. Research literature asserts that there are two 
types of medication adherence: intentional and unintentional. Intentional non-adherence involves 
a conscious decision not to take medication according to prescribed regimens. This could be due 
to cost, side effects, inconvenience, and/or attitudes and beliefs (Atkins & Fallowfield, 2006; 
Barber, 2002; Delgado, 2000; Pratt et al., 2001). Intentional adherence can result from the 
decision that benefits of medication outweigh risks or side effects (Jacobsen, 2004). 
Unintentional non-adherence may be due to forgetfulness, inability to take medication on time, 
and/or misunderstanding of how to properly take medications (Atkins & Fallowfield, 2006; 
Barber, 2002; Delgado, 2000; Pratt et al., 2001). 
Krousel-Wood and colleagues (2009) assert that the multiple barriers to proper 
medication adherence include complex medication regimens, inconvenience and treatment of 
asymptomatic diseases. This is compounded by the lack of information regarding which patients 
are at greatest risk of non-adherence, which barriers influence low adherence and which 
interventions are best in overcoming these barriers to improve adherence in specific populations 
(Krousel-Wood et al., 2009). The Cohort Study of Medication Adherence in Older Adults was a 
prospective study of 2,194 adults aged 65 and older diagnosed with hypertension. Patient 
psychosocial behavior, quality of life, clinical factors and their effect on medication adherence 
were assessed over a two-year period.  Overall, 14.1% of the participants had low medication 
adherence, and low adherence was more prevalent in patients who were under the age of 75 and 
African American. Additionally, African American participants had a significantly higher 
prevalence of uncontrolled blood pressure compared to Caucasian participants (Krousel-Wood et 
al., 2009).  
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In a qualitative study of 20 African American women diagnosed with hypertension at an 
inner city free clinic, Fongwa and associates (2008) discovered three categories of barriers to 
medication adherence: beliefs about hypertension, facilitators of adherence, and barriers to 
treatment adherence.  Beliefs about the disease were reflected in reported perceptions about what 
hypertension is and the concern that hypertensive medication may be addictive or should only be 
taken with the presence of symptoms.  Among the reported facilitators to treatment adherence 
were changes made by the participant, disease knowledge, adherence self-care, and social 
support. Barriers to adherence included disbelief of having hypertension, medication side effects, 
and environmental factors, such as financial and social issues (Fongwa et al., 2008). Examination 
of these categories emphasizes the biopsychosocial aspects of barriers to and facilitators of 
medication adherence.  
In an effort to measure adherence of antihypertensive therapy and identify factors 
associated with adherence, Hashmi and associates (2007) administered the Morisky Medication 
Adherence Scale (MMAS), a standardized 8-item self report of medication adherence, to 460 
hypertensive Pakistani patients. Over three quarters (77%) of the patients self-reported being 
adherent to their drug regimens, and univariate analysis revealed that increased age, better drug 
awareness and increased number of medications being taken significantly improved adherence. 
Multivariate analysis showed that taking the antihypertensive medication for symptomatic relief 
adversely affected medication adherence. (Hashmi et al., 2007). This study reported the issue of 
taking chronic medication symptomatically, an issue illustrated in the introduction’s case study. 
Improved drug awareness is a factor that implies a higher level of medication knowledge, which 
could be due to higher health literacy, but health literacy was not assessed in this study. 
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 Patient-provider relationships were examined in an assessment of ARV medication 
adherence among 946 HIV-diagnosed patients in Sweden (response rate 97.5%). MMAS was 
administered along with questions about factors potentially affecting adherence. In addition to 
being older and having shorter treatment time, patients classified as adherent (63%) were more 
likely to have a good relationship with their healthcare providers (Sodergard et al., 2006). The 
importance of patient participation in treatment decisions and goals, as well as effective 
patient/provider communication, is reflected in the results of this study. The aspect of duration of 
treatment is a variable not routinely addressed and provides added dimension to this study. 
The extent of non-adherence among 1,137 Scottish healthcare residents was evaluated 
through a 58 item mailed questionnaire, including MMAS, measuring patient self-assessment of 
medication risk, adherence, disability, health beliefs, health experiences, and health behavior. Of 
the 695 respondents, 645 (61.1%, mean age 78.2 years, SD=7.8) reported currently taking 
prescribed drugs. Over one quarter (28.1%) of respondents were non-adherent to their prescribed 
drug regimen. Analysis revealed that risk factors for non-adherence were younger age, confusion 
about the drugs, lack of access to consistent drug supply and administration, treatment interfering 
with lifestyle, and perceived risk outweighing perceived benefits of using medications as 
prescribed (George, Munro, McCaig, & Stewart, 2006). As reported in the study by Gatti et al. 
(2009) younger age was associated with lower adherence. Access to medication and the nuisance 
of taking medication were also reported factors.  
Lopes and colleagues (2008) examined medication adherence among 75 patients 
diagnosed with metabolic syndrome in a Brazilian university setting. A variation of MMAS was 
used to measure adherence, revealing an average level of adherence of 5.44 (SD=0.68) on a scale 
of 1.00 to 6.00. This particular study found no statistically significant association between 
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compliance and the measured independent variables (access to medication, use of medication, 
and level of knowledge of cardiovascular risk factors) (Lopes, Zanini, Casella-Filho & Chagas, 
2008). This study could be a reflection of its university setting, where patient education may be 
heightened. It may also indicate the need for a separate measure of factors affecting adherence. 
Additionally, there may be a cultural factor affecting the high rate of adherence. 
 Patient beliefs about medication adherence to chronic drug therapy were examined 
among participants at an outpatient primary care pharmacy by Phatak & Thomas (2006). MMAS 
was administered to measure adherence and BMQ was given to assess beliefs about medications. 
Bivariate analysis revealed a positive association between adherence and perceiving the 
medications as harmful or as overprescribed by the physician. Patient beliefs about medications 
explained a significant portion of variation in adherence (22.4%) (Phatak & Thomas 2006). Here 
again the patient’s personal psychosocial attributes are decisive factors in intentional adherence. 
 Similar issues as those above were examined by Mardby and colleagues (2007), who 
analyzed the association between medication beliefs and adherence. BMQ and MMAS measures 
were administered to 324 pharmacy clients in Sweden.  BMQ measured perceived harm 
(General-Harm) and perceived benefit (General-Benefit) of medications as well as beliefs about 
whether doctors overprescribed (General-Overuse). Over half of the patients (54%) reported 
being non-adherent. There was an association between General-Harm and adherence. Adherence 
behavior was associated with more beneficial beliefs about medicines and higher education level 
was associated with less harmful beliefs about medicines. Interestingly, users of herbal 
medicines and non-users of medicines were more likely to believe that doctors overprescribed 
(Mardby, Akerlind, & Jorgensen, 2007).  The findings of these two studies (Mardby et al., 2007; 
Phatak & Thomas, 2006) emphasize the importance of optimal patient education. 
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Odegard and Gray (2008) identified several challenges to properly adhering to 
medication among 67 patients diagnosed with diabetes. MMAS and BMQ were administered 
during a randomized controlled collaborative diabetes intervention in a clinic setting. The most 
prevalent challenges found in this study were paying for medications (34%), remembering 
(31%), reading prescription labels (21%), and obtaining refills (21%).  Taking more than two 
daily doses of medication and difficulty reading prescription labels were significantly associated 
with higher hemoglobin A1C, which indicates a poor control of blood sugar. These findings 
indicate a need for attention to patient ability to read and understand medical material such as 
prescription labels (Odegard & Gray, 2008).  The authors noted the implications for 
collaboration between the profession of pharmacy and diabetes healthcare providers and 
educators. Social work could provide important expertise and resources for the healthcare team 
as well. 
Medication adherence in breast cancer patients.  Analysis of the literature did not 
produce much information regarding the investigation of medication adherence among breast 
cancer survivors, including those underserved with comorbid conditions. There was little 
empirical evidence of using a standardized self-report measure to assess medication adherence 
like those used in the studies reviewed above. Even so, analysis of the studies below provides 
beneficial information regarding factors that affect medication adherence among breast cancer 
survivors, including those dealing with comorbid health issues. 
Ridner and Dietrich (2008) studied a convenience sample of 149 breast cancer survivors 
to ascertain whether there was difference in type and number of comorbid conditions in patients 
with and without lymphedema. Analysis of self-report surveys revealed that survivors with 
lymphedema had more comorbid conditions, were older and had lower incomes. No measure of 
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adherence to medication regimen was administered, and patients with comorbid conditions that 
can cause edema of the limbs were excluded from the study. Of the conditions included, 41 
(27%) were taking medications for depression or anxiety, 32 (22%) were taking antihistamines 
or using an inhaler, 29 (19%) were taking anti-inflammatory medications, 51 (34%) were treated 
for cardiac conditions or hypertension, 24 (16%) were treated for cholesterol, 26 (17%) were 
treated for thyroid conditions, and 62 (42%) were treated for osteoporosis (Ridner & Dietrich, 
2008). This study illustrates the complex health and drug issues that breast cancer patients may 
face in addition to the treatments they may undergo for breast cancer. These issues should be 
considered when assessing adherence among this population.  
A study by Atkins and Fallowfield (2006) investigated the prevalence of adherence and 
factors associated with non-adherence among 131 medically stable breast cancer patients in the 
London area. These patients were recruited while waiting for follow-up appointments to assess 
the patients’ preferences for routes of administration of breast cancer drugs. Structured questions 
were asked to assess non-intentional (“how often do you forget to take your tablets?”) and 
intentional (“how often do you choose not to take your tablets?”) adherence to medication. In 
addition, an 18-item questionnaire that measured locus of control was administered to assess the 
patients’ feelings of self-control over their illness. Mean age was 59.4 years (SD = 11.53), and 
52.7% had secondary education or more. Over half (55%) of the patients were non-adherent, and 
83.3% reported this non-adherence as unintentional due to forgetting medication. In contrast, 
16.7% reported the intentional choice of not taking their medication. Evidence suggested that 
intentions for non-adherence were patients’ belief of having significantly less influence over 
their own health (Atkins & Fallowfield, 2006). This study did not indicate that the patients did or 
did not have comorbid health issues that were being treated with medication. However, feeling a 
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lack of control over patient health is a formidable issue to be considered. The psychosocial 
aspect of this dilemma needs to be addressed, as the following study illustrates. 
Adherence to oral adjunctive therapy is a significant issue for breast cancer survivors that 
affects treatment delivery and impairment of health (Ruddy, Mayer, & Partridge, 2009). The 
responsibility of proper administration of medication shifts from the healthcare providers to the 
patient who may experience barriers to adherence such as cost, complex dosing, and lack of 
understanding (Moore, 2010). In order to assess barriers to adherence to oral hormone therapy 
among breast cancer survivors, Kirk and Hudis (2008) posted a 30-item online survey developed 
by a marketing firm on the Y-Me National Breast Cancer Organization website, now known as 
the Breast Cancer Network of Strength (2010), which is a nonprofit organization that provides 
information and support for breast cancer survivors. Surveys were completed from 328 
respondents during a four-month period in 2005. Three-quarters (75.2%) of the respondents were 
ages 41-60. Of those who responded to the questions, 44.2% reported receiving instruction on 
proper adherence. Taking therapy as directed was reported by 83.6%, though 57.4% rated their 
adherence as excellent (missing no doses in the previous month). Factors that were reported to 
increase adherence were management of treatment-related side effects (60.2%) and knowledge of 
the benefit of therapy (88.7%) (Kirk & Hudis, 2008). This study did not address any comorbid 
conditions that the patient may be dealing with or any other factors that may influence 
adherence. 
In order to assess the reasons for non-adherence with the adjuvant therapy tamoxifen, 
Grunfield and associates (2005) administered the 5-item MARS-5 adherence questionnaire, 
BMQ and questionnaires pertaining to its side effects to 110 treated breast cancer survivors.  
MARS- 5 was highly correlated with a single question adherence measure (“In the past week 
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have you taken your tamoxifen every day?”)(r= 0.497, p<0.001). Using the single item measure 
for analysis, 88% were classified as adherers and 12% as non-adherers. The main reason for not 
taking tamoxifen, as reported by 46% of the respondents, was side effects of the drug. It is 
noteworthy that 18% reported forgetting to take the medication. In general, non-adherers 
reported a lower perceived necessity for taking the drug than adherers. The authors mentioned 
implications for education by health professionals regarding the importance of proper adherence 
(Grunfeld, Hunter, Sikka & Mittal, 2005). As in previously reviewed studies, this research was 
conducted without regard to any comorbid issues which the patients may be experiencing.  
Discussion. As shown in the studies above, medication adherence is affected by a myriad 
of factors. Issues such as access to medications, obtaining information about medications, self-
efficacy, stigma, and perceived beliefs about medications and prescribers are a reflection of the 
complex biopsychosocial structure in which patients exist. Although it is difficult to assess these 
subjective factors, attempts at measuring them and assessing the impact on a patient’s ability or 
intent to properly take medications has provided recognition of areas that need to be addressed.  
Although one study analyzed above (Lopes et al., 2008) did not find association between 
adherence and measured variables, the remaining reviewed studies provided information on 
biopsychosocial factors that can impact medication adherence.  Patients age 65 and older are 
more likely to have better adherence (Hashmi et al., 2007; Krousel-Wood et al., 2009; Pratt et al. 
2001; Gatti et al., 2009; George et al., 2006 ). Psychological factors (Diiorio et al., 2009), self-
efficacy (Diiorio et al., 2009; Duong et al., 2001), social support (Duong et al., 2001; Fongwa et 
al., 2008), and socioeconomic issues (Fongwa et al., 2008; George et al., 2006; Odegard & Gray, 
2008) are factors that can impact the ability to adhere to regimens. Race was reported as a 
significant factor in only one study (Krousel-Wood et al., 2009). 
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 Complexity of drug regimens affects adherence (Gatti et al., 2009;  Hashmi et al., 2007;  
Krousel-Wood et al., 2009), as well as knowledge of the medications and the disease states 
(Fongwa et al.; George et al., 2006; 2008; Hashmi et al., 2007;  Kirk & Hudis, 2008), education 
(Mardby et al., 2007), intention to adhere (2001Atkins & Fallowfield, 2006; Pratt et al., 2001), 
remembering to take medication (Atkins & Fallowfield, 2006;  Odegard & Gray, 2008) and the 
ability to read labels (Odegard & Gray, 2008). Treatment of asymptomatic diseases can pose as a 
hindrance to proper medication adherence since the absence of symptoms may lessen the 
perceived need for medication for patients with inadequate knowledge about their disease (Gatti 
et al., 2009; Krousel-Wood et al., 2009). Coupled with a financial need to make medications last 
longer, this type of non-adherence can be detrimental to health. The patient relationship with the 
healthcare provider was reported as a factor in adherence, influencing the acquisition of 
knowledge and the belief of the importance of adherence (Pratt et al., 2001; Phatak & Thomas, 
2006). Patient beliefs about medications regarding side effects (Atkins & Fallowfield, 2006; 
Diioria et al., 2009;  Duong et al., 2001; Fongwa et al., 2008; Gatti et al., 2009; Grunfeld et al., 
2005; Kirk & Hudis 2008) and harm or benefit of their use was reported as a significant barrier 
or facilitator to patient medication adherence (Fongwa et al., 2008; George et al., 2006;  Mardby 
et al., 2007; Phatak & Thomas, 2006;  ). 
Self-Efficacy  
Definition and Overview. Literature reveals that the manner in which a patient adheres 
to a prescribed medication regimen strongly influences health outcomes, health care utilization, 
medication knowledge, self-efficacy, and health care costs (Chewning & Sleath, 1996; Delgado 
2000).  Self-efficacy is based on Bandura’s Social Cognitive Theory, and addresses the personal, 
behavioral, and environmental factors of health and disease (Bandura, 1977; Bandura, 1997; 
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Lorig & Holman, 2003). Self-efficacy is defined as the confidence a person has in his or her 
ability to take action and to successfully perform that action (Markland et al., 2005;Rimer & 
Glanz, 2005). It is the desire and ability to explore, seek to master or seek to adapt to one’s 
environment (Ryan & Deci, 2000; Vansteenkiste & Sheldon, 2006). Self-efficacy is considered a 
primary factor affecting whether or not a person will change a behavior and has become a 
foundation of several behavioral theories (Rimer & Glanz, 2005). Self-efficacy is an essential 
component of assessing medication adherence (Risser, Jacobsen & Kripilani, 2007). 
Self-Efficacy and Locus of Control. Medication adherence is affected by the combined 
influence of self-efficacy and locus of control. Locus of control with respect to health behavior 
refers to the belief that health outcomes are controlled by either personal behavior or external 
factors (Stecher, DeVellis, Becker & Rosenstock, 1986; Wallston & Wallston, 1984). Internal 
locus of control is the belief or perception that one has control over health outcomes, and 
external locus of control is the belief or perception that non-behavioral issues control health 
outcomes. These perceptions or beliefs may be dissimilar to reality (Ajzen, 2002). Rosenstock 
and colleagues  (1988) assert that both expectation of outcome due to internal locus of control 
and expectation of efficacy are necessary for behavior to take place Rosenstock, Strecher & 
Becker, 1988). Figure 1 illustrates the combinations that can occur between locus of control and 
self-efficacy. 
Self-Efficacy Locus of Control        Low    High Internal  External 
 
Figure 1 
Combinations of Self-efficacy and Locus of Control  
(Rosenstock, Strecher & Becker, 1988) 
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Self-Efficacy and Medication Adherence. Duong and colleagues (2001) discovered that 
psychological and behavioral factors are critical in proper medication adherence through a study 
of 149 HIV-infected patients on antiretroviral therapy (ARV). The standardized Patient 
Medication Adherence Questionnaire (PMAQ), a 61 item self-report of ARV usage, was 
administered, and adherence was validated through plasma levels of ARV. Sixteen participants 
(11%) were classified as non-adherent. Analysis of questionnaire responses showed that 
sociodemographic background, social support, confidence in personal skills, and optimistic 
attitude were significantly associated with medication adherence (Duong et al., 2001). The study 
emphasized the fact that psychosocial concerns influence medication usage and that 
improvement of medication adherence is a multidimensional issue that necessitates a nonlinear, 
multidisciplinary approach.  
A study of 260 HIV/AIDS patients by Pratt and colleagues (2001) assessed the 
psychosocial factors affecting adherence to ARV therapy while comparing three self-report 
measures: MMAS, Reported Adherence to Medication (RAM) and Patient Adjustment to 
Medication Scale (PAM). Among the significant associations with low adherence were living 
alone, feeling depressed, media influence and lack of confidence.  Greater adherence was 
associated with positive mental attitude about disease. Analysis revealed intentional non-
adherence and unintentional non-adherence as two constructs (Pratt et al., 2001). The results of 
this study also indicate that when assessing the behavioral aspects of medication adherence the 
intent of the individual towards taking medication properly needs to be included in the 
assessment.  
In a randomized control trial testing of  a psychosocial model of medication adherence, 
baseline data from a questionnaire administered to 236 predominately male African American 
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recruited HIV/AIDS clinic patients were evaluated for personal, social, and provider variables 
(Diiorio et al., 2009). Self-efficacy and depression were directly associated with adherence, 
while stigma and social support were indirectly associated with self-efficacy and depression 
(Diiorio et al., 2009). These findings support the hypothesis that adherence is affected by a 
complex, interconnected psychosocial variables, as corroborated by Krousel-Wood et al. (2009). 
Gatti and associates (2009) administered MMAS, a measure for health literacy 
(REALM), and BMQ to 275 primarily African American patients from an inner city hospital 
pharmacy. The average age of the respondents was 53.9 years, nearly 60% of the respondents 
read at less than high school reading level and over half (52.7%) had low medication adherence. 
Multivariate logistic regression was performed to determine predictors of adherence, patient 
characteristics, and characteristics of drug regimens. Among the factors associated with low 
adherence were negative medication beliefs, age and low self-efficacy. The authors reported that 
patients less than 65 years of age with low medication self-efficacy or negative medication 
beliefs reported low medication adherence (Gatti, Jacobson, Gazmararian, Schmotzer, & 
Kripalani, 2009). These factors emphasize the psychosocial aspect of medication usage.  
Measure of Self-Efficacy in Medication Adherence. There are very few measures 
available for measurement of self-efficacy with respect to medication adherence. A new measure 
of self-efficacy in medication adherence has recently been developed and was selected as a 
measurement for the study. A multidisciplinary team of experts in medication adherence and 
health literacy developed The Self-Efficacy for Appropriate Medication Use (SEAMS). It is 
developed for use in populations with a broad range of literacy. This measure was used to 
conduct an evaluation of psychometric properties with 436 patients with comorbid conditions. 
Results show that SEAMS is both reliable and valid as an effective assessment of medication 
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self-efficacy in chronic disease management in patients with low literacy (Risser, Jacobsen & 
Kripalani, 2007). The SEAMS questionnaire will be discussed further in the methods section of 
this proposal. 
Summary. It has been previously pointed out that medication adherence can be affected 
by multiple interrelated psychosocial factors. Among these factors are Psychological factors 
(Diioria et al., 2009), self-efficacy (Diioria et al., 2009; Duong et al., 2001), social support 
(Duong et al., 2001; Fongwa et al., 2008), and socioeconomic issues (Fongwa et al., 2008; 
George et al., 2006; Odegard & Gray, 2008) . A recent study of 302 adults receiving treatment 
for HIV reported that higher self-efficacy in taking medication was associated with higher 
medication adherence (Colbert et al., 2012). For the purposes of this study, self-efficacy will be 
analyzed and evaluated in conjunction with medication adherence.  
The Role of Health Literacy in Medication Adherence 
Definition and Overview. Health Literacy is defined as “the degree to which individuals 
have the capacity to obtain, process, and understand basic health information and services 
needed to make appropriate health decisions” (USDHHS, 2000, p. 11-20). Results from the 2003 
National Assessment of Adult Literacy revealed that only twelve percent of the American 
population has proficient health literacy, as was measured according to guidelines specified by 
the Nationals Research Council’s Board on Testing and Assessment (BOTA) Committee on 
Performance Levels for Adult Literacy. Those not having healthcare coverage or insured by 
Medicaid or Medicare had lower health literacy (Kutner, M., Greenberg, E., Jin,Y., & Paulsen, 
2006).  
Health literacy is a critical factor in patient-provider communication, positive health 
outcomes, and provision of optimum health care (Jeppesen, Coyle, & Miser, 2009; Williams, 
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Davis, Parker, & Weiss, 2002). Health literacy affects all areas of health. Individuals with low 
health literacy have poorer health (Baker, Parker, Williams, & Clark, 1997; Baker et al., 2002), 
greater stigma or shame (Parikh, Parker, Nurss, Baker & Williams, 1996; Parker, Baker, 
Williams & Nurss, 1995;  Baker et al., 1996), higher rates of hospitalization (Baker et al., 1997; 
Baker, Parker, Williams, & Clark, 1998; Baker et al., 2002; Gordon, Hampson, Capell, & 
Madhok, 2002), and higher healthcare costs  (Friedland, 1998; Howard, Gazmararian, & Parker, 
2005).  
Patients with low health literacy and chronic medical conditions are less likely to 
properly manage their conditions due to decreased knowledge (Kalichman, Ramachandran, & 
Catz, 1999; Kalichman & Rompa, 2000; Schillinger et al., 2002; Schillinger et al., 2003; 
Williams, Baker, Honig, Lee & Nowlan, 1998; Williams, Baker, Parker & Nurss, 1998;), which 
includes lack of knowledge about the proper use of medication  (Gatti et al., 2009; Georges, 
Bolton & Bennett, 2004; Ngoh, 2009).  Edwards and colleagues (2012) assert that health literacy 
skills can be developed over time in patients with long-term conditions and that this skill can 
enable these patents to become more active participants in their healthcare (Edwards, Wood, 
Davies, and Edwards, 2012). The body of literature devoted to the association of measured 
health literacy with medication adherence is small and contains many limitations. The following 
section will address the importance of health literacy in medication adherence. 
Health Literacy and Medication Adherence. Fang and associates (2006) illustrated the 
benefits of a collaborative approach to the treatment of a specific patient population. This study 
administered S-TOFHLA, a modified version of the Test of Functional Health Literacy in 
Adults, to 179 ethnically diverse, low-income clinic patients taking the anticoagulant drug 
warfarin. Limited health literacy was associated with limited knowledge of medication. 
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However, after adjusting for control variables (age, sex, race/ethnicity, education, cognitive 
impairment and years taking warfarin) multivariate logistic regression revealed no significant 
association between limited health literacy and patient-reported missed doses (Fang, Machtinger, 
Wang, & Schillinger, 2006).  This study is representative of a collaborative care model providing 
verbal and written education of the medication as well as follow up meetings at each visit in 
conjunction with regular monitoring of laboratory values of warfarin levels under the supervision 
of a cardiologist. These factors may explain the lack of association between health literacy and 
medication adherence in this study. 
Roth and Ivey (2005) interviewed 100 patients (mean age 77.5, SD=8.7 years) enrolled in 
the North Carolina Eldercare assistance program to determine medication usage and identify 
potential problems. S-TOFHLA was administered and found that adequate health literacy was 
present in only 35% of participants. Results of the 4-item Morisky adherence questionnaire 
revealed non-adherence in 53%.  Poor health literacy, non-adherence and improper use of the 
medications posed several potential problems such as poor health outcomes, increased health 
costs, decrease in physical functioning and poorer quality of life (Roth & Ivey, 2005).  
Persell and associates (2007) explored the relationship between patient identification of 
medication, health literacy and reconciliation between self-report and medication record with 
119 nurse-referred patients diagnosed with hypertension at three primary care clinics in 
Michigan. S-TOFHLA was administered to assess health literacy. Patient responses to questions 
regarding medications were compared to chart records of medications prescribed. Nearly one-
third (31%) of patients had inadequate health literacy and were less able to name their 
antihypertensive medications than those with adequate health literacy (40.5% vs. 68.3%, p= 
0.005), with the difference remaining after adjustment for age and income. Furthermore, 
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agreement between patient report and record report of medication usage was lower for patients 
with inadequate health literacy compared to those with adequate health literacy.  The inadequate 
health literacy group had a higher percentage of African-Americans, persons with lower income 
and persons who had obtained less education. Health literacy was not associated with reported 
number of medications (Persell, Osborn, Richard, Skripkauskas & Wolf, 2007).  .  
 In order to investigate the association of low health literacy with poor glaucoma 
medication adherence, Muir and colleagues (2006) administered surveys, including the REALM 
measure, to 197 patients who were awaiting appointments at a university eye center (Muir et al., 
2006). Medication adherence was measured by contacting pharmacies to determine six-month 
refill history. Of the 163 participants prescribed medication, adherence was assessed with 142 of 
the participants. Over half (52%) of participants scored at a reading level of eighth grade or 
lower and 23 (11.7%) read at third grade level or below. Refill requests were not predicted by 
race, gender, age or education level as determined by linear regression and analysis of variance. 
There was a significant positive relationship between health literacy and the number of refills 
obtained for glaucoma medication (Muir et al., 2006). Among the barriers to proper medication 
adherence was the reported poor understanding of the disease among the participants, which 
indicates a need for proper education of the importance of treatment of glaucoma by the 
healthcare professionals (Muir et al., 2006). Two studies used the same population to address the 
issues of HIV medication adherence, health literacy and confounding factors among 204 patients 
receiving care at multisite infectious disease clinics across the United States (Waite et al., 2008; 
Wolf et al., 2007). REALM was administered as well as Patient Medication Adherence 
Questionnaire (PMAQ), a standardized measure of patient medication usage among HIV 
patients. In addition to medication adherence, PMAQ was used as a measure of self-efficacy and 
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social stigma. Results show that patients with low health literacy were 3.3 times more likely to 
be non-adherent to retroviral medication regimens. Wolf and associates (2007) report that patient 
self-efficacy mediates the impact of low health literacy on improper medication adherence to an 
HIV regimen (Wolf et al., 2007). Additionally, perceived stigma was found to be a mediating 
factor between health literacy and medication adherence, reducing the effect of health literacy by 
40% (Waite et al., 2008).  
In order to examine health literacy with respect to HIV medication adherence, Kalichman 
and associates (2008) conducted a four-month cross sectional study of 145 predominantly 
African American patients who were either referred or volunteered for the study. Health literacy 
was measured through the administration of TOFHLA, and medication adherence was measured 
by unannounced telephone-based pill counts. Medication adherence was poorer in those with 
lower health literacy, and lower health literacy explained variance in medication adherence more 
than years of education, emotional distress, internalized stigma, social support and alcohol use. 
(Kalichman et al., 2008).  
 Reported inadequate health literacy ranges from 31% (Persell et al, 2007) to 65% (Roth 
& Ivey, 2005).  Additionally, there is a statistically significant relationship between health 
literacy and medication adherence (Juzych et al., 2008; Kalichman et al., 2008; Muir et al, 2006, 
Persell et al., 2007; Waite, et al., 2008; Wolf et al., 2007). Patient self-efficacy (Wolf et al., 
2007) and perceived stigma (Waite et al., 2008) are mediating factors between health literacy and 
medication adherence. Further, inadequate health literacy is associated with race, income, and 
education (Juzych et al., 2008; Persell, et al., 2007). 
 A recent review of the literature examined English language articles pertaining to health 
literacy and medication adherence in older adults taking medications for diabetes or 
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cardiovascular illness. Of the 7 studies included in the analysis, one study reported a confirmable 
association between health literacy and medication adherence (Loke et al., 2012). 
Breast cancer survivors are at risk for inadequate healthcare services, lower health 
literacy, and improper medication adherence. There is a gap in research regarding these risk 
factors for this population. Further, empowering survivors to learn how to seek and ask for 
information concerning proper medication usage is an under-researched topic that needs to be 
examined.  
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Chapter 5 
Theoretical Framework 
Theoretical Framework of Dissertation Study 
  As previously mentioned, the medical model of health care is not conducive to meeting 
the unique needs of breast cancer survivors. Pychological distress and socioeconomic issues can 
compound the overwhelming obstacles that breast cancer survivors are expected to overcome. 
One such issue is the management of medication adherence while working within the patient’s 
level of health literacy. Collaboration among health care providers with the patient provides the 
opportunity for social workers and pharmacists to work together on the education of proper 
medication usage, screening for health literacy, providing access to resources and identification 
of barriers to proper medication use. It is important for social workers to be aware of patterns of 
medication adherence, and it is equally important for pharmacists to be cognizant of health 
literacy issues. All those in the chain of providing healthcare, particularly social workers and 
pharmacists, must be aware of the psychosocial barriers that hinder medication adherence. The 
collaborative framework and team approach is the best fit for achieving this outcome. 
 No one theory embodies the ideal conceptual framework in which to examine the 
constructs of knowledge, attitudes and barriers of medication adherence (Wu, 2008). Several 
health behavior change models address the importance of motivation for change and improving 
processes that effect change, as well as recognize the psychosocial roles of self-efficacy, social 
support, decision processes and perception of relevance and susceptibility (Emmons & Rollnick, 
2001). This research was conducted within a collaborative framework and examined issues of 
health literacy and medication adherence with the population of underserved breast cancer 
survivors through the lens of the Health Belief Model. Within this model, the theory of Self-
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Determination was the foundation on which the hypotheses were tested through. The first 
subsection will provide a brief overview of the Health Belief Model (HBM) as it pertains to the 
study. The second subsection will examine Self Determination Theory (SDT) with respect to its 
biopsychosocial aspects and the ways that the theory relates to empowerment and self-efficacy. 
  Health Belief Model. One of the oldest theories of health behavior, HBM was born in 
the 1950’s by the US Public Health Service to explain the lack of population participation in 
programs to detect and prevent disease. Social psychologists theorized that people’s beliefs and 
perceived benefit influenced the readiness to act (Rimer & Glanz, 2005). Through the years the 
model has been expanded to include six constructs: 1) percieved susceptibility, 2) perceived 
severity, 3) perceived benefits, 4) percieved barriers, 5) cues to action, and 6) self-efficacy 
(Rimer & Glanz, 2005). These constructs along with definitions and strategies for change are 
listed in Figure 2 below.  
  The primary focus of HBM is motivation for health. It is a suitable framework for 
examining short and long-term behavior change strategies within the health care fields. This is 
accomplished while keeping in mind the feelings of target populations towards health problems, 
their perceptions of the severity of the problems, and whether their actions can reduce the threat 
of severity (Rimer & Glanz, 2005).  HBM has been the catalyst for studies researching 
medication adherence, predicting patient beliefs concerning their conditions and possible 
outcomes and the impact of beliefs on medication usage (Ownby, 2006). Medication adherence 
within the framework of HBM has been examined in patients with health issues and disease 
states that include mental disorders  (Baloush-Kleinman et al., 2002; Dolder & Lacro, 2004; 
Fenton, Blyler & Heinssen, 1997; Osvath, 2010; Perkins, 1999; Sapra,Vahia, Reyes, Ramirez & 
Cohen, 2008; Zeber, Grazier, Valenstein, Blow & Lantz, 2007), HIV (Cox, 2009;  Ferguson et 
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al., 2002), cardiovascular disease (Garavalia et al., 2009, Jacobsen, 2004), diabetes (Park et al., 
2010), and dementia (Ownby, Hertzog, Crocco, Duara, 2004). 
 
Concept Definition Potential Change Strategies 
Perceived susceptibility Beliefs about the chances of 
getting a condition 
• Define what population(s) are at risk and 
their levels of risk 
• Tailor risk informationn based on an 
individual’s characteristics or behaviors 
• Help the individual develop an accurate 
perception of his or her own risk 
Perceived severity Beliefs about the 
seriousness of a condition 
and its consequences 
• Specifiy the consequences of a condition 
and recommended action 
Perceived benefits Beliefs about the 
effectiveness of taking 
action to reduce risk or 
seriousness 
• Explain how, where, and when to take 
action and what the potential positive 
results will be  
Pereceived barriers Beliefs about the material 
and psychological costs of 
taking action 
• Offer reassurances, incentives, and 
assistance; correct misinformation 
Cues to action Factors that activate 
“readiness to change” 
• Provide “how to” information, promote 
awareness, and employ reminder systems 
Self-efficacy Confidence in one’s ability 
to take action 
• Provide training and guidance in 
performing action 
• Use progressive goal setting 
• Give verbal reinforcement 
• Demonstrate desired behaviors 
 
 
Figure 2 
Constructs of the Health Belief Model (Rimer & Glanz, 2005) 
  HBM and Breast cancer. Despite the limitations of HBM noted by Ashing-Giwa 
(1999), HBM has been used as the theoretical framework with African American breast cancer 
survivors in the evaluation of early detection (Barruso et al., 2000; Douglass, Bartolucci, 
Waterbor & Sirles, 1995 ), mammography (Champion & Scott, 1997; Champion et al., 2008; 
Champion & Springston, 1999; Erwin, Spatz, Stotts, Hollenberg  & Deloney, 1996; Farmer, 
Reddick, D’Agostino & Jackson, 2007; Russell, Champion & Skinner,  2006), self-examination 
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(Champion & Scott, 1997; Erwin et al., 1996; Graham, Liggons & Hypolite, 2002) and beliefs 
and perceptions (Gullate, 2006; McDonald et al., 1999; Sadler, G. R., et al. 2007). 
  Limitations to HBM. As previously mentioned, research of medication adherence 
among breast cancer survivors, particulary the underserved, is extremely limited. Consequently, 
application of the Health Belief Model in this population with reference to medication adherence 
is limited as well. However, in the afformentioned studies, the beliefs and perceptions of the 
populations studied have significant influence on medication usage (Atkins & Fallowfield, 2006; 
Grunfeild, et al., 2005; Kirk & Hudis, 2008; Moore, 2010).  
 As noted by Ferguson and colleagues, HBM may have limitations when addressing the 
adherence issues of people of color and women with respect to psychosocial barriers to 
adherence (Ferguson et al., 2002).  Ashing-Giwa (1999) provides even further insight into the 
limitations that may exist when addressing the unique needs of African American breast cancer 
survivors with respect to mammography screening. Although she agrees that the constructs are 
helpful in explaining influences of screening practices, there are limitations to the model. First, 
perceived barriers may not convey the reality of this population. There is an underlying 
assumption of what the barriers are and these may not be the true barriers. Second, assumptions 
are made about risks and concerns associated with perceived susceptibility and severity that may 
not be applicable to African American women. Many women of this population do not perceive 
themselves to be at risk. Third, the author asserts that assumptions of personal control over 
health status and disease embedded in HBM are inconsistent with the data of the survival of 
African American breast cancer patients. Finally, this population lives in a collective 
environment where percieved personal risk is assessed within the context of group risk (Ashing-
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Giwa, 1999). The following section will examine these limitaitons in light of a modified Health 
Belief Model. 
  Expanded HBM. Expansion of the HBM has provided a more comprehensive 
framework in which to evaluate the subjective and individual factors that influence adherence to 
medication regimens. Sapra and colleagues (2008) employed a modified HBM to examine the 
subjective, clinical and psychosocial factors that were associated with medication adherence 
among 198 community dwelling patients diagnosed with schizophrenia. Their findings revealed 
that lower education, increased medication side effects and higher depression scores were 
associated with higher scores of influence of others (Sapra et al., 2008).  An earlier literature 
review of medication adherence in schizophrenic patients resulted in the description of a 
modified health belief model in which medication related factors as well as social support and 
the quality of  the therapeutic alliance between patient and providers affect adherence and 
offered areas in which to individualize the approach to patient care (Fenton, Byler & Heinssen, 
1997).  
 In his evaluation of adherence of statin medication regimens in cardiac patients, Jacobsen 
(2004) employed the use of a modified HBM that merits consideration for this study. Figure 3 
provides a diagram of this model. The following section will examine this particular modified 
HBM as it applies to the paramaters of the study and will use the case study presented at the 
beginning of the paper  to illustrate its application. 
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LIKELIHOOD OF ADHERING TO TREATMENT RECOMMENDATIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
Modified Health Behavior Model. Adapted from Jacobsen, 2004 
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Application of modified HBM to study.  
  Benefits of treatment. Treatment of asymptomatic diseases is challenging for health care 
professionals. Louise does not have a perceived susceptibility to the adverse consequences to 
improper adherence. She may also be examining the benefits of taking medication for an 
asymptomatic disease if the medication makes her feel worse. Her adherence to tamoxifen, even 
though it produces side effects, may be due to the desire to prevent a recurrance of breast cancer.   
  Risks of illness. As illustrated by the case study, Louise does not comprehend the risk of 
her diabetes and hypertension because the absence of symptoms cause her to percieve a lack of 
severity. She may be dealing with the belief that she is not at risk for the covert symptoms of 
hypertension and diabetes. These issues are compounded by psychosocial issues and her lack of 
use of resources. 
  Costs of treatment. The costs of the medication not covered by Tenncare are treatment 
issues that Louise must take into consideration, as is illustrated by her strategies to make the 
medications last longer. Psychological effects of treatment may be an issue that Louise deals 
with due to the repercussions of prolonged chemotherapy and radiation.  She may be 
experiencing depression and cognitive issues that need to be addressed. Furthermore, Louise is 
coping with the inconvenience of complicated drug regimens. 
  Barriers. Louise experiences several barriers to adequate adherence. Being the primary 
caretaker for two children is challenging, especially for a 58 year-old woman who is enduring the 
challenges of breast cancer treatment and questionably controlled asthma. In addition, she faces 
financial difficulties and cognitive issues with remembering to take the complex medication 
regimen she is required to take. This is further compounded by her lack of adequate health 
literacy to understand the information given her.  
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  Cues to act .The benefits of having a cue such as the pillbox are overshowdowed by the 
barriers that exist in Louise’s life. She has resources available through healthcare providers at the 
pharmacy and the clinic, but her lack of self-determination and her inability to successfully 
communicate with her providers renders these resources useless at the present time. 
 HBM, medication adherence, and health literacy. No one theoretical framework 
encompasses the multiple issues that affect the medication usage of patients. Each person 
presents a unique set of biopsychosocial factors that influence the propensity to adhere or not 
adhere to medication regimens. Even so, HBM provides a goodness of fit for the study. Patient 
beliefs are the most influential set of factors affecting medication adherence (Veazie & Cai, 
2007).  Even so, perceived severity, perceived benefits, recognition of barriers and beliefs of 
outcomes are affected by access to information and the ability to understand it. Davis et al. 
(2002) posit that patients with low health literacy respond to interventions and provision of 
information within the framework of HBM. It is within this framework that precedence is given 
to actions and motivation based on empowerment. Davis further asserts that patients with low 
health literacy desire information that enhances their sense of well being and helps with solving 
immediate health problems (Davis et al., 2002; Doak, Doak & Root, 1996).  
 Motivation to adhere is not always an objective and rational decision. Subjective 
perceptions of risk and benefit often contribute to the decision making process. These individual 
assessments include the perceived social norms, group norms and the consequences and 
acceptability of proposed behavior (Van Dulman et al., 2007). Veazie & Cai (2007) assert that 
patient sense of uniqueness is a moderating factor in individual information processing. This 
belief in oneself contributes to self-determination and the motivation to change behavior. This 
study employed Motivational Interviewing (MI) in the intervention phase  and used Self-
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Determination Theory (SDT) as its theoretical framework. The following section will provide a 
brief overview of SDT as it applies to Motivational Interviewing. 
Motivational Interviewing and Self-Determination Theory   
  Motivational interviewing. Originally developed as a method of treating alcohol 
addiction (Miller, 1983), MI is defined as a “client-cented, directive method for enhancing 
motivation to change by exploring and resolving ambivilance” (Miller & Rollnick, 2002, p. 25). 
There are five main principles of MI: 1) expression of empathy, 2) develop discrepency, 3) avoid 
argumentation, 4) roll with reisitance and 5) support self-efficacy (Miller & Rollnick, 1991). MI 
is developed from a clinical perspective and strives to encourage the patient to be a proactive 
participant in the process of change (Vanseenksite & Sheldon, 2006). It is defined as a style of 
therapy rather than a specific technique ( Miller, 1996). MI was developed without a theoretical 
basis (Britt, Hudson & Blampied, 2004; Hettema, Steele & Miller, 2005; Markland, Ryan, Tobin 
& Rollnick, 2005; Miller & Rose, 2009). There is considerable support for the use of Self-
Determination Theory as a theoretical framework for MI. The following sections will provide a 
brief overview of Self-Determination Theory (SDT) followed by the rationale of applying SDT 
to MI in the study.  
  Self Determination Theory. SDT focuses on the inner resources of the individual for 
personality development , behavioral self-regulation and self-motivation (Markland et al., 2005; 
Ryan, 1995; Ryan & Deci, 2000; Ryan, Kuhl & Deci, 1997). SDT is a broadly based theory of 
human motivation that conceptualizes the general conditions that support or weaken motivation 
(Markland et al., 2005; Vansteenkiste & Sheldon, 2006). Since the theory was developed from 
field and experimental investigations of the effect of external events on intrinsic motivation 
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(Deci & Ryan, 1980; Markland et al., 2005), SDT also recognizes the social and environmental 
factors that contribute to the motivation of an individual (Ryan & Deci, 2000). 
  According to SDT there are three psychological needs – competence, autonomy, and 
relatedness – that are innate and necessary for self-motivation (Markland et al., 2005; Ryan & 
Deci, 2000). First, competence, or self-efficacy, is the desire and ability to explore and seek to 
master or adapt to one’s environment (Ryan & Deci, 2000; Vansteenkiste & Sheldon, 2006), and 
a confidence in one’s ability to carry this out (Markland et al., 2005). Second, autonomy is 
described by Ryan and Dec as regulation by the self (Ryan & Deci, 2006). Autonomy brings 
with it the belief that one has a choice in a situation (Vansteenkiste & Sheldon, 2006). Third, 
relatedness refers to the need to expereince a connectedness to others through satisfying and 
supportive social relationships (Markland et al., 2005). Although autonomy and relatedness may 
appear to be antagonistic to one another, Ryan and Deci (2000) assert that within the framework 
of SDT, autonomy refers to a feeling of volition separate from an independent or dependent 
context.  
  SDT hypothesizes that motivation and behavior can be conceptualized as a continuum of 
autonomy that indicates a person’s endorsement of and commitment to behavior (Markland et 
al., 2005; Ryan & Deci, 2000). Figure 2 illustrates this concept in relation to type of behavior, 
type motivation, and type regulation, and the extrinsic factors that may augment or undermine 
the motivational process (Cook & Fielding, 2010; Ryan & Deci, 2000).  
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__________________________________________________________ 
Behavior             
 
Non-self determined             Self-Determined 
Motivation  None                                        Non-internalized                                          
 
Internalized 
Type motivation          Amotivation  Extrinsic Motivation                        Intrinsic Motivation 
 
Type regulation         Non-regulation       External       Introjected      Identified     Integrated               Intrinsic 
__________________________________________________________ 
Figure 4 
Continuum of autonomy. Adapted from Ryan & Deci (2000) and Cooke and Fielding (2010) 
 
  Amotivation is an unwillingness to comply or behave in a certain way. There is either no 
action or no intent to act . There is no self-determination involved, and there is no external or 
internal regulation (Ryan & Deci, 2000). The only type autonomous motivation that is 
completely internalized is intrinsic motivation. This motivation comes from within a person and 
produces actions and behavior that are done purely for the enjoyment and self-satisfaction of the 
individual (Markland et al., 2005; Ryan & Deci, 2000; Vansteenkiste & Sheldon, 2006). It is 
entirely self-determined and no external factors or regulation affect the motivation or outcome.  
Between these two extremes of the continuum lie four categories of extrinsic motivation where 
external factors - cues, praise, rewards, punishments, threats - either enhance or deter a desired or 
anticipated behavior. The type of extrinsic motivation approaching the fully autonomous intrinsic 
motivation is integrated regulation, where the person has conscious value of the goal or behavior 
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and it is considered in line with personal core beliefs (Markland et al., 2005; Ryan & Deci, 
2000). 
  According to empirical findings (Deci & Ryan, 1985) there are specific behaviors 
associated with autonomy support for engaging in behaviour, which include: 1) developing a 
personally meaningful rationale, 2) minimizing external controls (rewards and punishments, 3) 
providing opportunities for participation and choice, and 4) acknowledging negative feelings 
(Markland et al., 2005). Furthermore, the need for relatedness is imperative for the successful 
internalization of motivation (Deci & Ryan, 2000). To summarize, a feeling of competence does 
not guarantee motivation or engagement  This must occur within a context of self-determination 
in an environment conducive to providing autonomy support and fulfilling the need for 
relatedness and connectedness (Markland et al., 2005). Providing these parameters in an 
encouraging environment that supports the improvement of internalized motivation is a 
foundational aim of MI (Foote, 1999). The following section will discuss the application of SDT 
to MI. 
  Application of SDT to MI. Motivation is not a singular concept but rather a fluid 
paradigm  affected by values, coercion, commitment and fear (Ryan & Deci, 2000). Motivation 
to change is an even more complex phenomenon. Self-determination theory provides a 
theoretical framework  in which to examine the psychological processes of motivational change 
(Foote et al., 1999). Since MI is, by origin and design, atheoretical (Britt et al., 2004;  Hettema et 
al., 2005; Markland et al., 2005; Miller & Rose, 2009), there is a need to determine the best 
theoretical fit for the study. Both SDT and MI have a similar apporach to human nature and 
treatment and possess the common origin of birth from practice (Vansteenkiste & Sheldon, 
2006).  
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  There are several reasons for the “goodness of fit” between theory and practice. First, 
both SDT and MI share the assumption that patients possess the potential for change and a 
natural tendency towards personal development (Markland et al., 2005; Vansteenkist & Sheldon, 
2006). Second, MI and SDT both posit that treatment is not a prescriptive activity in which the 
therapist or counselor directs the process of change. Both regard the change process as 
originating within the patient or client who draws on his or her own motivation (Vansteenkist & 
Sheldon, 2006). Third, SDT and MI advocate an approach to treatment and change that is free of 
content. The focus is on the how, or manner, of the tratment rather than what is actually being 
presented (Vansteenkist & Sheldon, 2006). Thus, there is no set “cookbook” method for goal 
attainment (Markland et al., 2005).  
  MI fulfills SDT’s requirement for satisfaction of needs (Ryan & Deci, 2000), thus 
providing a framework in which the patient is the expert in his or her experience and is heard in a 
facilitative atmosphere where relatedness is promoted, autonomy is vital, and competence is 
encouraged (Markland et al., 2005).  Provision of clear information, helping the patient to expect 
realistic outcomes, and providing positive, non-judgemental feedback support the need for 
competence. Support for autonomy is given through avoidance of confrontation (rolling with 
resistance) and coercion, exploring options and developing discrepency between current 
behavior and desired outcomes in order to choose a course of action. Relatedness is made 
possible in MI through the warmth, interest, and unconditional support provided by the facilitor 
(Markland et al., 2005). Figure 4 illustrates the parallels between the social and environmental 
factors of SDT and the principles of MI.  
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Figure 5 
Self-Determination Theory and Motivational Interviewing. Adapted from Markland et al. (2005) 
Methodology  
  Evidence for MI. Motivational interviewing was developed to treat patients with alcohol 
abuse (Handmaker, Miller & Manicke, 1999; Heather , Rollnick , Bell & Richmond, 1996; 
Miller, 1996; PMRG, 1993; PMRG 1997; Sellman, Sullivan , Dore , Adamson & MacEwan, 
2001) and was later expanded for treatment of chemical depencency (Martino, Carroll, O’Malley 
&  Rounsaville, 2000; Saunders, Wilkinson & Phillips, 1995; Stephens, Roffman & Curtin, 
2000; Stotts, Schmitz, Rhoades & Grabowski, 2001; van Bilsen, 1991; van Bilsen, 1995; ). This 
method of treatment functions on the premise of working through feelings of ambivalance about 
behavior change (Resnicow et al., 2002). MI has since been used to affect change across 
disciplines for treatment of weight control (Woollard et al., 1995), mammography screening 
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(Ludman, Curry, Meyer & Taplin, 1999)  smoking cessation (Emmons, Hammond, Velicer, 
Evans & Monroe, 2001; Rollnick, Butler & Stott, 1997; Valanis et al., 2001;), exercise adherence 
(Harland et al., 1999) and eating disorders (Killick & Allen, 1997; Schmidt & Treasure, 1997; 
Treasusre & Ward, 1997).  
  A meta-analysis of 72 randomized control trials was conducted by Rubak and colleagues 
(2005), examining studies using MI as intervention in the areas of alcohol abuse, psychiatric 
issues, addiction, diabetes, asthma, weight issues and smoking cessation. Their findings revealed 
that MI outperformed traditional interventions aimed at giving advice in approximately 80% of 
the studies. There were no reports of MI causing harm or adverse effects. MI was effective in 
single as well as multiple sessions with encounters as brief as 15 minutes. Limitations of the 
review with respect to the study are threefold. First, there was limited reporting of group 
interventions, which is the format of the study.  The majority of the studies used individual 
interviews (n=68), while three of the studies used group therapy where no effect was shown. 
Second, none of the studies measured medication adherence as an outcome. Third, there was no 
report of interventions conducted by a pharmacist (Rubak, Sanbaek, Lauritzen, &  Christensen, 
2005). 
  Although empirical literature is limited (Possidente, 2005), there is mounting evidence 
that MI is an effective treatment intervention in medication adherence, particularly within the 
areas of  mental illness (Coffey, 1999; Kemp et al., 1998; Reniscow et al., 2002; Swanson , 
Pantalon & Cohen, 1999; Zygmunt et al., 2002), HIV and antiretroviral therapy (DiIorio et al., 
2003; Safren et al., 2001), diabetes (Doherty & Roberts, 2002;), and asthma (Schmaling, Blume 
& Afari, 2001). There were no studies found that specifically dealt with randomization of breast 
cancer survivors with the intent of evaluating medication adherence and health literacy through 
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an intervention based on MI. However, there are reports of randomized control trials (RCT) with 
aspects similar to the study and will be discussed below. 
  Randomized control trials, Motivational Interviewing, and Medication Adherence. 
In order to examine the effectiveness of therapy addressing medication adherence among patients 
diagnosed with psychotic disorders in an acute treatment setting, Kemp and colleagues (1996, 
1998) randomly assigned 74 patients to receive four to six sessions of compliance therapy 
employing techniques of MI or non-specific counseling, tested in two studies, and followed over 
18 months. Booster sessions of both treatments were offerd at 3, 6, and 12 months. Outcome 
measures included observer-rated adherence attitudes to treatment, insight into illness, and social 
functioning. In both studies, patients in the MI group showed significantly greater improvements 
in attitudes to treatement with medication, better insight into their particular illness and increased 
medication adherence compared to participants in group with non-specific counseling (Kemp, 
Hayward, Applewhate, Everitt & David, 1996; Kemp, Kirov, Everitt, Hayward & David, 1998). 
There are, however, some limitations to the study with respect to the study. First, the setting of 
the study limits its generalizability. Second, limiting assessment of  adherence to subjective 
rating by the observer limits the input of the participant. These limitations apply to another  study 
conducted by Hayward and colleagues (1995) in which MI was used with 21 randomly assigned 
hospitalized patients diagnosed with schizophrenia or affective disorder. The intervention group 
(n=10) received two to three sessions of MI. Attitudes toward medications, measured by standard 
questionnaire, were improved in the intervention group, though not statistically significant 
(p=.35) (Hayward, Chan, Kemp, Youle & David, 1995). However, results should be taken with 
caution due to the small sample size. 
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  A review of the literature revealed the use of MI in RCT’s involving populations on 
antiretroviral (ARV) therapy. The complicated nature of these medication regimens lends 
themselves to investigation regarding adherence patterns. DiIorio and colleagues (2003) 
randomly assigned 20 patients on ARV medications to either a control group or an intervention 
consisting of three counseling sessions by a MI-trained nurse. Adherence was measured by two 
standardized questionnaires (UCSF Adherence Questionnarie, The Antiretroviral Adherence 
Scale). Statistical significance was achieved for only one measure of adherence. The majority of 
the intervention group (83%) agreed that discussing motivation, confidence and values regarding 
medication usage was helpful. However, a smaller percentage of the intervention group reported 
being unable to take medications as recommended by their providers (x2=5.13, p=.024) (DiIorio 
et al., 2003). These results should be taken with caution due to the small sample size. 
  DiIorio later conducted a RCT of primarily low-income men and women with HIV in a 
clinic setting in Atlanta (DiIorio, 2008). The intervention group (n=125) received five sessions of 
MI through individual counseling by a nurse. The control group contained 122 participants. 
Medication adherence was assessed using the Medication Event Monitoring System (MEMS) 
from baseline up to 12 months. Patients in the intervention group showed a weak trend of higher 
mean percent of prescribed doses taken and a greater percent of doses taken on schedule. These 
trends were observed beginning at the eighth month of assessment until the final month (DiIorio, 
2008). 
  A study by Samet and colleagues (2005) randomized and assessed 141 HIV-infected 
patients and employed MI techniques to address medication adherence. This multicomponent 
intervention was not associated with change in adherence. The sample also had a history of 
alcohol problems and assessment of alcohol consumption did not reveal any changes both at 
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short and long term follow-up. This led the authors to conclude that high risk populations need to 
have adherence issues addressed with supervised medication delivery or simplified regimens 
(Samet et al., 2005). 
  There are a limited number of studies using MI with a study design similar to this present 
study.  Safren et al. (2001) conducted a study using patients on ARV medicaitions in a 
community setting with 56 HIV-infected patients. Patients were randomly assigned to self-
monitoring (n=26) or Life-Steps (n=30), a one-session intervention combining cognitive-
behavioral and problem solving techniques along with MI. Adherence and depression were 
assessed by questionnaire at baseline, two weeks, and 12 weeks post intervention. Patients in the 
Life-Steps program who presented with adherence problems at baseline showed faster 
improvements in adherence than in the self-monitoring group, and improvement appeared to be 
maintined three months after the intervention. Greater depressed mood accounted for 13% of 
variance in all adherence scores (Safren et al., 2001). 
  Ogedegbe and colleagues (2007, 2008) tested the effectiveness of MI on medication 
adherence among 190 African American participants with uncontrolled hypertension. The 
control group received standard care while the intervention group received standard care plus 
four sessions of MI at three month intervals. Adherence to antihypertensive medication was 
measured via MEMS and Morisky self-report. Secondary measures were changes in blood 
pressure, self-efficacy, and motivation between baseline and 12 months. Results revealed a 
steady maintenance of adherence in the intervention group compared to a significant decline in 
the control group (Ogedegbe et al., 2007; Ogedegbe et al., 2008).  
  In a cluster randomization study of  patients with Type 2 diabetes, intervention 
participants  received  MI through  a one day course with two half day follow ups during the first 
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year (Rubak, Sandbaek, Lauritzen, Borch-Johnsen & Christen, 2011).  Both the intervention and 
control groups received intensive treatment of type 2 diabetes. After the first year, there was 
significant improvement in metabolic status (HbA1c, p<.01) in both groups. In addition, 
medication adherence was close to 100% in both groups. The authors concluded that the results 
were possible due to the physicians’  use of core elements of MI in the control group and lack of 
use of the maximum allowable MI sessions by the intervention groups (Rubak et al., 2011). 
  Lastly, Schmaling and colleagues (2001) conducted a randomized pilot study to examine 
the effect of MI on adherence to asthma medications. In this study, 11 patients received MI (one 
30-60 minute session) plus education and 14 received education alone. Outcome measures were 
questionnaires aimed at assessing readiness to change with regards to asthma treatment, but there 
was no direct measure of medication adherence. Findings revealed that MI and education 
combined was more likely to show stable adherence or an increased level of readiness to adhere 
to medication regimens over time (Schmaling, Blume & Afari, 2001); however, results should be 
taken with caution due to the small sample size. 
Summary  
  The overarching collaborative model of health care upholds the assertion that this study 
must be conducted with the combined efforts of social work and pharmacy. These two 
disciplines provide the complimentary and cohesive expertise to examine medication adherence 
and health literacy from a biopsychosocial perspective. With this perspective in mind, it stands to 
reason that examination of medication ahderence must be conducted with the recognition of 
patient beliefs, self-efficacy, literacy level and perception of barriers. This is accomplished 
through the application of HBM. The HBM framework recognizes that the patient herself is the 
expert of her own situation. Furthermore, use of SDT as the theoretical basis for MI is part of the 
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foundation for the study. Figure 6 provides a visual interpretation of the the theories presented in 
this paper and how each relates and intersects with regard to the study.  
  Although the study contains multiple factors that need to be addressed, the examination 
of each of these factors will provide  information about the charactericstics and needs, of a 
population of overlooked and underserved women who struggle to have their voices heard and 
needs met. 
 
 
 
 
 
 
 
 
 
Figure 6 
Theoretical Framework of  Study 
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Self-Determination Theory 
(Method of Motivational Interviewing in 
Educational Workshop Format) 
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Chapter 6 
Methodology 
Preliminary Study 
 Pre-dissertation investigation of health literacy and medication adherence was conducted 
in June, 2009. This preliminary qualitative research was conducted with underserved African 
American breast cancer survivors who are members of the same population that was used for the 
dissertation study. Two focus groups were conducted for a total of 24 participants. Age range of 
the participants was 30-75, and the time since diagnosis ranged from one to five years. Issues 
involving health literacy, medication adherence, medication side effects, cognitive issues and 
difficulties accessing resources were addressed.  
 Thematic analysis revealed a lack of uniformity in access to medication information, high 
self-reported health literacy among participants and frustration at the inconsistency in medication 
coverage due to individual insurance medication formularies. Participants reported taking 
multiple medications for comorbid diseases, which affected medication understanding and 
adherence. Additional concerns included side effects and complications of medications, lack of 
support from health professionals regarding insurance issues and lack of support following 
completion of acute treatment of breast cancer. Participants also reported cognitive disabilities 
due to chemo brain (Rust & Davis, 2013). Overall, there was a reported lack of clearly defined 
patient-specific psychosocial services provided by social workers and other healthcare 
professionals.  
This preliminary study emphasizes the assertion that a lack of consideration for and 
recognition of the patient as an active participant in the decision making process disempowers 
the patient (Andrist, 1997) and does not utilize the patient’s knowledge of her personal situations 
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(Clark & Stovall, 2004; Walsh-Burke & Marcusenn, 1999; Stecher et al., 1986). This inhibits her 
ability to make informed decisions and reduces her connectedness throughout the treatment 
process (Davis, Darby, Likes & Bell, 2009; Sharf, 1997; Shields, 1995).  
This dissertation was developed based on the information garnered in the preliminary 
study and built on the previous study’s emphasis on empowerment and self-efficacy through the 
utilization of the Health Belief Model and Self-Determination Theory. The following sections 
will describe the research design and methods of the study. 
Objectives and Hypotheses 
Based on the assertions given in addition to the discussion of the literature provided, the 
following study was based on the following objectives and hypotheses: 
Primary Objectives 
Objective 1:  To evaluate the efficacy of a medication adherence skills intervention alone 
compared to a medication adherence skills intervention in conjunction with a cancer skills 
psychoeducational program in increasing medication adherence for underserved African 
American breast cancer survivors. 
Hypothesis 1.1:  Underserved breast cancer survivors provided with cancer survival skills 
training plus medication adherence skills training in a psychoeducational group setting 
will report significantly better medication adherence compared to survivors provided with 
medication adherence skills training only or those receiving no intervention at 4-6 month 
follow-up. 
Hypothesis 1.2:  Underserved breast cancer survivors provided with medication 
adherence skills training only in a psychoeducational group setting will report 
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significantly better medication adherence compared to survivors receiving no 
intervention at 4-6 month follow-up. 
           Objective 2: To evaluate the efficacy of a medication adherence skills intervention alone 
compared to a medication adherence skills training in conjunction with a cancer skills 
psychoeducational program in increasing self-efficacy in medication adherence for underserved 
African American breast cancer survivors. 
Hypothesis 2.1: Underserved breast cancer survivors provided with cancer survival skills 
training plus medication adherence skills training in a psychoeducational group setting 
will report significantly better self-efficacy in medication adherence compared to 
survivors only provided with medication adherence training or those receiving no 
intervention at 4-6 month follow-up. 
Hypothesis 2.2:  Underserved breast cancer survivors provided with medication 
adherence skills training only in a psychoeducational group setting will report 
significantly better self-efficacy in medication adherence compared to survivors receiving 
no intervention at 4-6 month follow-up. 
Secondary Objectives 
Objective 1: To collect data to determine whether there is a relationship between health 
literacy and medication adherence and between health literacy and self-efficacy. 
Objective 2: To collect data for future analysis to be conducted on the psychosocial 
factors (e.g. depression, quality of life) impacting medication adherence. 
Research Design and Methods 
Experimental Design. This pilot study utilized a three-arm, randomized, repeated 
measures, experimental design. The rationale  for implementing  a randomized experiment was 
 70 
 
to utilize the random assignment to control most threats to internal validity.   This  ensured that 
the intervention groups and control group were initially statistically equivalent,   making 
implausible such threats to internal validity as selection bias, providing a basis for valid causal 
inferences. Since the recruited participants were volunteers, there was no random selection of the 
population of breast cancer survivors, which makes inferences about the entire population 
uncertain. Randomization also allows for statistical control of extraneous or spurious variables 
(Rubin & Babbie, 2008). Furthermore, the repeated measures that were collected over a 4-6 
month period allowed for analysis of trends as illustrated by previously cited studies (DiIorio, 
2008; Safren et al., 2003).  IRB approval for this study was obtained from the University of 
Tennessee IRB (See appendix). Figure 7 illustrates the design of the study. 
Research Participants & Study Site. The study sample consisted of an intervention 
group (n=23) of cancer survival skills (CSS) training, which included medication adherence 
skills training, one intervention group (n=24) of medication adherence skill training only (MTM) 
and one control group (n=24) with a total study population of 71 participants. Eligibility 
requirements were that all participants must be 1) female, 2) African-American, 3) underserved, 
4) self-identified as being diagnosed with breast cancer, 5) within 1 year of acute treatment, 6) at 
least 18 years of age and 7) provide written consent (initial or name) to participate. All 
participants were compensated for participation with gift cards from a choice of Wal-Mart or 
Kroger.  
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Figure 7 
Study Design 
 
 Recruitment. Participants were primarily recruited by the staff of the Carin’ and 
Sharin’ Organization in Memphis, Tennessee through events, website, flyers and physician 
referral. Carin’ and Sharin’ is a community-based organization for underserved and minority 
women diagnosed with breast cancer. It provides breast health education, 
supportive services, medical referrals, case management, transportation and 
financial assistance to underserved women diagnosed with breast cancer. Interested participants 
were initially screened by personnel to ensure that all participants met eligibility requirements. 
     Sample 
       N=71 
Intervention 
(group 1) 
N=23 
Control 
(group 3) 
N=24 
Intervention 
(group 2) 
N=24 
 
Underserved Breast Cancer 
Survivors 
 72 
 
       Eligible participants were randomly assigned to either the intervention groups or control 
group. Visits were conducted by staff of Carin’ and Sharin’ to obtain a signed informed consent 
and baseline data. Training was provided to the research staff by Dr. Cindy Davis, and Connie 
Rust, principal investigator for the dissertation study. This training was a one-day workshop in 
Nashville, Tennessee that covered randomization, recruitment, data collection, program 
implementation, and the importance of consistency and continuity throughout the study. 
            Recruitment for the groups was slower and more difficult than anticipated. Additional 
participants for the MTM group were recruited through contacts with the American Cancer 
Society in Knoxville, Tennessee and Chattanooga, Tennessee as a means to ensure equivalency 
in group numbers. Methods of recruitment and randomization remained consistent at these sites. 
Informed consent and baseline data were obtained at these sites either prior to the workshops or 
via home visits. 
 Design of intervention. Upon acceptance, participants were assigned a number in order 
of inclusion into the study. This number corresponded to the number of a specific folder. Due to 
the timing of the project, participants were first recruited and randomized to the CSS group and 
control group and then recruited and randomized to the MTM group and the control group.   
 Group 1 (CSS) received medication adherence skills training following a six-week course 
of cancer survival skills training and Group 2 (MTM) received medication adherence skills 
training only. Group 3 (control) received no intervention (i.e., standard care).  The skills training 
workshops are described below. 
 Intervention Group 1:Cancer Survival Skills Training (CSS): Group 1 first received a 
6-week series of skills workshops conducted via psychoeducational group sessions led by a 
trained oncology social worker and one session on medication adherence skills training led by a 
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licensed pharmacist. The three subgroups (n=23) were conducted consecutively and met weekly 
for seven weeks for two-hour sessions.  These intervention groups were a small group format. 
There were three groups with no more than 10 participants per group. Meals were provided, and 
transportation was provided for those who needed it.  The oncology social work group facilitator 
implemented the Cancer Survival Skills Training adapted from the Cancer Survival Toolbox 
Training Manual (NCCS, 2006). In order to increase consistency in the groups, the same 
oncology social worker conducted all of the skills training sessions.  (See Intervention Protocol 
below) 
 Intervention Group 2: MTM ONLY:  Group 2 received only one session consisting of 
the materials covered in Week 7 on MTM (See Intervention Protocol below). This group was 
also a small group format (four groups) with no more than 9 participants per group. Meals were 
provided, and transportation was provided for those who needed it.  
 The CSS and MTM workshops were facilitated by an oncology social worker. Guest 
speakers provided additional information to the participants. The same speakers were used 
throughout the study to help ensure continuity. MTM workshops conducted in Memphis were 
conducted by Dr. Lawrence Brown, PharmD.. MTM workshops in Knoxville and Chattanooga 
were conducted by Ms. Rust, who is a licensed pharmacist (D.Pharm) and holds her master’s 
degree in social work (MSW). Ms. Rust was assisted by an MSW student in Chattanooga, and 
assumed the dual role of oncology social worker and presenter in Knoxville.    
 Control Group. The control group received standard care as usual with no skills trainings 
during the study. At the end of the study, the control participants received handouts on 
medication adherence and a copy of the Cancer Survivor Toolbox. These handouts were identical 
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to those distributed to the participants of the intervention groups. The control group was not 
denied any standard services during this study.  
Intervention Protocol 
 
Week 1:  Toolbox Session I - Communicating 
1. Welcome and introductions 
2. Information gathering 
3. Introduction to self-advocacy 
4. Introduction to the Cancer Survival Toolbox 
5. Communication skills (e.g, being assertive, using "I" messages, active listening, checking the 
message, and expressing feelings 
6. Exercises 
7. Completing evaluation forms & Closing 
Week 2:  Toolbox Session II - Information Seeking 
1. Welcome and introductions 
2. The importance of information 
3. Finding information 
4. Computer assisted exercises 
5. Completing evaluation forms & Closing 
Week 3:  Toolbox Sessions III - Decision-Making 
1. Welcome and introductions 
2. The importance of decision-making for survivors 
3. Experiential exercises (e.g., identifying decision-making style & weighing the pros & cons) 
4. Completing evaluation forms & Closing 
 75 
 
Week 4:  Toolbox Session IV - Problem-Solving 
1. Welcome and introductions 
2. Introduction to problem-solving 
3. Steps to problem-solving 
4. Managing discouragement 
5. Completing evaluation forms & Closing 
Week 5:  Toolbox Session V - Negotiating 
1. Welcome and introductions 
2. Introduction to negotiating 
3. Negotiation skills 
4. Insurance benefits and employee rights 
5. Completing evaluation forms & Closing 
Week 6:  Toolbox Session VI - Standing Up for Yourself 
1. Welcome and introductions 
2. The importance of standing up for your rights 
3. Exercises 
4. Examples of how survivors have learned to stand up for their rights 
5. Completing evaluation forms & post-test 
Week 7: Medication Adherence Skills Training (MTM) The MTM workshop is described below. 
 Medication Adherence Skills Training (MTM). This workshop consisted of a two-hour 
group workshop conducted by a licensed pharmacist. The pharmacist covered proper medication 
usage, communication skills on how to discuss medication usage with health care professionals, 
and how to overcome barriers to proper medication adherence. Even though the population of the 
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study was restricted to breast cancer survivors, many of the participants were taking medications 
for comorbid diseases. The workshops were designed to address issues that may be encountered 
while taking multiple medications for various acute and chronic conditions.  The rationale for 
providing this type format was to address the issues of health literacy and medication adherence 
within a collaborative framework, increase participant confidence in accessing necessary 
resources for improved medication usage and enhance personal self-efficacy regarding health 
care.   
The MTM workshop was developed based on standardized training materials that focus 
on proper medication usage. The interventions were conducted using the techniques of 
Motivational Interviewing (MI). As previously stated in the literature review, MI is a method of 
enhancing motivation for change through the resolution of ambivalence (Miller & Rollnick, 
2002). Defined as a style of therapy rather than a technique (Miller, 1996), schools of thought 
have differed in regard to use of manual-driven techniques, but emerging literature considers the 
use of MI to be a fluid process that is impeded by employing scripted workshops (Emmons & 
Rollnick, 2001; Hettema, Steele & Miller, 2005). For this reason, the interventions used were not 
a scripted format, although all of the targeted issues were addressed. The interventions followed  
the five main principles of MI: expressing empathy, developing discrepencey, avoiding 
argumentation, rolling with reisitance, and supporting self-efficacy (Miller & Rollnick, 1991).  
The workshops lasted approximately 2 hours and followed the following agenda: 
1. Welcome and introductions 
2. Introduction to medication adherence 
3. Skills to improve adherence and health literacy 
4. Identification to barriers to proper medication usage and adherence 
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5. Exercises 
6. Closing 
Items 3-6 employed elements of the protocol of Life-Steps, a single-session intervention 
utilized by Safren and colleagues (2001) to address adherence issues with HIV medications. This 
intervention used cognitive-behavioral, problem solving and motivational interviewing 
techniques to address issues of adherence (Safren et al., 2001). The following sections will 
examine each of the components: communication with providers, obtaining medications, 
adherence and review.  
Communication with providers. Through techniques of MI, participants were given the 
opportunity to verbalize the opportunities and barriers that exist regarding communication with 
health care providers, particularly pharmacists. The need for the participants to be well-informed 
about their medications through collaboration with providers was stressed. 
Obtaining medications. Access to medications was discussed, including the need to 
inform providers when obtaining medications is difficult. Anticipated barriers to accessing 
medications were addressed, such as transportation to pick up medications, lack of insurance, 
high costs of medications and forgetting to have medications filled or refilled.  
Taking medication, successful adherence, and slips in adherence. Cues for taking 
medication, storage, medication schedules and slips in adherence were addressed. Behavior 
modification strategies (WHO, 2010) were incorporated into the workshops to explore successful 
adherence. These strategies included skill building and reinforcement, organizational skills, self-
management skills, coping with side effects and utilization of social supports and family 
members. Within this strategy, it was important to appeal to the emotional aspect of the 
participants and make them feel empowered to make a difference in their situation (WHO, 2010).  
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Review.  The review portion of the workshop was used as a time for wrapup, questions 
and answers, and a recap of the topics that had been covered. The review also included  
provision of handouts: 1) “Ask Me 3,” a brochure developed to help in communicating with 
health care providers (NPSF, 2011) and 2) “My Medicines,” a personal medication record with 
advice and tips on how to take medication correctly (FDA, 2012).  
Measures. In addition to demographic data, questionnaires were administered to measure 
patient self-efficacy in medication usage, medication adherence and a three question measure for 
health literacy. These measures were given pre-intervention (baseline) and at 4-6 months post 
intervention via face-to-face interviews.  
The Adherence to Refills and Medications Scale (ARMS) is a reliable and valid scale with 
good performance in populations with chronic diseases and low literacy. The measure has high 
internal consistency and high correlation with older standardized measures (Krippalani, Risser, 
Gatti & Jacobson, 2009). (ARMS questionnaire in appendix.) This measure for medication 
adherence is a 12 item, 4 point Likert scale measure with a possible composite score range of 4-
48. Item 12 was reversed scored. Lower scores indicate better medication adherence. Analysis of 
pretest scores revealed high reliability (Cronbach’s alpha = .82).  
The Self-Efficacy for Appropriate Medication Use Scale (SEAMS) is a validated self-
report scale measuring patient confidence in the ability to take medications properly. The 
measure has high internal consistency and strong criterion-related validity (Risser, Jacobson & 
Kripalani, 2007). This measure for self-efficacy is a 13 item, 3 point Likert scale measure with a 
possible composite score range of 3-39. Higher scores indicate better self-efficacy. Analysis of 
pretest scores revealed high reliability (Cronbach’s alpha = .91). 
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The three question measure for health literacy was developed and validated with 
REALM and S-TOFHLA, which are older and longer measures of health literacy (Chew, 
Bradley & Boyko, 2004; Wallace, Rogers, Roskos, Holiday & Wiess, 2006). The shorter, three 
item measure was chosen due to the large number of questionnaires being administered to the 
participants and the fact that it could be given orally if needed.  
In addition to these questionnaires, a post workshop survey questionnaire measure was 
given at the completion of the MTM workshops. This questionnaire provided immediate 
feedback on the day of the workshop regarding the participants’ perception of the intervention. 
The rationale for using this questionnaire was to maintain uniformity among the skills workshop. 
Surveys were administered at the completion of each skills workshop. Each survey was a 4 item 
Likert scale questionnaire. Possible survey responses ranged from 1 (not at all) to 5 (a great 
deal). 
  Additional data was collected on quality of life, depression and positive growth from a 
cancer experience.  However, this data will not be utilized to address the current hypotheses in the 
study.  This data will be utilized in later analyses to address the role of psychosocial factors in 
medication adherence. 
Data collection and data entry   
  Data for baseline and posttest data were collected via face to face interviews with 
participants. Data collection was conducted in Memphis by the same social workers throughout the 
study via home visits. Data in Chattanooga was collected by Ms. Rust and her assistant via home 
visits and on site collection prior to workshops, and data in Knoxville was collected by Ms. Rust in 
the same manner. Upon completion of the posttest data, folders were collected and prepared for 
data entry. A trained research assistant entered all data for all participants, thus allowing for 
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continuity and decreasing the possibility of data entry error. Data was entered into SPSS and data 
analysis was conducted using SPSS. 
 
Timeline 
Table 1 provides the timeline that was followed for the study. 
Table 1 
Timeline of Study 
 
 
 
 
 
 
 
  
Recruitment of participants December, 2010 – October, 2011 
Administration of  pretest questionnaires February, 2011 – March, 2012 
Implementation of intervention April, 2011- March 17, 2012 
Collection of posttest data May, 2011 – July, 2012 
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Chapter  7 
Results 
Statistical analysis 
  Descriptive. Demographic information was analyzed with descriptive statistics. Patient 
response to demographic questions regarding comorbid disease states and medications were 
analyzed according to number of disease states and number of medications. Data on individual 
disease states and individual medications was also collected and will be used for future analyses. 
  ANOVA. Analysis of the study data with respect to the hypotheses was conducted using 
repeated measures analysis of variance (ANOVA). The assumptions for repeated measures of 
ANOVA are that 1) there is a continuous dependent variable, 2) there is approximate normal 
distribution of the dependent variable, 3) sphericity, or the variance of the differences of all 
levels are equal and 4) there is at least one independent variable where participants are tested on 
the same dependent variable at least two times (Laerd Statistics, 2012).  
  These assumptions were problematic but not impossible for a study of such small size. 
Several steps were taken to minimize the problems. The recruiters screened potential participants 
to make sure that they met eligibility criteria. The pharmacists and oncology social workers were 
trained to apply the treatment consistently in each workshop. The rigorous design of this project 
was done to reduce the possibility of outliers in the data, thus increasing the probability of 
satisfying the assumptions.  
  Post hoc data analysis. The three questions in the health literacy questionnaire were 
treated as three individual variables in addition to analyzing the composite score. Repeated 
measures ANOVA were used to analyze the three health literacy questions and group assignment 
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to determine a relationship between interventions and health literacy. The post workshop survey 
was analyzed using frequency measures. 
Descriptive analysis  
Completion status. A total of 71 women began the study. Seventy women participated in 
pretest data collection. Throughout the course of the study 4 participants withdrew for unknown 
reasons, 2 were unable to attend and 3 died. The number of women completing the study was 62.  
Group assignment and completions status. Treatment group 1 (CSS) was assigned 24 
participants, Group 2 (MTM) was assigned 24 participants and Group 3 (Control) was assigned 
23 participants. A total of 62 women completed the study – 18 in the CSS group, 24 in the MTM 
group and 20 in the control group. Of the CSS group, 3 withdrew for unknown reasons, and 3 
were unable to attend. Of the control group, 1 withdrew for unknown reason, and 3 died. The 
table does not reflect attrition in the MTM group. This is due to the fact that all participants 
completed the study except one. She could not be located for the follow-up posttest completion 
and was not included in the study. 
Age and age at diagnosis. The mean age of the participants was 54.14 years of age 
(SD=9.70). The mean age at diagnosis was 51.85 years (SD=9.64). 
Number of people living in household. The mean number of people living in household 
was 2.39 (SD = 1.61). Eighty percent (n=63) had 0 to 3 people living in their household. Eight 
participants (11.3%) had four people, 3 (4.2%) had five, 2 (2.8%) had 7 and 1 participant (1.4%) 
had 8 people living in her household. 
Education. The mean number of years of school completed was 13.44 (SD=2.70). Nine 
(12.7%) of the participants did not finish high school. Over one-third of the participants (36.6%) 
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completed high school, 19 (26.8%) had earned an Associate’s or technical degree, twelve 
(16.9%) a college degree, 3 (4.2%) a masters degree and 1 (1.4%) a doctoral or professional 
degree. 
Employment status. Nearly one quarter (24.3%) of the participants were unemployed. 
Twenty-one (30%) were receiving disability benefits, and 15 (21.4%) were retired. Fourteen 
participants (20%) were working full time, and 3 (4.3%) part time. 
Household monthly income. Over half (61.5%) of the participants reported a monthly 
household income as under $2000 (<$1000-$4999). One quarter (25.7%) reported $2000-$4999, 
and the remaining respondents (12.7%) reported a monthly household income as over $5000.  
Stage of cancer. As per enrollment criteria, all participants were self-reported African 
American breast cancer survivors. Of those who reported their stage of cancer (n=46), nearly one 
quarter (34.8%) of the participants were diagnosed as having Stage 2 breast cancer, 28.3% 
reported having Stage 1, and those having Stages 3 and 4 were both 17.4%  of the participants. 
Medications and comorbidity. The mean number of medication was 3.8 (SD=2.86). 
Reported comorbid diseases were high blood pressure (60%, n=42), heart disease (11.4%, n=8), 
stroke (2.9%, n= 2), diabetes (31.4%, n=22), arthritis (41.4%, n=29), and osteoporosis (8.6%, 
n=6). 
Insurance. Three of the participants (4.3%) had no insurance. Over one-third (40.6%) 
had private insurance. Twenty-five of the participants (36.2%) had TennCare, and 9 (13%) had 
Medicare. 
Table 2 summarizes descriptive analyses of demographic data by group. Table 3 provides 
results of bivariate analyses of demographic data by group. Based on mean values of insurance, 
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employment status, and household monthly income, approximately half of the sample appeared 
to be underserved. 
 
Table  2 
Descriptive Analyses of Demographic Variables by Group 
                        Total           CSS     MTM   Control             
     
N 
 
Mean(SD) 
 
N 
    Mean(SD)  
N 
      
Mean 
    
N 
    Mean(SD)  
p          
Age of 
participant  70 54.14(9.70)  23 53.30(7.64)  24 51.1(9.98)  23 58.2(10.25) .04      
Age at 
diagnosis 
   
66 
 
51.85(9.64) 
   
22 
   
49.95(7.75) 
   
22 
    
48.64(9.60) 
   
22 
     
49.95(7.75) 
 
.01 
Years of 
school 
completed 
70 13.44(2.70  23 12.70(1.80) 24 14.08(2.30)  23 13.52(3.62) .21 
 
Number of 
medications 
56 3.80(2.86) 19 4.21(2.70) 16 3.06(2.74)  21 4.00(3.10) .47 
 
Number of 
children 
    
70 
 
   2.58(2.18) 
 
  23 
     
    2.43(1.80) 
     
  24 
         
    2.17(1.27) 
    
 23 
 
    3.08(3.07) 
 
.34 
        
 
Number  in 
household 
 70 2.39(1.61) 23 2.30(1.49) 24 2.63(1.76) 23 2.22(1.60) .66 
 
Table  3  
Bivariate Analyses of Demographic Variables by Group  
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*3 cells (50.0%) have expected count less than 5 
 Total (n/%) CSS (n/%) MTM  (n/%) Control  (n/%)     x2  
Insurance       .182 
     Private 28(40.6) 5(22.7) 14(58.3) 9(39.1)  
    TennCare 25(36.2) 11(50.0) 6(25.0) 8(34.8)  
    Medicare 9(13.0) 2(9.1) 2(8.3) 5(21.7)  
    None 3(4.3) 2(9.1) 0(0) 1(4.3)  
    Other 3(4.3) 1(4.5) 2(8.3) 0(0)  
    Total* 69(100) 22(31.9) 24(34.8) 23(33.3)  
      
Stage of Cancer     .215 
    1 13(28.3) 3(27.3) 5(26.3) 5(31.2)  
    2 16(34.8) 1(9.1) 10(52.6) 5(31.2)  
    3 8(17.4) 3(27.3) 1(5.3) 4(25.0)  
    4 8(17.4) 3(27.3) 31(15.8) 2(12.5)  
    5 1(2.2) 1(9.1) 0(0.0) 0(0.0)  
Total 46(100) 11(23.9) 19(41.3) 16(34.8)  
      
Marital Status     .304 
    Married 27(38.6) 9(39.1) 12(50.0) 6(26.1)  
    Divorced 15(21.4) 3(13) 4(16.7) 8(34.8)  
    Widowed 8(11.4) 2(8.7) 2(8.3) 4(17.4)  
    Single 19(27.1) 9(39.1) 5(20.8) 5(21.7)  
    Other 1(1.4) 0(0) 1(4.2) 0(0)  
    Total 70(100) 23(32.9) 24(34.3) 23(32.9)  
      
Employment      .183 
    Unemployed 17(24.3) 9(39.1) 4(16.7) 4(17.4)  
    Disability 21(30.0) 8(34.8) 9(37.5) 4(17.4)  
    Retired 15(21.4) 2(8.7) 7(29.2) 6(26.1)  
    Part time 3(4.3) 1(4.3) 1(4.2) 1(4.3)  
    Full time 14(20.0) 3(13.0) 3(12.5) 8(34.8)  
    Total 70(100) 23(32.9) 24(34.3) 23(32.9)  
      
Household 
monthly income 
    .235 
<$1000 13(18.6) 6(26.1) 2(8.3) 5(21.7)  
$1000-1499 14(20.0) 2(8.7) 5(20.8) 7(30.4)  
$1500-1999 16(22.9) 8(34.8) 5(20.8) 3(13.0)  
$2000-4999 18(25.7) 6(26.1) 8(33.3) 4(17.4)  
>$5000 9(12.9) 1(4.3) 4(16.7) 4(17.4)  
Total 70(100) 23(32.9) 24(34.3) 23(32.9)  
      
Comorbidity      
Blood pressure 42(60.0) 13 (56.5)       14 (58.3) 15(65.2) .82 
Heart disease 8(11.4)    1(4.3)          3(12.5) 4(17.4) .37* 
Stroke 2(2.9)    1(4.3)          0(0) 1(4.3) .58* 
Diabetes 22(31.4) 10 (43.5 )          2 (8.3) 10 (43.5) .01 
Arthritis 29(41.4)  11(47.8)          8 (33.3) 10 (43.5)           .58 
Osteoporosis 6(8.6)    3(13.0)          0(0)      3(13.0) .18* 
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Comparative analyses of demographic data by group. Demographic variables were 
analyzed by group assignment to determine the success of randomization. 
ANOVA. ANOVA was conducted to determine differences among demographic data 
between groups. Analysis showed significant main effects in age (p=.036, F=3.50, df = 2) and 
age at diagnosis (p=.00, F= 5.37, df=2). Post hoc Bonferroni tests showed significant variance in 
age between the control group and MTM groups, with the mean age of the MTM group (51.1 
years) being younger than the control (58.2 years) (p=.04). There was significant variance for 
age at diagnosis between the CSS group (50.0 years) and the control group (57.0 years) (p=.04), 
and the MTM group (48.6 years) and the control group (p=.01). Levene’s test showed no 
significant variance between groups with respect to all of the variables except for number of 
years of school completed. Analysis showed no significant difference between the groups with 
respect to number of people living in the household, years of school completed and number of 
medications taken (p>.05).  Table 2 above summarizes the findings. 
Chi-square. Chi-square analyses were conducted between groups with respect to 
insurance, stage of cancer, marital status, employment and household monthly income. The 
analyses failed to indicate a significant difference for all of the variables. The sample size was 
not large enough to meet an expected cell frequency of five. Chi square tests were performed to 
determine if the indicated variables were distributed differently with respect to group 
assignment.  
Additional analyses were conducted between groups with respect to comorbidity (high 
blood pressure, heart disease, stroke, diabetes, arthritis and osteoporosis). The test failed to 
indicate a significant difference for all of the variables except for one. Patients with comorbid 
diabetes showed significant difference by group (x2=9.04, p=.01). Crosstab analysis showed that 
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8.3% of the MTM group (n=2) were diagnosed with diabetes while 43.5% (n=10) of the CSS and 
control groups were diagnosed.  Table 3 above summarizes the findings. Participants with a 
diagnosis of the comorbid disease are presented (n and percent of within group). Variables with 
cells having an expected count less than 5 are identified. 
Analysis of Dependent Variables by Group Assignment. ARMS and SEAMS. Pretest 
means of composite scores of the dependent variables (ARMS and SEAMS) were analyzed by 
group assignment. Baseline scores revealed no significance difference in mean scores for the 
ARMS or SEAMS among the CSS, MTM, and CSS groups. Table 4 summarizes these findings.  
Table 4 
ANOVA analysis of ARMS and SEAMS scores by Group assignment 
 CSS (n) MTM(n) Control(n)  p 
ARMS1  15.74(23) 17.75(24) 18.67(24) .08 
SEAMS1 32.83(23) 30.42(24) 32.67(24) .30 
 
Testing of Hypotheses 
 Hypotheses 1.1 and 1.2  
Hypothesis 1.1:  Breast cancer survivors provided with cancer survival skills training 
plus medication adherence skills training in a psychoeducational group setting will report 
significantly better medication adherence compared to survivors provided with medication 
adherence skills training  only or those receiving no intervention at 4-6 month follow-up. 
Hypothesis 1.2:  Breast cancer survivors provided with medication adherence skills 
training only in a psychoeducational group setting will report significantly better medication 
adherence compared to survivors receiving no intervention at 4-6 month follow-up. 
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Results. Hypotheses 1.1 and 1.2 were tested using the ARMS questionnaire as the 
repeated measure dependent variable. Question 12 was reverse scored and the total composite 
score for the ARMS questionnaire was used in the data analysis. Reapeated measures ANOVA 
showed that there was no statistically significant difference within groups. Consequently, no 
analysis between groups was warranted. Results are summarized in Table 5 and Figure 8. 
Table  5 
Repeated Measures of ANOVA Test of Within-Group Effects of ARMS  
SS  df  F  p 
______________________________________________________________________________
  
Time    13.87  1  2.18  .15 
Time x Intervention   4.67  2   2.33  .70 
_____________________________________________________________________________ 
   
 
 
 
 
 
Figure 8  
Estimated Marginal Means of ARMS 
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            Hypothesis 2.1:  Breast cancer survivors provided with cancer survival skills training 
plus medication adherence skills training in a psychoeducational group setting will report 
significantly better self-efficacy in medication adherence compared to survivors provided with 
medication adherence skills training only or those receiving no intervention at 4-6 month follow-
up. 
           Hypothesis 2.2:  Breast cancer survivors provided with medication adherence skills 
training only in a psychoeducational group setting will report significantly better self-efficacy in 
medication adherence compared to survivors receiving no intervention at 4-6 month follow-up. 
 Results. Hypotheses 2.1 and 2.2 were tested using the SEAMS questionnaire as the 
repeated measure dependent variable. Total score for the SEAMS questionnaire was used in the 
data analysis. Reapeated measures ANOVA showed that there was no statistically significant 
difference within groups. Consequently, no analysis between groups was warranted. Results are 
reported in Table 6 and Figure 9. 
Table 6 
Repeated Measures of ANOVA Test of Within-Group Effects of SEAMS  
SS  df  F   p 
______________________________________________________________________________ 
Time      5.75  1  .22  .64 
Time x Intervention  18.19  2  .34  .71 
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Figure 9 
Estimated Marginal Means of SEAMS 
Post-hoc analyses 
Health literacy 
The questions of the 3 question health literacy questionnaire were analyzed individually 
and collectively using repeated measures ANOVA. There was no statistically significant 
outcome within any of the three groups for each of the questions analyzed or for the composite 
score (Qtot). Consequently, no analysis between groups was warranted. Table 7 and Figures 10-
13 summarize the findings. 
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Table 7 
Repeated Measures of ANOVA Test of Within-Group Effects of Health Literacy Questionnaire 
SS  df  F  p  
______________________________________________________________________________ 
Q1 Time    .96  1  1.92  .17  
       Time x Intervention  .09  2    .09  .91 
Q2 Time    .05  1    .05  .82  
       Time x Intervention  1.39  2    .76  .47 
Q3 Time    1.41  1  1.49  .23  
      Time x Intervention  1.19  2    .63  .54  
Total Time    3.80  1  1.71  .20   
       Time x Intervention  4.23  2    .95  .39 
Q1: How often do you have problems learning about  your medical condition because of 
difficulty understanding written informaion? 
Q2: How often do you have someone help you read hospital materials? 
Q3: How confident are you filling out medical forms by yourself? 
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Figure 10 
Question 1 
 
 
 
 93 
 
 
 
Figure 11 
Question 2 
 
 
Figure 12 
Question 3 
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Figure 13 
3 Question Composite 
 
 
Analysis of treatment groups. Treatment groups 1 and 2 (CSS + MTM) were treated as 
one group to determine if any type of intervention had an effect on medication adherence and 
self-efficacy. Analyses were conducted using independent samples t-test. The changes in pre and 
post test scores for medication adherence and self-efficacy were computed and compared by 
treatment and control groups. There was a no significant change found between the two groups 
for either medication adherence or self-efficacy. Tables 8 and 9 summarize the findings. 
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Table 8 
Comparison of change in ARMS scores in treatment group and control 
 N Mean SD p 
Treatment (CSS+MTM) 42  .45 3.74 .61 
Control 19 1.05 3.08  
 
Table 9.  
Comparison of change in SEAMS scores in treatment group and control 
 N Mean SD p 
Treatment (CSS+MTM) 42 -1.00 8.05 .42 
Control 19  .63 4.82  
 
 
Analysis of medication adherence, self-efficacy, and demographic variables. 
Bivariate correlations were used to analyze the effect of demographic variables that may affect 
either medication adherence or self-efficacy post intervention. The variables tested were 1) age 
of participant 2) age at diagnosis, 3) number of children, 4) number of people living in 
household, 5) years of school completed and 6) number of medications. The dependent variables 
tested were the ARMS composite posttest and the SEAMS composite posttest. Results showed a 
significant, weak negative correlation between medication adherence and age (r = -.25), and a 
significant, weak relationship between medication adherence and number of people living in 
household (r=.26). There was a significant, positive correlation between age and self-efficacy 
(r=.34), and age at diagnosis and self-efficacy (r=.29). In addition, there was a weak, negative 
 96 
 
relationship between number of people in household and self-efficacy (r=.26). Tables 10 and 11 
summarize the findings. 
Table 10  
Bivariate Correlations of Medication Adherence and Demographic Variables 
         r         p  
Age of participant      -.25          .05  
Age at diagnosis      -.24        .07  
Number of Children      -.12       .36  
Number of people living in household        .26       .04  
Number of medications      -.01                                .96  
Number  years of school completed                         -.01                       .96  
 
Table 11 
Bivariate Correlations of Self-Efficacy and Demographic Variables 
 r  p  
Age of participant .34  .01  
Age at diagnosis .29 .     .03  
Number of Children              .01  .95  
Number of people living in household -.26  .04  
Number of medications .17  .25  
Number  years of school completed .04  .76  
 
Variables showing a significant correlation were analyzed individually using regression 
analysis. Regression analysis indicated a significant, negative relationship between age and 
medication adherence (B=-.11, p=.05) and a positive relationship between number of people 
living in household and medication adherence (B=.64, p=.04). There was a significant positive 
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relationship between age and self-efficacy (B=.20, p=.01), age at diagnosis and self-efficacy 
(B=.17, p=.03), and a significant negative relationship between number of people living in 
household and self-efficacy (B=-.88, p=.04). Tables 12 and 13 summarize the findings. 
Table  12 
Regression Analysis: Medication Adherence, Age, and Number of People Living in Household 
 F R R2   B p 
Age 
Number of people living in household 
3.96 
4.19 
.25 
.26 
.06 
.07 
  -.11 
    .64 
.05 
.04 
 
Table 13 
Regression Analysis: Self-Efficacy, Age, Age at Diagnosis, and Number of People Living in 
Household 
 F R R2   B p 
Age 
Age at diagnosis 
Number of people living in household 
7.45 
4.91 
4.33 
.34 
.29 
.26 
.11 
.08 
.07 
.20 
.17 
-.88 
.01 
.03 
.04 
 
Analyses of post workshop surveys.  Descriptive analyses were conducted comparing 
the means of the composite scores of the post workshop surveys. The range for composite scores 
for all surveys was 5-20. Table 14 summarizes the mean scores of the individual questions asked 
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on the MTM post workshop survey. Results indicated favorable responses for all four questions. 
Table 15 provides mean response scores for question four (“Has this training session been 
helpful to you?”) of all seven post workshop surveys. Results are summarized in Table 14. 
Scores indicate favorable responses for all workshops. 
Table 14 
Descriptive Summary of MTM Post Workshop Survey 
           
N 
        
Min   Max 
     
Mean 
           
SD 
 
Has your confidence about your ability to gain 
information about your medications increased? 
 
40 
 
3 
 
5 
 
4.70 
           
.61 
 
Has your understanding of the importance of 
following medication directions increased? 
 
    40 
 
3 
 
5 
 
4.85 
                  
.43 
 
Has your confidence in taking your medications 
increased? 
 
40 
 
3 
 
5 
 
4.55 
             
.75 
 
Has this training session been helpful to you? 40 4 5 4.95  .22  
Total 40 15 20 19.05   1.47  
 
Table 15 
 Descriptive Summary of Post Workshop Surveys Question Four Scores  
 N Mean SD 
Session 1: Communication 15 4.87 .35 
Session 2: Finding Information  14 5.00 .00 
Session 3: Making Decisions 16 4.94 .25 
Session 4: Problem Solving 8 5.00 .00 
Session 5: Negotiating 7 4.86 .38 
Session 6: Standing up for your Rights 15 5.00 .00 
Session 7: Medication Adherence 40 4.95 .22 
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Chapter 8 
Discussion  
Analysis of Findings.  
Testing of Hypotheses. Results of analyses testing hypotheses revealed that the null 
hypotheses of objective one and objective two of the study could not be rejected. The study 
could not confirm that cancer skills training plus medication adherence testing nor medication 
adherence skills training alone had a positive effect on medication adherence or self-efficacy. 
Even so, results support previous research that higher self-efficacy is associated with higher 
medication adherence (Colbert et al., 2012). Ad hoc testing of health literacy did not show a 
statistically significant association between health literacy and medication adherence or self-
efficacy.  
It needs to be noted that baseline scores for both the ARMS and the SEAMS were high, 
which may have influenced the lack of significance. High pretest scores indicate initially high 
medication adherence and self-efficacy, which makes significant improvement difficult to attain. 
Possible explanations for high pretest scores are discussed in the limitations section of this 
chapter. 
Ad hoc Testing 
Additional ad hoc testing using regression analysis indicated significant relationships 
between medication adherence, age, and number of people living in household, and self-efficacy, 
age, age at diagnosis, and number of people living in household. These findings support the 
theory that women, particularly African American women, are often the primary caretakers of 
the family system (Abel & Subramanian, 2008; Staat & Segatore, 2005). They are also members 
of a population that lives in a collective environment where perceived personal risk is assessed 
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within the context of group risk (Ashing-Giwa, 1999). Having the added burden of taking care of 
themselves and additional family members may cause the patient to feel overwhelmed, distressed 
and disempowered (Darby, Davis, Likes & Bell, 2009; Davis, Darby, Likes & Bell, 2009; Davis, 
Emerson, & Husaini, 2005; Hamilton, et al., 2010; Mosavel and Sanders, 2010, Sharf, 1997; 
Shields, 1995).  
Competence and self-determination must occur in an environment conducive to providing 
autonomy support while fulfilling the need for relatedness and connectedness (Markland et al., 
2005).  Self-efficacy is an essential component of assessing medication adherence (Risser, 
Jacobsen & Kripilani, 2007). Having additional members of the household may directly 
influence both the internal and external locus of control of the breast cancer survivor (Ajzen, 
2002, Rosenstock, Strecher & Becker, 1988, Strecher, DeVellis, Becker & Rosenstock, 1986; 
Wallston & Wallston, 1984). 
             Post workshop survey. Analysis of the post workshop surveys revealed that means of the 
composite scores ranged from 18.33 to 19.33, indicating a positive response to the skills 
workshops. This corroborates research that discussion of medication usage is helpful (DiIorio et 
al., 2003). It also supports the literature regarding the importance of providing health information 
in a format that is easily accessible and communicated in an understandable fashion (Atkins & 
Fallowfield, 2006; Barber, 2002; Chew, Bradley, & Boyko, 2004; Ransom, Jacobsen et al., 2005; 
Davey, 2010; Jeppesen, Coyle & Misser, 2009; Royak-Schaler, 2008).   
Limitations 
Recruitment and Randomization. The participants of the study were randomized, and 
analysis of demographic data reflected this. However, methods of recruitment may have skewed 
the sample.  
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 Eligibility Criteria. Participants were eligible only within one year of treatment for 
breast cancer. This may have also skewed the data since the participants had recently been under 
the care of health care professionals for an extended period of time.  
 Sample. Recruitment for the study was challenging due to the narrow window of 
eligibility. This led to small sample size and low numbers in each study group. Post hoc analysis 
revealed that the low sample size did not allow for adequate power for the study and affected the 
robustness of the study. Furthermore, the majority of the participants were breast cancer 
survivors who were members of breast cancer support groups that provided social support, 
education and access to resources. The relationship between the participants and their health care 
providers may have been a factor in the high test scores (Pratt et al., 2001; Phatak & Thomas, 
2006). The mean number of medications (3.80) was less than that reported by Puts et al. (2009). 
The pretest scores reflected an existing grasp of proper medication adherence and self-efficacy in 
taking medications as well as functional health literacy.  
 Variability of workshops. Due to slow recruitment, multiple workshops were required 
over a one and one-half year period. Even though every effort was made to ensure continuity of 
the workshops, variability in presenters, locations and time may have had an impact on the study. 
Implications for Future Research 
 Although there were no significant findings with respect to medication adherence and 
self-efficacy, additional studies with larger sample sizes, expanded eligibility criteria and 
alternative measures of health literacy and medication adherence are suggested. Additional 
measures (quality of life, depression, cancer skills) that were administered for future data 
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analysis may allow for further investigation with medication adherence, self-efficacy and health 
literacy. 
Many studies report that distress related to a woman’s physical and psychological 
adjustment to breast cancer can be detrimental to decision making, treatment compliance and 
outcomes (Allen et al., 2002; Blake-Mortimer, Gore-Felton, Kimerling, Turner-Cobb & Spiegel, 
1999; Ganz  et al., 1993; Ganz,  et al., 2004; Graves, 2003; Heim, Valach & Schaffner, 1997; 
McCaul et al., 1999; Patrick-Miller, Broccoli, Much & Levine, 2004; Schnoll, Harlow, Stolbach 
& Brandt, 1998; Stanton, 2006; Stanton  et al., 2000). Further research into the effect of distress 
on medication adherence and self-efficacy warrants consideration. 
In addition to the research proposed above, exploration of the effect of empowerment on 
health literacy, medication adherence and self-efficacy is indicated. Empowerment promotes 
self-efficacy, which is the ability to make informed decisions (Davis, Darby, Likes & Bell, 2009; 
Sharf, 1997; Shields, 1995), and allows individuals to manage their lives (Clark & Stovall, 1996; 
Gray, Doan & Churchm 1991; Henderson & Thomas, 1987). Emphasis on the tenet that patients 
should be engaged in their health care (Clark & Stovall, 1996; Clark & Stovall, 2004; Stecher, 
DeVillis, Becker & Rowenstack, 1986; Walsh-Burke & Marcusenn, 1999) would provide 
valuable information in the areas that were explored in this study. Empowering breast cancer 
survivors and their families to gain access to services and support throughout treatment and 
recovery is crucial in improving quality of life for breast cancer patients and their family systems 
(Freeman. 2006; Hiatt et al., 2003; Till, 2001). 
 Finally, the most startling find of this study for this researcher was the lack of specific 
measure for pharmacy literacy. The most common measures that exist for health literacy have 
been validated for measurement of health literacy on a global level, and include the ability to 
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read and understand health information, appointment dates, insurance information and nutrition 
labels. Although there has been some preliminary activity (Jacobson et al. 2007), the lack of 
measurement of knowledge of prescription labels, medication information, side effects, drug 
interactions and information provided by health care providers about medications was alarming 
at best for this researcher. This area of research is rich with possibilities for collaboration 
between the professions of social work and pharmacy to explore this particular knowledge gap. 
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Chapter 9 
Conclusions  
 “It’s not about the destination…it’s about the journey.” I have said and believed this 
saying for quite some time. I have even offered versions of this saying to my children and fellow 
breast cancer survivors throughout my adult life. During this dissertation process, I have had to 
modify and cling to this adage. Although not a young student, I approached the doctoral program 
and dissertation like a wide-eyed, idealistic neophyte, not necessarily trying to change the world 
with one study, but at least prove that my beliefs were obvious truths. These truths were that 
health literacy has an impact on medication adherence and that providing skills training to breast 
cancer survivors would not only improve medication adherence and self-efficacy but would 
impact health literacy as well. 
 The opportunity to participate in a randomized controlled study for my dissertation is 
something of which most doctoral students only dream.  Having the good fortune to receive the 
Doctoral Training Grant from the American Cancer Society afforded me the opportunity to 
expand my study into an experimental design. This has been an incredible learning experience 
for me, and, although I envisioned (and I write this tongue in cheek) a perfect, seamless study 
with extraordinary, groundbreaking results worthy of international renown, I can truly say that I 
have learned more by the lack of results to report. 
 “It’s not about the results…it’s about the process.” How true. If I had been able to reject 
the null on all my hypotheses and have a “perfect” study I may never have delved into secondary 
data analysis and learned how to search for the most miniscule bit of information. Lack of 
“perfection” has helped to make me a better researcher. Lack of “perfection” has helped me to 
realize how little I know and how many opportunities for growth lie ahead.  
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 While in the master’s program I participated in a pilot program for Medication Therapy 
Management. Two years later I co-authored an article on Medication Therapy Management that 
was written for social workers (Rust & Davis, 2011). This particular article was designed to 
introduce the process of providing extensive medication counseling to patients and opportunities 
for social work in this process. Through this dissertation process, I feel even more strongly that 
opportunities abound for social workers to be viable participants in the collaborative health care 
process when it comes to medication adherence and health literacy – especially within oncology 
social work. 
 One important example of this collaboration is a recent program developed through the 
combined efforts of the Oncology Nursing Society, National Coalition for Cancer Survivorship, 
National Association of Social Workers and the Association of Oncology Social Work. A one-
day multidisciplinary workshop was provided for teams of oncology social workers, nurses and 
pharmacists to be trained as trainers for workshops in oral chemotherapy medication adherence 
(NCCS, NASW, ONS & AOSW, 2011). It is encouraging to see and experience collaborations 
such as this.  
 Working on this study within a collaborative framework between social work and 
pharmacy provided the opportunity to experience firsthand the process of obtaining outcome 
measures to provide evidence based data. Although the outcomes were not anticipated, the 
process ignited a desire to continue down the path of investigating the role of pharmacy literacy 
in medication adherence, particularly with breast cancer survivors. 
 
 
  
 106 
 
List of References  
 107 
 
Abel, E. K., & Subramanian, S.K. (2008). After the Cure: The Untold Stories of Breast Cancer 
 Survivors. New York: New York University Press. 
Ajzen, I. (2002). Perceived behavioral control, self-efficacy, locus of control, ant the theory of 
planned behavior. Journal of Applied Psychology. 32(4), 665-683. 
Alfano, C. M., & Rowland J. H. (2006). Recovery issues in cancer survivorship: a new challenge 
for supportive care Cancer Journal, 12: 432-443. 
Allen, S., Shah, A., Nezu, A., Nezu, C., Ciambrone, D., Hogan, J., & Mor, V. (2002) A problem-
solving approach to stress reduction among younger women with breast carcinoma: A 
randomized controlled trial. Cancer,  94(12), 11. 
American Cancer Society (ACS) (2007). Breast Cancer Facts & Figures 2007-2008. Atlanta, 
GA: American Cancer Society, Inc. 
American Cancer Society (ACS) (2009). Breast Cancer Facts & Figures 2009-2010. Atlanta, 
GA: American Cancer Society, Inc. 
American Psychosocial Oncology Society (APOS) (2000).  APOS Standards of Care for the 
Management of Distress in Patients with Cancer.  Charlottesville, VA, American 
Psychosocial Oncology Society. 
Anders, C. K., Hsu, D. S., Broadwater, G., Acharya, C. R., Foekens, J. A., Zhang, Y., Blackwell, 
 K. L. (2008). Young age at diagnosis correlates with worse prognosis and defines a subset 
of breast cancers with shared patterns of gene expression. Journal of Clinical Oncology, 
26(20), 3324-3330 
Anderson, B. L., Kiecolt-Glaser, J. K., & Glaser, R. (1994). A biobehavioral model of cancer 
stress and disease course. American Psychologist, 49(5), 389-404. 
Andrade, S. E., Kahler, K. H., Frech, F. & Chan, K. A. (2006). Methods for evaluation of 
 108 
 
medication adherence and persistence using automated databases. 
Pharmacoepidemiology and Drug Safety. 15, 565-574. 
Andrist, L. (1997). A feminist model for women's health care. Nursing Inquiry,  4(4), 268-274. 
Andrykowski M.A., Carpenter J.S., Studts J.L., Cordova M.J., Cunningham L.L.C., Beacham A., 
et al. (2002). Psychological impact of benign breast biopsy: a longitudinal, comparative 
study. Health Psychology,  21(5), 485-494. 
Ashing – Giwa, K. (1999) Health behavior change models and their socio-cultural relevance for 
breast cancer screening in African American women. Women & Health,  28(4) 1999, 53-
71. 
Ashing-Giwa, K.T., Padilla, G., Tejero, J., Kraemer, J., Wright, K., Coscarelli, A., et al. (2004). 
Understanding the breast cancer experience of women: a qualitative study of African 
American, Asian American, Latina and Caucasian cancer survivors. Psychooncology, 
13(6),  408-428. 
Association of Oncology Social Work (AOSW) (2009). Mission statement. Retrieved September 
16, 2009 from www.aosw.org 
Atkins, L. & Fallowfield, L.  (2006). Intentional and non-intentional non-adherence to 
medication amongst breast cancer patients.  European Journal of Cancer,  42(14), 2271-
2276. 
Ayanian, J. Z., Kohler, B. A., Abe, T., & Epstein, A. M. (1993). The relation between health 
insurance coverage and clinical outcomes among women with breast cancer. New 
England Journal of  Medicine, 329, 326-331. 
Aziz, N.M. &  Rowland, J.H. (2002). Cancer survivorship research among ethnic minority and 
medically underserved groups. Oncology Nursing Forum. 29(5), 789-801. 
 109 
 
Bagozzi, R. P. & Yi, Y. (1989) On the use of structural equation models in experimental designs. 
Journal of Marketing Research. 26(3), 217-284. Retrieved March 16, 2011 from 
http://www.jstor.org/stable/3172900 
Baker, D. W., Gazmararian, J. A., Williams, M. V., Scott, T., Parker, R. M., Green, D., Ren, J. 
…Peel, J. (2002). Functional health literacy and the risk of hospital admission among 
Medicare managed care enrollees. American Journal of Public Health, 92(8), 1278-1283. 
Baker, D. W., Parker, R. M., Williams, M. V. & Clark W. S., (1997). The relationship of patient 
reading ability to self-reported health and use of health services. American Journal of 
Public Health,  87(6),  1027-1030. 
Baker, D. W., Parker, R. M., Williams, M. V. & Clark, W. S., (1998). Health literacy and the risk 
of hospital admission. Journal of General Internal Medicine,  13(12), 791-798. 
Baker, D. W., Parker, M. R., Williams, M.V., Ptikin, K., Parikh, N.S., Coates, W. & Imara, M., 
(1996). The health care experience of patients with low literacy. Archives of Family 
Medicine,  5(6),  329-334. 
Baloush-Kleinman, V., Poyurovsky, M., Koren, D., Schneidman, M., Weizman, A., & Shnitt, D. 
(2002). Adherence to antipsychotic medication in schizophrenia patients . Harefuah, 
141(12), 1042-1049, 1090. 
Baquet, C. R., Mishra, S. I., Commiskey, P., Ellison, G. L. & DeShields, M.  (2008). Breast 
cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival 
rates and histology. Journal of the National Medicine Association, 100(5), 480-488. 
Bandura, A. (1977). Self-efficacy: toward a unifying theory of behavioral change. Psychology 
Review. 84, 191-215. 
Bandura, A. (1997). Self-Efficacy: the Exercise of Control. New York: W. H. Freeman. 
 110 
 
Barber, N. (2002). Should we consider medication non-compliance a medical error? Quality 
Safety Health Care, 11, 81-84. 
Barroso, J., McMillan, S., Casey, L., Gibson, W., Kaminski, G. & Meyer, J. (2000). Comparison 
between African-American and white women in the beliefs about breast cancer and their 
health locus of control. Cancer Nursing,  23, 268-276. 
Bird, C. E., & Rieker, P. P. (1999). Gender matters: an integrated model for understanding men's 
and women's health. Social Science & Medicine, 48(6), 745-755. 
Blackman, D. J.,& Masi, C.M. (2006). Racial and ethnic disparaties in breast caner mortality: are 
we doing enough to address the root causes? Journal of Clinical Oncology,  24(14), 
2170-2178. 
Blake-Mortimer, J., Gore-Felton, C., Kimerling, R., Turner-Cobb, J.M. & Spiegel, D. (1999). 
Improving the quality and quantity of life among patients with cancer: a review of the 
effectiveness of group psychotherapy. European Journal of Cancer,  35(11) , 1581-1586. 
Boon, H., Stewart, M., Kennard, M. A., Gray, r., Sawka, C., Brown, J., B., McWilliam, A., G., et 
al., (2000), Use of complementary/alternative medicine by breast cancer survivors in 
Ontario: prevalence and perceptions.  Journal of Clinical Oncology, 18(13), 2515-2521.  
Boston Consulting Group,The (2003). The hidden epidemic: finding a cure for unfulfilled 
prescriptions and missed doses. BCG/Focus, December, 1-8. 
Bowen, D. J., Alfano, C. M., McGregor, B. A., Kuniyuki, A., Bernstein, L., Meeske, K., . . . 
Barbash, R. B. (2007). Possible socioeconomic and ethnic disparities in quality of life in 
a cohort of breast cancer survivors. Breast Cancer Res Treat, 106(1), 85-95 
Breast Cancer Network of Strength Website (2010). http://www.networkofstrength.org/ 
 111 
 
Breen, N., Kessler, L.G. & Brown, M.L. (1996). Breast cancer control among the underserved--
an overview. Breast Cancer Research and Treatment,  40(1):105-115. 
Britt, E., Hudson, S. M. & Blampied, N. M. (2004). Motivational interviewing in health settings: 
a review. Patient Education Counseling,  53(2),  147-155.  
Brush, J. E., Rensing, E., Song, F., Cook, S., Lynch, J., Thacker, L. …Valentine, M. (2009). A 
statewide collaborative initiative to improve the quality of care for patients with acute 
myocardial infarction and heart failure. Circulation, 119, 1609-1615. 
Burke, S. & Kissane, D.W. (1998). Psychosocial Support for Breast Cancer Patients: A review of 
Interventions by Specialist Providers. A Summary of the Literature 1976-1996. Sydney, 
Australia: NHMRC National Breast Cancer Centre: Woolloo. 
Calnan, M., & Johnson, B. (1985). Health, health risks and inequalities: an exploratory study of 
women's perceptions. Sociology of Health and Illness,  7(1), 55-75. 
Cappiello, M., Cunningham, R. S., Knobf, M.T., & Erdos, D. (2007). Breast cancer survivors 
information and support afar treatment. Clinical Nursing Research, 16(4), 278-293. 
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K. … Millikan, 
R. C. (2006).  Race, breast cancer subtypes, and survival in the Carolina breast cancer 
study. JAMA, 295(21), 2492-2502. 
Carr, D. D. (2009). Building collaborative partnerships in critical care: the RN case 
manager/social work/dyad in critical care. Professional Case Management, 14(3), 121-
132. 
Carver, C. S., Pozo, C., Harris, S. D., Noriega, V., Scheier, M. F., Robinson, D. S., 
 112 
 
Ketcham, …Clark, K. C. (1993). How coping mediates the effect of optimism on distress: 
a study of women with early stage breast cancer. Journal of Personality and Social 
Psychology,  65(2), 375-390. 
Centers for Disease Control and Prevention (CDC) (2009). United States Cancer Statistics. 
Retrieved from http://www.cdc.gov/cancer/npcr/uscs/2006/qa.htm#3 
Champion, V. L., Monahan, P. O., Springston, J. K., Russell, K., Zollinger, T. W., Saywell, R. M., 
et al. (2008). Measuring mammography and breast cancer beliefs in African American 
women. Journal of Health Psychology, 13(6), 827-837. 
Champion, V. L. & Scott, C. R. (1997). Reliability and validity of breast cancer screening belief 
scales in African American women. Nursing Research,  46, 331-337. 
Champion, V. L. & Springston, J. (1999). Mammography adherence and beliefs in a sample of 
low-income African American women. International  Journal of  Behavioral Medicine, 
6(3),  228-240. 
Chang-Quan, H., Bi-Rong, D., Chan, L., Yuan, Z., Yu-sheng, P, & Qing-Xiu, L. (2009). 
Collaborative care interventions for depression in the elderly: a systematic review of 
randomized controlled trials. Journal of Investigative Medicine, 57(2), 446-455. 
Chew, L. D., Bradley, K. A., & Boyko, E. J., (2004). Brief questions to identify patients with 
inadequate health literacy. Family Medicine, (36)8, 588-594. 
Chewning, B. & Sleath, B. (1996). Medication decision-making and management: a client-
centered model. Social Science & Medicine, 42(3), 389-398. 
Choumanova, I., Wanat, S., Barrett, R., & Koopman, C. (2006). Religion and spirituality in 
coping with breast cancer: perspectives of Chilean women. Breast Journal 12(4) 349-
352. 
 113 
 
Christiansen, N., Chen, L. et al. (2012). Association between African American race and 
outcomes in patients with nonmetastatic triple negative breast cancer: a retrospective 
analysis using results from the Georgia cancer specialist database. Clinical Breast 
Cancer, 12(4), 270-275. 
Clark,  E. J, & Stovall, E. L. (1996). Advocacy: the cornerstone of cancer survivorship. Cancer 
Practice,  Sep-Oct, 4(5):239-244. 
Clark, E. & Stovall, E. (2004). Survivors as advocates. In: Hoffman B, ed. A Cancer Survivor’s 
Almanac. New York: John Wiley, 302-308. 
Coffey, M. (1999).  Psychosis and medication: strategies for improving adherence. British  
Journal of  Nursing,  8,225-30. 
Colbert, A. M., Sereika, S. M. & Erlen, J. A. (2012) Functional health literacy, medication-taking 
self-efficacy and adherence to antiretroviral therapy. Journal of Advanced Nursing, 
 doi: 10.1111/j.1365-2648.2012.06007.x 
Compliance Strategic Initiative (CSI) (2011). Getting the most out of your breast cancer 
treatments: why it’s important to take your medicine. Retrieved March 11, 2011 from 
 http://www.talkaboutrx.org/documents/CSI_Patient_Fact_Sheet_Handout.pdf 
Cooke, A. &  Fielding, K. (2010) Fun environmentalism!: Potential contributions of autonomy 
supportive psychology to sustainable lifestyles. Management of Environmental Quality: 
An International Journal, 21( 2), 155 – 164. 
Copeland G, Lake A, Firth R, et al., eds. (2009) Cancer in North America,2002-2006. Volume 
One: Combined Cancer Incidence for the United States and Canada. Springfield, IL: 
North American Association of Central Cancer Registries, Inc. 
Cott, C. (1997). We decide, you carry it out: a social network analysis of multidisciplinary long-
 114 
 
term care teams. Social  Science &  Medicine, 45(9), 1411-1421. 
Coyne, J.C., Palmer, S.C., Shapiro, P.J., Thompson, R. & DeMichele, A. (2004). Distress, 
psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer 
waiting room sample. General Hospital Psychiatry,  26(2), 121-128. 
Cox, L. E. (2009). Predictors of medication adherence in an AIDS clinical trial: patient and 
clinician perceptions. Health and Social Work, 34(4), 257-264(8). 
Curtis, E., Quale, C., Haggstrom, D., & Smith-Bindman, R. (2008). Racial and ethnic differences 
in breast cancer survival: how much is explained by screening, tumor, severity, biology, 
treatment, comorbidities, and demographics? Cancer, 112(1), 171-180. 
Darby, K., Davis, C., Likes, W. & Bell, J. (2009). Exploring the financial impact of breast cancer 
for African American medically underserved women: A qualitative study. Journal of 
Health Care for the Poor and Underserved, 20,721-728. 
Davey, M. P.Kissil, K., Nino, A. & Tubbs, C.Y.  (2010). They paid no mind to my state of mind: 
African American breast cancer patients' experiences of cancer care delivery. Journal of 
Psychosocial Oncology, 28(6), 683-698. 
Davies, M. A., McBride, L., & Sajatovic, M. (2008). The collaborative care practice model  in 
the long-term care of individuals with bipolar disorder: a case study. Journal of 
Psychiatric and Mental Health Nursing,  15(8), 649-653. 
Davis, C. (2009) Oncology Social Work Practice in the Care of Breast and Ovarian Cancer 
Survivors. New York: Nova Science Publishers, Inc. 
Davis, C., Darby, K., Likes, W., & Bell, J. (2009). Social workers as patient navigators for breast 
cancer survivors: what do African-American medically underserved women think 
of this idea? Social Work in Health Care, 48, 561–578.  
 115 
 
Davis, C., Emerson, J.S.  &  Husaini, B.A.. (2005). Breast cancer screening among African     
American women: adherence to current recommendations. Journal of Health Care for 
the Poor and Underserved, 16(2):308-314. 
Davis, T. C., Williams, M. V., Marin, E., Parker, R. M. & Glass, J. (2002). Health literacy and 
cancer communication. CA Cancer Journal for Clinicians, 52, 134-149. 
Deci, E. L. & Ryan, R. M. (2002) (Eds.). Handbook on Self-Determination Research. Rochester: 
University of Rochester Press. 
Delgado, P. L. (2000). Approaches to the enhancement of patient adherence to antidepressant 
medication treatment. Journal of Clinical Psychiatry,  61 Suppl 2: 6-9. 
Department of Health and Human Services (DHHS) (2009). Cancer Survivorship: Survive 
Cancer and Live. Center for Disease Control. Retrieved from 
 http://www.cdc.gov/CANCER/survivorship/pdf/brochure.pdf 
DiIorio, C., Resnicow, K., McDonnell, M., Soet, J., McCarty, F. & Yeager, K. (2003).Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. Journal of the Association of  Nurses in AIDS Care, 14,52-62. 
DiIorio, C., McCarty, F., DePadilla, L, Resnicow, K.,Holstad, M. M., Yeager, K. Sharma, S. M., 
... Lundberg, B. (2009). Adherence to antiretroviral medication regimens: a test of a 
psychosocial model.  AIDS Behavior, 13(1): 10-22. 
DiIorio, C., McCarty, F., Resnicow, K., Holstad, M.  M., Soet, J., Yeager, S. M., Sharma, D. E., 
…Lundberg, B. (2008). Using motivational interviewing to promote adherence to 
antiretroviral medications: a randomized controlled study. AIDS Care,  20(3), 273-283.  
Doak, C. C., Doak, L., G. & Root, J. H. (1996). Teaching Patients with Low-literacy Skills. 2nd 
ed. Philadelphia. J. B. Littincott Co. 
 116 
 
Dolder, C. R., Lacro, J. P. Warren, K. A., Golshan, S., Perkins, D. O., Jeste, D. V. (2004). Brief 
evaluation of medication influences and beliefs: development and testing of a brief scale 
for medication adherence. Journal of Clinical Psychopharmacology,  24(4), 404-409. 
Dohan, D. & Schrag, D. (2005). Using navigators of underserved patients:current parctices and 
approaches. Cancer,  104(4), 848-855. 
Doherty, W. J. & McCubbin, H. I. (1985). Families and health care: an emerging arena of theory, 
research, and clinical intervention. The Family and Health Care,  34(1), 5-11.  
Doherty, Y. & Roberts, S. (2002). Motivational interviewing in diabetes practice. Diabetes  
Medicine,  19,1–18. 
Douglass, M., Bartolucci, A., Waterbor, J. & Sirles, A. (1995). Breast cancer early detection: 
differences between African American and white women's health beliefs and detection 
practices. Oncology Nursing Forum,.  22(5),  835-837. 
Dow, K. H., Ferrell, B. R., Leigh, S., Ly, J., & Gulasekaram, P. (1996). An evaluation of the 
quality of  life among long-term survivors of breast cancer. Breast Cancer Research & 
Treatment, 39(3), 261-273. 
Duong,  M., Piroth, L, Grappin, M., Forte, F., Peytavin, G., Buisson, M., Chavanet, P.,…Portier, 
H. (2001). Evaluation of the Patient Medication Adherence Questionnaire as a tool for 
self-reported adherence assessment in HIV-infected patients on antiretroviral regimens. 
HIV Clinical Trials,  2(2), 128-135. 
Edwards, M., Wood, F., Davies, M., & Edwards, A. (2012). The development of health literacy 
in patients with a long-term health condition: the health literacy pathway model. BMC 
Public Health, 12(130), 1-15. Retrieved August 27, 2012 from  
http://www.biomedcentral.com/content/pdf/1471-2458-12-130.pdf 
 
 117 
 
Emmons, K. M., Hammond, S. K., Velicer, J. L., Evans, W. F. & Monroe, A. D. (2001). A 
randomised trial to reduce passive smoking exposure in low-income households with 
young children. Pediatrics, 108,18–24. 
Emmons, K. M. & Rollnick, S. (2001). Motivational interviewing in health care settings. 
Opportunities and limitations. American Journal of  Preventive Medicine, 20(1), 68-74. 
Engel, G. L. (1977). The need for a new medical model: a challenge for biomedicine. Science, 
196(4286), 129-136. 
Engel, J., Kerr, J., Schlesinger-Raab, A., Eckel, R., Sauer, H., & Holzel, D. (2003). Predictors of 
quality of life of breast cancer patients. Acta Oncology, 42(7), 710-718. 
Erwin, D. O., Spatz, T. S., Stotts, R. C., Hollenberg, J. A., & Deloney, L. A. (1996). Increasing 
mammography and breast self-examination in African American women using The 
Winess Project Model. Journal of Cancer Education, 11, 210-215.  
Fallowfield, L., Ratcliffe, D., Jenkins, V, & Saul, J. (2001). Psychiatric morbidity and its 
recognition by doctors in patients with cancer. British Journal of Cancer, 84: 1011-1015. 
Fang, M. C., Machtinger, E. L.,Wang, F., & Schillinger, D. (2006). Health literacy and 
anticoagulation-related outcomes among patients taking warfarin. Journal of General 
Internal Medicine, 21(8): 841-846. 
Farmer, K. (1999). Methods for measuring and monitoring medication regimen adherence in 
clinical trials and clinical practice. Clinical Therapeutics. 21(6), 1074-1090. 
Farmer, D., Reddick, B., D’Agostino, R., Jackson, S. A. (2007). Psychosocial correlates of 
mammography screening in older African American women. Oncology Nursing Forum, 
34(1), 117-123. 
Fenton, W. S., Blyler, C. R. & Heinssen, R. K. (1997). Determinanats of medication compliance 
 118 
 
in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin, 23(4), 637-651. 
Foley, G. (1995). Everybody's talking, not communicating. Cancer Practice. 3(2):71. 
Ferguson, T. F., Stewart, K. E., Funkhouser, E., Tolson, J., Westfall, A. O. & Saag, M. S. (2002). 
Patient-perceived barriers to antiretroviral adherence: associations with race. AIDS 
Care,14(5), 607-617. 
Fongwa, M. N., Evangelista, L. S., Hays, R. D., Martins, D. S., Elashoff, D., Cowan, M. J., 
Morisky, D. E. (2008). Adherence treatment factors in hypertensive African American 
women. Vascular Health Risk Management, 4(1), 157-166. 
Food and Drug Administration (FDA) (2012). My medicines. Retrieved February , 2012 from  
 www.fda.gov/downloads/ForConsumers/.../UCM304679.pdf 
Foote, J., DeLuca, A.,Magura, S., Warner, A., Grande, A., Rosenblum, A., & Stahl, S. (1999). A 
motivational group treatment for chemical dependency. Journal of Substance Abuse 
Treatment, 17(3), 181-192. 
Fredette, S. L. (1995).  Breast cancer survivors: concerns and coping. Cancer Nursing 18(1): 35-
46. 
Freeman, H. P. (2006). Patient navigation: a community centered approach to reducing cancer 
mortality. Journal of Cancer Education, 21(1 Supplement), S11-14. 
 
Friedland, R. (1998). New estimates of the high costs of inadequate health literacy. In 
Proceedings of Pfizer Conference “Promoting Health Literacy: A Call to Action.” 
October 7-8, 1998. Washington, D.C.: Pfizer, Inc. , 6-10. 
Ganz, P. A. (1995). Advocating for the woman with breast cancer. CA: A Cancer Journal for 
Clinicians, 45(2),114-126. 
Ganz, P. A., Coscarelli, A., Fred, C., Kahn, B., Polinsky, M.L., Petersen, L. (1996). Breast cancer 
 119 
 
survivors: psychosocial concerns and quality of life. Breast Cancer Research and 
Treatment, 38(2),183-199. 
Ganz, P.A., Hirji, K., Sim, M.S., Schag, C.A., Fred, C., Polinsky, M.L. (1993). Predicting 
psychosocial risk in patients with breast cancer. Medical Care,  31(5), 419-431. 
Ganz, P. A., Kwan, L., Stanton, A. L., Krupnick, J. L., Rowland, J. H., Meyerowitz, B. E., et al. 
(2004). Quality of life at the end of primary treatment of breast cancer: first results from 
the moving beyond cancer randomized trial. Journal of the National Cancer Institute, 
96(5), 376-387. 
Ganz, P.A., Polinsky, M. L., Schag, C. A. & Heinrich, R. L. (1989). Rehabilitation of patients 
with primary breast cancer: assessing the impact of adjuvant therapy. Recent Results in 
Cancer Research, 115, 244-254. 
Ganz, P.A., Polinsky, M. L., Schag, C. A., Heinrich, R. L. & Flack, V.F. (1987). Rehabilitation 
needs and breast cancer: the first month after primary therapy. Breast Cancer Research 
and Treatment. 10(3), 243-253.  
Ganz, P.A., Schag, C.C., Polinsky, M.L., Heinrich, R.L. & Flack, V.F. (1987). Rehabilitation 
needs and breast cancer: the first month after primary therapy. Breast Cancer Research 
and Treatment, December, 10(3),243-253. 
Garber, M. C., Nau, D. P., Erickson, S. R., Aikens, J. E. & Lawrence, J. B. (2004). Concordance 
of self-report with other measures of medication adherence. Medical Care. 42(7), 649-
652. 
Garavalia, L., Garavalia, B., Spertus, J. & Decker, C. (2009). Exploring patients' reasons for 
discontinuance of heart medications. Journal of  Cardiovascular Nursing. 24(5), 371-
379. 
 120 
 
Gatti, M. E., Jacobson, K. L., Gazmararian, J. A., Schmotzer, & Kripalani, S. (2009). 
Relationships between beliefs about medications and adherence.  American Journal of 
Health System Pharmacy, 66(7), 657-664. 
Gehlert, S. & Browne, T. A., eds. (2006). Handbook of Health Social Work. Hoboken, New 
Jersey, John Wiley & Sons.  
George, J., Munro, K., McCaig, D. J. & Stewart, D. C. (2006). Prescription medications: beliefs, 
experiences, behavior, and adherence of sheltered housing residents. Annals of 
Pharmacotherapeutics, 40(12), 2123-2129.  
Georges, C. A., Bolton, L. B., & Bennett, C., (2004). Functional health literacy: an issue in 
African- American and other ethnic and racial communities. Journal of Black Nurses 
Association, 15(1), 1-4. 
Gilbody, S., Bower, P., Fletcher, J., Richards, D., & Sutton, A. J. (2006). Collaborative care for 
depression: a cumulative meta-analysis and review of longer-term outcomes. Archives of 
Internal Medicine, 166(21), 2314-2321. 
Goldhirsch, A., Gelber, R. D., Yothers, G., Gray, R. J., Green, S., Bryant, S.,  Gelber, S., … 
Coates, A. S.  (2001). Adjuvant therapy for very young women and breast cancer: need 
for tailored treatments. Journal of the National Cancer Institute 
    Monograph, 30, 44-51. 
Gordon, M. M., Hampson, R., Capell, H., A., Madhok, R. (2002). Illiteracy in rheumatoid 
arthritis patients as determined by the Rapid Estimate of Adult Literacy (REALM) score. 
Rheumatology, 41(7), 750-754. 
Graham, M. E., Liggons, Y. & Hypolite, M. (2002). Health beliefs and self breast examination in 
black women. Journal of Cultural Diversity, 9,4-54. 
 121 
 
Graves, K.D. (2003). Social cognitive theory and cancer patients' quality of life: a meta-analysis 
of psychosocial intervention components. Health Psychology, March, 22(2), 210-219. 
Gray, R.E., Doan, B. & Church, K. (1991). Empowerment issues in cancer. Health Values, 15(4), 
22-28. 
Gray, R.E., Doan, B. & Church, K. (1991). Empowerment issues in cancer. Health 
Values,15(4),22-28. 
Grunfeld, E. A., Hunter, M. S., Sikka, P. & Mittal, S. (2005). Adherence beliefs among breast 
cancer patients taking tamoxifen. Patient Education Counseling, 59(1), 97-102. 
Gullate, M. (2006). The influence of spirituality and religiosity on breast cancer screening delay 
in African American women: application of the Theory of Reasoned Action and Planned 
Behavior (TRA/TPB).  ABNF Journal, 17(2), 89-94. 
Halpern, M. T., Bian, J., Ward, E., M., Schrag, N. M., & Chen, A.Y., Insurance status and stage 
of cancer at diagnosis among women with breast cancer. Cancer, 110(2), 403-411. 
Hamilton, J. B., Moore, C. E., Powe, B.D., Agarwal, M., Martin, P. (2010). Perceptions of 
support among older African American cancer survivors. Oncology Nursing Forum, 
37(4), 484-493. 
Handmaker, N. S., Miller, W. R. &  Manicke. M. (1999). Findings of a pilot study of 
motivational interviewing with pregnant drinkers. Journal of Studies on Alcohol, 60, 
285–7. 
Harland, J., White, M., Drinkwater, C., Chinn , D., Farr, L. & Howel, D. (1999). The Newcastle 
exercise project: a randomised controlled trial of methods to promote physical activity in 
primary care. BMJ, 25,828–32. 
Hashmi, S. K., Afridi, M. B., Abbas, K., Sajwani, r. A., Saleheen, D., Frossard, M., … Ahmad, U. 
 122 
 
(2007). Factors associated with adherence to anti-hypertensive treatment in Pakistan. 
PLoS One, 2(3), e280. Hayward, P., Chan, N., Kemp, R., Youle,S. & David, A. (1995). Medication self-management: a preliminary report on an intervention to improve medication compliance. Journal of 
Mental  Health, 4,511-7. 
Heather, N., Rollnick, S., Bell, A. & Richmond, R. (1996). Effects of brief counseling among 
male heavy drinkers indentified on general hospital wards. Drug Alcohol Review, 15, 29–
38. 
Hedrick, S. C., Chaney, E. F., Felker, B., Liu, C. F., Hasenberg, N., Heagerty, P., et al. (2003). 
Effectiveness of collaborative care depression treatment in veterans' affairs primary care. 
Journal of General Internal Medicine, 18(1), 9-16. 
Hegel, M. T., Moore, C. P., Collins, E. D., Kearing, S., Gillock, K. L., Riggs, R. L., Clay, K. F.  
et al. (2006). Distress, psychiatric syndromes, and impairment of function in women with 
newly diagnosed breast cancer. Cancer,107(12), 2924-2931. 
Heim, E., Valach, L. & Schaffner, L. (1997). Coping and psychosocial adaptation: longitudinal 
effects over time and stages in breast cancer. Psychosomatic Medicine, 59(4), 408-418. 
Henderson, P. & Thomas, D.N. Skills in Neighborhood Work. 2nd ed. New York: Routledge; 
1987. 
Hettema, J., Steele, J. & Miller, W. R. (2005). Motivational interviewing. Annual Review of  
Clinical Psychology, 1, 91-111. 
Hewitt, M., Greenfield, S. & Stovall, E. (2006) From cancer patient to cancer survivor: Lost in 
transition. Washington, D.C.: Institute of Medicine and National Research Council. 
Hewitt, M., Herdman, R. & Holland, J., eds. (2004). Meeting the Psychosocial Needs of Women 
 123 
 
with Breast Cancer: National Cancer Policy Board. Washington, DC: The National 
Academic Press. 
Hiatt, R. A., Pasick, R. J., Stewart, S., Bloom, J., Davis, P., Gardiner, P., et al. (2001). 
Community-based cancer screening for underserved women: design and baseline findings 
from the Breast and Cervical Cancer Intervention Study. Preventive Medicine, 33(3), 190-
203. 
Hoffman, B. & Stovall, E. (2006). Survivorship perspectives and advocacy. Journal of Clinical 
Oncology,  24(32), 5154-5159. 
Holmes-Rovner, M. & Charles, S. (2003). The mammography screening controversy: who and 
what is heard in the press?  Patient Education and Counseling, 51, 75–81. 
Horner, M. J., Ries, L. A.G., Krapcho, M., Neyman, N., Aminou, R., Howlader, N.et al., eds. 
(2008) SEER Cancer Statistics Review, 1975-2006. National Cancer Institute. Bethesda, 
MD. Retrieved from http://seer.cancer.gov/csr/1975_2006/ 
Howard, D. H., Gazmararian, J., & Parker, R., M. (2005). The impact of low health literacy on 
the medical costs of medicare managed care enrollees. The American Journal of 
Medicine, 118, 371-377.  
 Husaini, B. A., Sherkat, D. E., Bragg, R., Levine, R., Emerson, J. S., Mentes, C. M. & Cain, V. 
A., (2001). Predictors of breast cancer screening in a panel study of African American 
women. Women Health,  34(3),35-51. 
Jacobsen, T. A. (2004). The forgotten cardiac risk factor: noncompliance with lipid-lowering 
therapy. Medscape Cardiology, 8(2). Retrieved February 26, 2011 from 
http://www.medscape.com/content/2004/00/49/61/496144/496144_fig.html 
Jacobson, K. L., Gazmararian, J. A., Kripalani, S., McMorris, K. J., Blake, S. C. & Brach, C. 
 124 
 
(2007). Is pharmacy meeting patients’ needs? A pharmacy health literacy assessment tool 
user’s guide. Prepared for Agency for Healthcare Research and Quality. (Prepared under 
contract No. 290-00-0011 T07.) AHRQ Publication No. 
07-0051. Rockville, MD 
Jansen, C., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). Potential mechanisms 
for chemotherapy-induced impariments in cognitive function. Continuing Education 
Oncology Nursing Forum, 32(6), 1151-1163. 
Jeppesen, K. M., Coyle, J. D., & Miser, W. F. (2009). Screening questions to predict limited 
health literacy: a cross-sectional study of patients with diabetes mellitus. Annals of 
Family Medicine, (7)1, 24-31. 
Johnson, P. (2002). The use of humor and its influences on spirituality and coping in breast 
cancer survivors. Oncology Nursing Forum 29(4), 691-695. 
Juzych, M. S., Randhawa, S., Shukairy, A., Kaushal, P., Gupta, A., Shalauta, N., et al. (2008). 
Functional health literacy in patients with glaucoma in urban settings. Archives of 
Ophthalmology, 126(5), 718-724. 
Kalichman, S.C., Benotsch, E, Suarez, T., Catz, S., Miller, J. &  Rompa D. (2000). Health 
literacy and health-related knowledge among persons living with HIV/AIDS. American 
Journal of Preventive Medicin,. 18(4), 325-331. 
 Kalichman S.C., Pope H., White, D., Cherry, C,. Amaral, C.M., Swetzes, C., Flanagan, J, … 
Kalichman, M.O. (2008). Association between health literacy and HIV treatment 
adherence: further evidence from objectively measured medication adherence. Journal of 
International Association of Physicians AIDS Care, 7(6), 317-323. 
Kalichman, S.C., Ramachandran, B.B. & Catz, S.P. (1999). Adherence to combination 
 125 
 
antiretroviral therapies in HIV patients of low health literacy. Journal of General Internal 
Medicine, 14(5), 267-273. 
Kalichman, S. C. & Rompa, D. (2000). Functional health literacy is associated with health status 
and health-related knowledge in people living with HIV-AIDS. Journal of Acquired 
Immune Deficiency Syndromes and Human Retrovirology, 25(4), 337-344. 
Kantsiper, M. E., McDonald, E. L., Geller, G., Shockney, L., Snyder, C. F. & Wolff,  A. C., 
(2009). Transitioning to breast cancer survivorship: perspectives of patients, cancer 
specialists, and primary care providers. Journal of General Internal Medicine, 24 Suppl 
2: S459-466. 
Karakoyun-Cellik, O., Gorkin, I., Sahin, S., Orcin, E., Alanyali, H. & Kinay, M. (2010). 
Depression and anxiety levels in woman under follow-up for breast cancer: relationship 
to coping with cancer and quality of life. Medical Oncology, 27(1), 108-113. 
Katon, W., Von Korff, M., Lin, E., Simon, G., Walker, E., Unutzer, J., et al. (1999). Stepped 
collaborative care for primary care patients with persistent symptoms of depression: a 
randomized trial. Archives of General Psychiatry, 56(12), 1109-1115. 
Kemp, R., Hayward, P., Applewhaite, G., Everitt, B. & David, A. (1996). Compliance therapy in 
psychotic patients: randomized controlled trial. British Medical Journal. 372, 345-349. 
Kemp, R., Kirov, G. , Hayward, P. & David, A. (1998). Randomised controlled trial of 
compliance therapy-18 month follow-up. British Journal of Psychiatry, 172, 413-419. 
Killick, S. & Allen, C. (1997).  Shifting the balance: motivational interviewing to help behaviour 
change in people with bulimia nervosa. European Eating Disorders Review, 5,33–41. 
Kirk, M. C. & Hudis, C. A. (2008). Insight into barriers against optimal adherence to oral 
hormonal therapy in women with breast cancer. Clinical Breast Cancer, 8(2), 155-161. 
 126 
 
Kressin, N. R. (2005). Separate but not equal: the consequences of segregated health care. 
Circulation, 112, 2582-2584. 
Kripalani, S., Risser, S., Gatti, M.E., & Jacobson, T. A. (2009).  Development and evaluation of 
the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients 
with chronic disease. Value Health, 12(1), 118-123. 
Krousel-Wood, M., Muntner, P., Islam, T., Morisky, D. E., & Webber L. S. (2009). Barriers to 
and determinants of medication adherence in hypertension management: Perspective of 
the cohort study of medication adherence among older adults. Medical Clinics of North 
America, 93, 753-769. 
Kuo, G. M., Buckley, T. E., Fitzsimmons, D. S., & Steinbauer, J. R. (2004). Collaborative drug 
therapy management services and reimbursement in a family medicine clinic. American 
Journal of  Health System Pharmacy, 61(4), 343-354. 
Kutner, M., Greenberg, E., Jin,Y., and Paulsen, C. (2006). The Health Literacy of America’s 
Adults: Results From the 2003 National Assessment of Adult Literacy (NCES 2006-483) 
 U. S. Department of Education. Washington, DC: National Center for Education 
Statistics. 
Laerd Statistics (2012). ANOVA with repeated measures using SPSS. Retrieved August 30, 2012 
from https://statistics.laerd.com/spss-tutorials/one-way-anova-repeated-measures-using-
spss-statistics.php 
Lannin, D. R., Mathews, H. F., Mitchell, J., Swanson, M. S., Swanson, F. H. & Edwards, M. S. 
(1998). Influence of socioeconomic and cultural factors on racial differences in late-stage 
presentation of breast cancer. Journal of the American Medical Association, 279(22), 
1801-1807. 
 127 
 
Lannin, D. R., Mathews, H. F., Mitchell, J. & Swanson, M.S . (2002). Impacting cultural 
attitudes in African-American women to decrease breast cancer mortality. American 
Journal of Surgery, 184(5), 418-423. 
Lantz, P. M. & Reding, D. (1994). Cancer: beliefs and attitudes of migrant Latinos. Journal of 
the American Medical Association, 272(1), 31-32. 
Lantz, P .M., Dupuis, L., Reding, D., Krauska, M. & Lappe, K. (1994). Peer discussions of 
cancer among Hispanic migrant farm workers. Public Health Reports, 109(4), 512-520. 
Lee, M. M., Lin, S. S., Wrensch, M. R., Adler, S. R. & Eisenberg, D. (2000). Alternative 
therapies used by women with breast cancer in four ethnic populations. Journal of the 
National Cancer Institute, 92(1), 42-47.  
Lerman, C., Daly, M., Walsh, W. P., Resch, N., Seay, J., Barsevick, A., Heggan, T., … 
Birenbaum, L (1993). Communication between patients with breast cancer and health 
care providers. Determinants and implications. Cancer, 72(9),2612-2620. 
Lindau, S. T., Laumann, E. O., Levinson, W. & Waite, L. J. (2003). Synthesis of scientific 
disciplines in pursuit of health: the interactive biopsychosocial model. Perspectives in 
Biology and Medicine, 46(3, Suppl.), 574-586. 
Liu, M. J., Hawk, H., Gershman, S. T., Smith, S. M., Karacek, R., Woodford, M. L., et al. (2005). 
The    effects of a National Breast and Cervical Cancer Early Detection Program on social 
disparities in breast cancer diagnosis and treatment in Massachusetts. Cancer Causes 
Control, 16, 27-33. 
Lopes, N., Zanini, A. C., Casella-Filho, A., & Chagas, A. C. (2008). Metabolic syndrome patient 
compliance with drug treatment. Clinics (Sao Paulo), 63(5), 573-580. 
 128 
 
Lorig, K. & Holman, H. (2003). Self-management education: history, definition, outcomes, and 
mechanisms. Annals of Behavioral Medicine. 26, 1-7. 
Ludman, E. J., Curry, S, J., Meyer, D., & Taplin, S.H. (1999). Implementation of outreach 
telephone counselling to promote mammography participation. Health Education 
Behavior, 26, 689–702. 
McCaul, K.D., Sandgren, A.K., King, B., O'Donnell, S., Branstetter, A. & Foreman, G. (1999). 
Coping and adjustment to breast cancer. Psycho-Oncology, 8(3), 230-236. 
McDonald, P. A., Thorne, D. D., Pearson, J. J. et al. (1999). Perceptions and knowledge of breast 
cancer among African-American women residing in public housing. Ethnic Disparitie,s 
9(1), 81-93. 
McElmurray, B. J., McCreary, L. L., Park, C. G., Ramos, L., Martinez, E., Parikh, R., Kozik, K., 
& Fogelfield, L. (2009). Implementations, outcomes, and lessons learned from a 
collaborative primary health care program to improve diabetes care among urban Latino 
populations. Health Promotion Practice, 10(2), 293-302. 
Mager, W. M. &  Andrykowski, M. A. (2002). Communication in the cancer 'bad news' 
consultation: patient perceptions and psychological adjustment. Psychooncology, 11(1), 
35-46. 
Mandelblatt, J. S., Gold, K., O'Malley, A. S., Taylor, K., Cagney, K., Hopkins, J. S. & Kerner, J. 
(1999). Breast and cervix cancer screening among multiethnic women: Role of age, 
health and usual source of care. Preventive Medicine, 128,418-425. 
Mardby, A. C., Akerlind, I., & Jorgensen, T. (2007). Beliefs about medicines and self-reported 
adherence among pharmacy clients. Patient Education Counseling, 69(1-3), 158-164. 
Markland, D., Ryan, R. M., Tobin, V. J. & Rollnick, S. (2005). Motivational Interviewing and 
 129 
 
self-determination theory. Journal of Social and Clinical Psychology, 24(6), 811-831. 
Martino, S., Carroll, K.M., O’Malley. S. S. & Rounsaville,  B. J. (2000). Motivational 
interviewing with psychiatrically ill substance abusing patients. American Journal of 
Addiction, 9,88–91. 
Mayer, M. ( 2003). After Breast Cancer: Answers to the Questions You're Afraid to Ask. 
Sebastopol, California: O'Reilly Media, Inc. 
Michael, Y. L., Kawaci, I., Berkman, L. F., Holmes, M. D. & Colditz, G. A. (2000). The 
persistent impact of breast carcinoma on functional health status: Prospective evidence 
from the nurses health study. Cancer,  89(11), 2176-2186. 
Miller, W.R. (1983). Motivational interviewing with problem drinkers. Behavioural 
Psychotherapy, 11, 147–172. 
Miller, W.R. (1996). Motivational interviewing: Research, practice, and puzzles. Addictive 
Behaviors, 21, 835–842. 
Miller, W.R.,&Rollnick, S. (1991). Motivational interviewing: Preparing People to Change 
Addictive Behavior. New York: Guilford Press. 
Miller, W. R. &Rollnick, S. (2002). Motivational interviewing: Preparing People for 
Change.(2nd ed.). New York: Guilford Press. 
Miller, W. R. & Rose, G. S. (2009). Toward a theory of motivational interviewing. American 
Psychology ,64(6), 527-537. 
Mitchell, A. J. (2007).  Accuracy of distress thermometer and other ultra-short methods of 
detecting cancer-related mood disorders: Pooled results from 38 analyses. Journal of 
Clinical Oncology, 25(29), 1-12. 
 130 
 
Moore, R. J. (2001). African American women and breast cancer: notes from a study of 
narrative. Cancer Nursing, 24(1), 35-42; quiz 43. 
Moore, S. (2010). Nonadherence in patients with breast cancer receiving oral therapies.  Clinical  
Journal of  Oncology Nursing, 14(1), 41-47. 
Morgan, P. D., Gaston-Johansson F., & Mock, V. (2006). Spiritual well-being, religious coping, 
and the quality of life of African American breast cancer treatment: a pilot study. The 
ABNF Journal, 17(2), 73-77. 
Morris S.R., Carey, L.A. (2007). Molecular profiling in breast cancer. Reviews in Endocrine & 
Metabolic Disorders, 8(3),185-198. 
Mosavel, M. & Sanders, K. D.  (2010). Photovoice: a needs assessment of African American 
cancer survivors. Journal of Psychosocial Oncology, 28(6), 630-643. 
Muir, K. W., Santiago-Turla, C., Stinnett, S. S., Herndon, L. W., Allingham, R. R., Challa, P., & 
Lee, P. P. (2006). Health literacy and adherence to glaucoma therapy. American Journal 
of Ophthalmology, 142(2), 223-226. 
Mullan, F. (1985). Seasons of survival: Reflections of a physician with cancer. New England 
Journal of Medicine, 313, 270-273. 
National Coalition for Cancer Survivorship (NCCS). Cancer survivor toolbox. 2006; 
www.cancersurvivaltoolbox.orb/default.aspx. Accessed October 4, 2010. 
National Coalition for Cancer Survivorship (NCCS), National Association of Social Workers 
(NASW), Oncology Nursing Society (ONS) & Association of Oncology Social Work 
(AOSW) (2011) Train-the-trainer conference on cancer oral medication adherence. 
Washington, DC, Wednesday June 15.  
Newman, L., A., Griffith, K. A., Jatoi, I., Simon, M. S., Crowe, J. P. & Colditz, G. A. (2006). 
 131 
 
Meta-analysis of the survival in African-American and white American patients with 
breast cancer: ethnicity compared with socioeconomic status. Journal of Clinical 
Oncology, 24(9), 1342-1349. 
Ngoh, L. N. (2009).  Health literacy: a barrier to pharmacist-patient communication and 
medication adherence.  Journal of the American Pharmacists Association, 49(5), e132-
146; quiz e147-139. 
North American Association of Central Cancer Registries (NAACCR) (2009). Cancer Incidence 
 Statistics. Retrieved from http://www.naaccr.org 
Northouse, P. & Northouse, N. (1987). Communication and cancer: Issues confronting patients, 
health professionals, and family members. Journal of Psychosocial Oncology. 5(3):17-
46. 
National Patient Safety Foundation (2010). Ask me 3. Retreived February 7, 2011 from  
 http://www.npsf.org/askme3/pdfs/AskMe_brochure_8-pg_printer%20quality.pdf 
Odegard, P. S. & Gray, S. L. (2008). Barriers to medication adherence in poorly controlled 
diabetes mellitus. Diabetes Education, 34(4), 692-697. 
Ogedegbe, G., Chaplin, W., Schoenthaler, A., Statman, D., Berger, D., Richardson, T., . . . 
Allegrante, J. P. (2008). A practice-based trial of motivational interviewing and 
adherence in hypertensive African Americans. American Journal of Hypertension, 
21(10), 1137-1143. 
Ogedegbe, G., Schoenthaler, A., Richardson, T., Lewis, L., Belue, R., Espinosa, E., . . . 
Charlson, M. E. (2007). An RCT of the effect of motivational interviewing on medication 
adherence in hypertensive African Americans: rationale and design. Contemporary 
Clinical Trials, 28(2), 169-181. 
 132 
 
O'Hair, D. H., Villagran,, M. M., Wittenberg, E., Brown, ,K .,Ferguson,, M ., Hall, H.T., & Doty, 
T.  (2003). Cancer survivorship and agency model: implications for patient choice, 
decision making, and influence. Health Communication, 15(2), 193-202. 
Osterberg, L., & Blaschke, T.(2005). Adherence to medication. New England Journal of 
Medicine, (535)5, 487-497. 
Osvath, P. (2010). The multidimensional approach of treatment adherence and its role in the long 
term management of mental disorders. Psychiatric Hungary, 25(1), 19-30. 
Ownby, R. (2006). Medication adherence and cognition: medical, personal and economic factors 
influence level of adherence in older adults. Geriatrics, 61(2), 30-35. 
Parikh, N. S., Parker, R. M., Nurss, J. R., Baker, D. W., & Williams, M. V. (1996). Shame and 
health literacy: the unspoken connection. Patient Education and Counseling, 27(1), 33-
39. 
Park, K., Kim, J., Kim, B., Kam, S., Kim, K., Ha, S. & Hyun, S. (2010). Factors that affect 
medication adherence in elderly patients with diabetes mellitus. Korean Diabetes, 34(1), 
55-65. 
Parker, R. M., Baker, D. W., Williams, M. V., Nurss, J.R.  (1995). The test of functional health 
literacy  in adults: a new instrument for measuring patients' literacy skills. Journal of 
General Internal Medicine, 10(10), 537-541. 
Patrick-Miller, L.J., Broccoli, T.L., Much, J.K. & Levine, E. (2004). Validation of the distress 
thermometer: A single item screen to detect clinically significant psychological distress 
in ambulatory oncology patients. Journal of Clinical Oncology, 22(14, Suppl.):6024. 
Perkins, D. O. (1999). Adherence to antipsychotic medications. Journal of Clinical Psychiatry, 
60 Suppl 21: 25-30. 
 133 
 
Persell, S. D., Osborn, C. Y., Richard, R., Skripkauskas, S., & Wolf, M. S. (2007).  Limited 
health literacy is a barrier to medication reconciliation in ambulatory care. Journal of 
General Internal Medicine, 22(11), 1523-1526. 
Phatak, H. M. & Thomas, J., 3rd (2006). Relationships between beliefs about medications and 
nonadherence to prescribed chronic medications. Annals of Pharmacotherapeutics, 
40(10), 1737-1742. 
Phelps, K. W., Howell, C. D., Hill, s. G., Seemann, T. S., Lamson, A. L., Hodgson, J. L., & 
Smith, D. A. (2009). A collaborative care model for patients with type-2 diabetes. Family 
Systems Health, 27(2), 131-140. 
Polinsky, M. L., Fred, C, Ganz, P.A. (1991). Quantitative and qualitative assessment of a case 
management program for cancer patients. Health Social Work.16(3),176-183. 
Pollack, L.A., Greer, G.E., Rowland, J.H., Miller, A., Doneski, D., Coughlin, S. S., Stovall, E. & 
Ulman, D. (2005). Cancer survivorship: a new challenge in comprehensive cancer 
control. Cancer Causes & Control, 16 Suppl 1:51-59. 
Possidente, C. J., Bucci, K. K. & McClain, W. J. (2005). Motivational interviewing: a tool to 
improve medication adherence? American Journal of Health Systems Pharmacy,  62(12), 
1311-1314. 
Pratt, R. J., Robinson, N., Loveday, H. P., Pellowe, C. M., Franks, P. J., Hankins, M. & Loveday, 
C. (2001) Adherence to antiretroviral therapy: appropriate use of self-reporting in clinical 
practice. HIV Clinical Trials, 2(2), 146-159. 
Project MATCH Research Group (PMRG) (1993). Project MATCH: rationale and methods for a 
multi-site clinical trial matching patients to alcoholism treatment. Alcohol, 17,1130–45. 
Project MATCH Research Group. (PMRG) (1997). Project MATCH secondary a priori 
 134 
 
hypotheses. Addiction. 92,1671–98. 
Purcell, D. W., Metsch, L. R., Latka, M. Santibanez, S., Gomez, C. A., Eldred, L. & Latkin, C. A. 
(2004). Study group interventions for seropositive injectors-research and evaluation: an 
integrated behavioral intervention with HIV-positive injection drug users to address 
medical care, adherence, and risk reduction. Journal of Acquired Immune Deficiency 
Syndromes, 37(Suppl 2). S110-S118. 
Puts, M. T., Costa-Lima, B., Girre, M. J., Wolfson, C., Batist, G. & Bergman, H. (2009). 
Medication problems in older, newly diagnosed cancer patients in Canada: How common 
are they? A prospective pilot study. Drugs & Aging, 26(6), 519-536. 
Rehse, B. & Pukrop, R. (2003). Effects of psychosocial interventions on quality of life in adult 
cancer patients: meta analysis of 37 published controlled outcome studies. Patient 
Education Counseling, 50(2), 179-186. 
Resnicow, K., DiIorio, C., Soet, J., Borrelli, B., Ernst, D., Hecht, J., & Thevos, A. (2002). 
Motivational interviewing in medical and public health settings. In W. Miller & S. 
Rollnick (Eds.), Motivational interviewing: Preparing people for change (2nd ed., pp. 
251–269). New York: Guilford Press. 
Richardson, L. C. (2004). Treatment of breast cancer in medically underserved women: a review. 
Breast Journal, 10, 2-5. 
Richardson, M. A., Sanders, T., Palmer, J. L., Greisinger, A. & Singletary, S. E. (2000). 
Complementary/alternative medicine use in a comprehensive cancer center and the 
implications for oncology. Journal of Clinical Oncology, 18(13), 2505-2514. 
 135 
 
Ridner, S. H. & Dietrich, M. S. (2008). Self-report comorbid conditions and medication usage in 
breast cancer survivors with and without lymphedema. Oncology Nursing Forum, 
35(1), 57-63. 
Rimer, B. K. & Glanz, K. (2005). Theory at a Glance: A Guide for Health Promotion Practice. 
2nd ed. National Institute of Health. Retrieved February 23, 2011 from 
http://www.cancer.gov/cancertopics/cancerlibrary/theory.pdf 
Risser, J., Jacobson, T. A. & Kripalani, S. (2007). Development and psychometric evaluation of 
the self-efficacy for appropriate medication use scale (SEAMS) in low-literacy patients 
with chronic disease. Journal of Nursing Measurement, 15(3), 203-219. 
Rojas, M., Mandelblatt, J., Cagney, K., Kerner, J. & Freeman, H. (1996). Barriers to follow-up 
of abnormal screening mammograms among low-income minority women. Cancer 
Control Center of Harlem. Ethnicity & Health, 1(3), 221-228. 
Rolland, J. S. (1994). Families, Illness, and Disability: an Integrative Treatment Model. New 
York: Basic Books.  
Rollnick, S.R., Butler, C.C. &  Stott, N.C.H. (1997). Helping smokers make decisions: the 
enhancement of brief intervention for general medical practice. Patient Education 
Counseling, 31,191–203. Rosen, M. I., Ryan, C., Rigsby, M. (2002). Motivational enhancement and MEMS review to improve medication adherence. Behavior Change, 19,183-90. Rosenstock, I. M., Strecher, V. J. & Becker, M. H. (1988). Social learning theory and the health belief model. Health Education Quarterly. 15(2), 175-183. 
Roth, M. T. & Ivey, J. L. (2005). Self-reported medication use in community-residing older 
adults: a pilot study. The American Journal of Geriatric Pharmacotherapy, 3(3), 196-204. 
 136 
 
Rowland, J.H. (1990). Intrapersonal resources: Coping. In: Holland JC, Rowland JH, eds. 
Handbook of Psychooncology. New York: Oxford University Press, 44-57. 
Rowland, J.H. (2006). Survivorship research: Past, present, and future. In: Chang AE, Ganz PA, 
Hayes DF, et al., eds. Oncology: An Evidence Based Approach. New York, NY: 
Springer; 1753-1767. 
Royak-Schaler, R., Passmore, Gadella, S., Hoy, M. K., Shan, M., Tkaczuk, K., Harper, L. M., et 
al. (2008). Exploring patient-physician communication in breast cancer care for African 
American women following primary treatment. Oncology Nursing Forum, 35(5), 836-
843. 
Rubak, S., Sandbaek, A., Lauritzen, T. Borch-Johnsen, C. & Christen, B. (2011). Effect of 
?motivational interviewing? on quality of care measures in screen detected type 2 
diabetes patients: A one-year follow-up of an RCT, Abstract only. ADDITION.  
Denmark. Scandavian  Journal of  Primary Health Care, February 9. 
http://www.ncbi.nlm.nih.gov.proxy.lib.utk.edu:90/pubmed/21306296 
Rubak, S., Sandbaek, A. Lauritzen, T. & Christensen, B. (2005). Motivational interviewing: a 
systematic review and meta-analysis. British Journal of General Practice, 55(513), 305-
312. 
Rubin, A., & Babbie, E. R. (2008). Research Methods for Social Work. (6th ed.). Belmont, CA: 
Thomson Brooks/Cole. 
Ruddy, K., Mayer, E. & Partridge, A. (2009). Patient adherence and persistence with oral 
anticancer treatment. CA Cancer Journal for Clinicians, 59(1) 56-66. 
 137 
 
Russell, K. M., Champion, V., Skinner, C. S. (2006). Psychosocial factors related to repeat 
mammography screening over 5 years in African American women. Cancer Nursing, 
29(3), 236-243.  
Rust, C. & Davis, C. (2011). Medication therapy management and collaborative health care: 
implications for social work practice. Health Social Work. 36(1), 69-73. 
Rust, C. & Davis, C. (2013). "Chemo Brain in Underserved African-American Breast Cancer 
Survivors: a Qualitative Study." Clinical Journal of Oncology Nursing. In press, 
Scheduled publication April, 2013. 
Ryan, R. M. (1995). Psychological needs and the facilitation of integrative processes. Journal of 
Personality, 63, 397-427. 
Ryan, R. M. & Deci,E. L. (2000). Self-determination theory and the facilitation of intrinsic 
motivation, social development, and well-being. American Psychologist, 55(1), 68-78. 
Ryan, R. M. & Deci, E. L. (2006). Self-regulation and the problem of human autonomy: does 
psychology need choice, self-determination, and will? Journal of Personality, 74(6), 
1557-1586. 
Ryan, R. M., Kuhl, J. & Deci, E. L. (1997). Nature and autonomy: organizational view of social 
and neurobiological aspects of self-regulation in behavior and development. Development 
and Psychopathology. 9, 701-728. 
Sadler, G. R., Ko C. M., Cohn, J. A., White, M. Weldon, R. & Wu, P. C. M. (2007). Breast cancer 
knowledge, attitudes, and screening behaviors among African American women: the 
Black cosmetologists promoting health program. BMC Public Health, 7, 57. Safren, S. A., Otto, M. W., Worth, E. S., Johnson, W., Mayer, K. & Boswell, S. (2001). Two strategies to increase adherence to HIV antiretroviral medication: life-steps and 
 138 
 
medication monitoring. Behavioral Research & Therapy. 39,1151-62. Samet, J. H., Horton, N. J., Meli, S., Dukes, K., Tripps, T., Sullivan, L. & Freedberg, K. A. (2005). A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antiviral Therapy. 10(1), 83-93. 
Sanson-Fisher, R., Girgis, A., Boyes, A., Bonevski, B., Burton, L. & Cook, P. (2000). The unmet 
supportive care needs of patients with cancer. Supportive Care Review Group. Cancer, 
88(1), 226-237. 
Sapra, M., Vahia, I. V., Reyes, P. N., Ramirez, P. & Cohen, C. I. (2008). Subjective reasons for 
adherence to psychotropic medication and associated factors among older adults with 
schizophrenia. Schizophrenia Research, 106(2-3), 348-355. 
Saunders, B., Wilkinson, C. & Phillips, M. (1995).The impact of brief motivational intervention 
with opiate users attending a methadone programme. Addiction, 90,415–24. 
Schag, C. A., Ganz, P. A., Polinsky, M. L., Fred, C., Hirji, K., & Petersen, L. (1993). 
Characteristics of women at risk for psychosocial distress in the year after breast cancer. 
Journal of Clinical Oncology, 11(4), 783-793. 
Schillinger, D., Grumbach, K., Piette, J., Wang, F., Osmond, D., Daher, C., Palacios, … 
Bindman, A. B. (2002). Association of health literacy with diabetes outcomes. Journal of 
the American Medical Association, 2888(4), 475-482.  
Schillinger, D., Grumbach, K., Wang, F., Wilson, C., Daher, C., Leong-Grotz, K., Castro, C.,… 
Bindman, A. B. (2003). Closing the loop: physician communication with diabetic patients 
who have low health literacy. Archives of Internal Medicine, 163(1), 83-90. Schmaling, K. B., Blume, A. W. & Afari, N. (2001). A randomized controlled pilot study of motivational interviewing to change attitudes about adherence to medications for 
 139 
 
asthma. Journal of Clinical Psychology Medical Settings, 8,167-72. 
Schmidt, U. H. & Treasure, J. (1997). A Clinician’s Guide to Management of Bulimia Nervosa: 
Motivational Enhancement therapy for Bulimia Nervosa. Hove (Sussex): Psychology 
Press; 1997. 
Schnoll, R.. A., Harlow, L. L., Stolbach, L. L. & Brandt, U. (1998). A structural model of the 
relationships among stage of disease, age, coping, and psychological adjustment in 
women with breast cancer. Psycho-Oncology, 7(2),69-77. 
Sellman, J. D., Sullivan, P.F., Dore, G.M., Adamson, S.J. & MacEwan, I. (2001). A randomized 
controlled trial of motivational enhancement therapy (MET) for mild-moderate alcohol 
dependence. Journal of  Studies on  Alcohol, 62,389–96. 
Sharf, B. F. (1997). Communicating breast cancer on-line: support and empowerment on the 
internet, Women & Health, 26(1), 65-84. 
Sharpe, M.,  Strong, V., Allen, K., Rush, R., Postma, K., Tulloh, A., Maguire, P.,  et al. (2004). 
Major depression in outpatients attending a regional cancer centre: Screening and unmet 
treatment needs. British Journal of Cancer, 90, 314-320. 
Shields, L. E. (1995). Women’s experiences of the meaning of empowerment. Qualitative Health 
Research, 5, 15-35.  
Shimozuma, K., Ganz, P. A., Petersen, L., & Hirji, K. (1999). Quality of life in the first year after 
breast  cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer 
Research and  Treatment, 56(1), 45-57. 
Singh, G. K., Miller, B. A.,Hankey, B. F., & Edwards, B. K. (2003). Area socioeconomic 
variation in US cancer incidence, mortality, stage, treatment, and survival 1975-1999. 
NCI Cancer Surveillance Monograph Series, Number 4. Bethesda, MD, National Cancer 
 140 
 
Institute, NIH Publication Number 03-5417. 
Smedley, B. D., Stith, A. Y., & Nelson, A. R. (Eds.). (2003). Unequal Treatment: Confronting 
Racial and Ethnic Disparities in Health Care. Washington, DC: Institute of Medicine. 
Sodergard, B., Halvarsson, M., Tully, M. P., Mindouri, S., Nordstrom, M. L., Lindback, S., 
Sonnerborg, A.,… Lindblad, A. K. (2006). Adherence to treatment in swedish HIV-
infected patients. Journal of Clinical Pharmacy Therapeutics, 31(6), 605-616. 
Sollner, W., DeVries, A., Steixner E, Lukas, P., Sprinzi, G., Rumpold, G., &  Maislinger, S. 
(2001). How successful are oncologists in identifying patient     distress, perceived social 
support, and need for psychosocial counseling? British Journal of  Cancer, 84, 179-185. 
Sommers, L. S., Marton, K. I., Barbaccia, J. C., & Randolph, J (2000). Physician, nurse, and 
social worker collaboration in primary care for chronically ill seniors. Archives of 
Internal Medicine, 160(12), 1825-1833. 
Sorrells-Jones, J., & Weaver, D. (1999). Knowledge workers and knowledge-intense 
organizations, Part 3. Implications for preparing healthcare professionals. Journal of 
Nursing Administration, 29(10), 14-21. 
Stanton, A.L.(2006). Psychosocial concerns and interventions for cancer survivors. Journal of 
Clinical Oncology, 24(32), 5132-5137. 
Stanton, A. L., Danoff-Burg, S, Cameron, C L, Bishop, M, Collins, C. A., Kirk, S B, Sworowski, 
L. A, et al. (2000). Emotionally expressive coping predicts psychological and physical 
adjustment to breast cancer. Journal of Consulting and Clinical Psychology, 68(5), 875-
882. 
Stanton, A. L. & Reed, G. M. (2003). The breast cancer notebook: The healing power of 
reflection. Washington, D.C.: American Psychological Association. 
 141 
 
Stanton, A.L. & Snider, P.R. (1993). Coping with a breast cancer diagnosis: a prospective study. 
Health Psychology, 12(1), 16-23. 
Staat, K., & Segatore, M. (2005). The phenomenon of chemo brain. Clinical Journal of 
Oncology Nursing, 9(6), 713-721.  
Stecher, V., DeVillis, B., Becker, M. & Rosenstock, I. (1986). The role of self-efficacy in 
achieving health behavior change. Health Education Quarterly, 13(1),73-92. 
Steiner, J. F., & Earnest, M. A. (2000). The language of medication-taking. Annals of Internal 
Medicine, 132, 926-930. 
Steiner, J. F. & Prochazka, A. V. (1997). The assessment of refill compliance using pharmacy 
records: methods, validity , and applications. Journal of Clinical Epidemiology. 50(1), 
105-116. 
Stephens, R.S., Roffman, R.A. &  Curtin, L. (2000). Comparison of extended vs. brief treatments 
for marijuana use. Journal of Consulting Clinical Psychology, 68,898–908. 
Stotts,  A. L., Schmitz, J. M , Rhoades, H. M. & Grabowski,  J. (2001) Motivational interviewing 
with cocaine-dependent patients: a pilot study. (2001).  Journal Consulting Clinical 
Psychology, 2001;69, 858–62. 
Stovall, E. (2006). Cancer advocacy. In: Chang AE, Ganz PA, Hayes DF, et al., eds. Oncology: 
An evidence based approach. New York, NY: Springer, 1955. 
Swanson, A. J., Pantalon, M. V. & Cohen,  K. R. (1999).  Motivational interviewing and 
treatment adherence among psychiatrically and dually diagnosed patients. Journal of 
Nervous Mental Disorders, 187,630–5. 
Tallibert, S., Voillery, D. & Bernard-Mary, C. (2007). Chemobrain: is systemic chemotherapy 
neurotoxic? Current Opinions in Oncology, 19, 623:627. 
 142 
 
Tammemagi, C. M., Nerenz, D., Neslund-Dudas, C., Feldkamp, C. & Nathanson, D. (2005). 
Comorbidity and survival disparities among black and white patients with breast cancer. 
JAMA, 294(14), 1765-1772. 
Thier, S. L., Yu-Isenberg, K. S., Leas, B. F., Cantrell, C. R., DeBussey, S., Goldfarb, N. I., et al. 
(2008). In chronic disease, nationwide data show poor adherence by patients to 
medication and by physicians to guidelines. Managed Care, 17(2), 48-52, 55-47. 
Thyer, B. A., Sowers, K. M., & Dulmas, C. N. (2008) Comprehensive Handbook of Social Work 
and Social Welfare: Human Behavior in the Social Environment. Hoboken, New Jersey: 
John Wiley & Sons. 
Till, J. E. (2003). Evaluation of support groups for women with breast cancer: importance of the 
navigator role. Health Quality of  Life Outcomes, 1, 16. 
Treasure, J. & Ward, A. (1997). A practical guide to the use of motivational interviewing in 
anorexia nervosa. European Eating Disorders Review, 5,102–14. 
U.S. Department of Health and Human Services. Healthy People 2010: Understanding and 
 Improving Health. 2nd ed. Washington, DC: U.S. Government Printing Office, November 
            2000. 
Valanis, B., Lichenstein, E., Mullooly, J. P., Labuhn, J. P., Brody, K., Severson, H. H., et al. 
(2001).  Maternal smoking cessation and relapse prevention during health care visits. Am 
Journal of Preventive Medicine, 20, 1–8. 
Van Bilsen, H. P. J.G. Motivational interviewing: perspectives from the Netherlands, with 
particular emphasis on heroin-dependent clients. In: Miller WR, Rollnick S, editors. 
Motivational Interviewing: Preparing People to Change Addictive Behaviour. New York: 
Guilford Press; 1991. p. 214–24. 
 143 
 
 Van Bilsen, H. P. J. G., Whitehead, B. (1994). Learning controlled drugs use: a case study. 
Behavioral Cognitive Psychology, 22, 87–95. 
Van Dulman S., Sluijs E., van Dijk L. et al. (2007). Patient adherence to medical treatment: a 
review of reviews. BMC Health Service Research,  7:55. 
Vansteenkiste, M. &  Sheldon. K. M. (2006). There's nothing more practical than a good theory: 
integrating motivational interviewing and self-determination theory. British Journal of  
Clinical Psychology 45(Pt 1), 63-82. 
Veazie, P. J. & S. Cai (2007). A connection between medication adherence, patient sense of 
uniqueness, and the personalization of information. Medical Hypotheses,  68(2), 335-342. 
Vernon, S.W., Vogel, V.G., Halabi, S., Jackson, G.L., Lundy, R.O. & Peters, G.N. (1992). Breast 
cancer screening behaviors and attitudes in three racial/ethnic groups. Cancer, 69(1), 
165-174. 
Wagner, E. H. (2000). The role of patient care teams in chronic disease management. British 
Medical Journal, 320(7234),  569-572. 
Waite, K. R.,  Paasche-Orlow, M., Rintamaki, L. S., Davis, T. C., & Wolf, M. S. (2008). Literacy, 
social stigma, and HIV medication adherence. Journal of General Internal Medicine, 
23(9): 1367-1372. 
Wallace, L. S. (2006). Patients health literacy skills: the missing demographic variable in primary 
care research. Annals of Family Medicine, 4, 85-86. 
Wallace, L. S., Rogers, E. S., Roskos, S. E., Holiday, D. B. & Weiss, B. D. 92006) Brief report: 
screening items to identify patients with limited health literacy skills. Journal of General 
Internal Medicine, 21(8), 874-877. 
Wallston, B. S. & Wallston, K. A. (1984). Social  psychological models of health mebavior: an 
 144 
 
examination and integration. In Baum, A., Taylor, S. E., & Singer, J. E. (eds.) Handbook 
of Psychology and Health Volume IV. Hillsdale, NJ, Erlbaum. 
Walsh-Burke, K. & Marcusen, C. (1999). Self-advocacy training for cancer survivors. The 
Cancer Survival Toolbox. Cancer Practice, 7(6), 297-301. 
Webb, C., & Koch, T. (1997). Women's experiences of non-invasive breast cancer: literature 
review and study report. Journal of Advanced Nursing, 25(3), 514-525. 
Weick, A. (1983). Issues in overturning a medical model of social work practice. Social Work, 
28(6), 467-471. 
Williams, M. V., Baker, D. W., Honig, E. G., Lee, T. M., & Nowlan, A. (1998). Inadequate 
literacy is a barrier to asthma knowledge and self-care. Chest, 114(4), 1008-1015. 
Williams, M. V., Baker, D. W., Parker, R. M. & Nurss, J. R. (1998). Relationship of functional 
health literacy to patients’ knowledge of their chronic disease: a study of patients with 
hypertension and diabetes. Archives of Internal Medicine, 158(2), 166-172. 
Williams, M. V., Davis, T., Parker, R. M., & Weiss, B. D. (2002). The role of health literacy in 
patient-physician communication. Family Medicine, 34(5): 383-389. 
Wolf, M S., Davis, T. C., Osborn, C., Skripkauskas, S., Bennett, C., & Makoul, G. (2007). 
Literacy, self-efficacy, and HIV medication adherence. Patient Education Counseling, 
65(2), 253-260. 
Wolff, M., Bates, T., Beck, B., Young, S., Ahmed, S.M., Maurana, C. (2003). Cancer prevention 
in underserved African American communities: Barriers and effective strategies-a review 
of the literature. Wisconsin Medical Journal, 102(5), 36-40. 
 145 
 
Woollard, J., Beilin, L., Lord, T., Puddey, I., MacAdam, D. & Rouse, I.(1995). A controlled trial 
of nurse counselling on lifestyle change for hypertensives treated in general practice: 
preliminary results. Clinical & Experimental Pharmacology Physiology, 22,466–8 
World Health Organization (WHO). Counseling for treatment adherence. Retreived October 4, 
2010 from http://www.searo.who.int/LinkFiles/Training_Materials_voluntary-module4-
2.pdf 
Zabora,  J., BrintzenhofeSzoc, K., Curbow, B., Hooker, C. & Piantadosi, S. (2001). The 
prevalence of psychological distress by cancer site. Psycho-Oncology, 10(1), 19-28. 
Zeber, J. E., Grazier, K. L., Valenstein, M., Blow, F. C. & Lantz, P. M. ( 2007). Effect of a 
medication copayment increase in veterans with schizophrenia. American Journal of 
Managed Care. 13(6 pt. 2), 335-346. 
Zebrack, B. &  Walsh- Burke, K. (2004). Advocacy needs of adolescent and young adult cancer 
survivors: Perspectives of pediatric oncology social workers. Journal of Psychosocial 
Oncology. 22(2):75-87. 
Zebrack, B. J., Yi, J., Petersen, L., Ganz, P.A.. (2007). The impact of cancer and quality of life 
for long-term survivors. Psycho-oncology. Nov 29.  
Zerhouni, E. (2003) Medicine: the NIH roadmap. Science, 3, 63-72. Zygmunt, A., Olfson, M., Boyer, C.A. & Mechanic, D. (2002). Interventions to improve medication adherence in   schizophrenia. American  Journal of Psychiatry. 159,1653-64.  
 146 
 
Appendices  
 147 
 
ARMS Questionnaire 
 
ADHERENCE TO REFILLS AND MEDICATIONS SCALE (ARMS) 
I will now ask you how often you actually
 
 miss taking your medicines and how often you can’t 
make it to your medical appointments. There are no right or wrong answers. For each question, 
please answer “none of the time,” “some of the time,” “most of the time,” or “all of the time.” 
                   
How often do you forget to take your medicine?                            1                     2            3               4 
         None          Some          Most           All 
 
How often do you decide not to take your medicine?                     1                     2                 3                 4 
 
How often do you forget to get prescriptions filled?                       1                     2                  3                4 
 
How often do you run out of medicine?                                          1                     2                  3                4      
 
How often do you skip a dose of your medicine before  
you go to the doctor?                                                                 1                     2                  3                4            
 
How often do you miss taking your medicine when  
you feel better?                                                                          1                      2                   3               4 
 
How often do you miss taking your medicine when  
you feel sick?                                                                             1                     2                   3               4        
How often do you miss taking your medicine when you 
are careless?                                                                               1                     2                   3               4 
 
How often do you change the dose of your medicines  
      to suit  your  needs (like when you take more or less pills 
      than you’re supposed to)?                                                            1                  2                     3               4 
 
 How often do you forget to take your medicine when you are  
supposed to take it more than once a day?                                   1                  2                    3               4                       
  
How often do you put off refilling your medicines because  
they cost too much money?             1                  2                   3           4 
 
How often do you plan ahead and refill your medicine                       1                  2                   3               4 
before they run out?  
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SEAMS Questionnaire 
SELF-EFFICACY ASSESSMENT 
 
A lot of people have trouble taking their medicines like their doctor prescribes. Sometimes, people also can’t make it to their doctor’s 
appointments. I would like to ask you your opinion about taking your medicines and keeping your appointments. I want to learn what you think 
you can do under several different conditions, not actually what you do
 
. For each situation, let me know whether you are “not at all confident,” 
“somewhat confident,” or “very confident.”  
How confident are you that you can take your medicines correctly……..   
                                                                                                Not                    Somewhat              Very 
                                                                                                                confident              confident            confident                         
12. When you take several different medicines each day.         1                        2                     3  
13. When you take medicines more than once a day.                1                        2                     3 
14. When you are away from home.                                          1                        2                     3   
15. When you have a busy day planned.                                    1                        2                     3      
16. When they cause some side effects.                                     1                        2                     3    
17. When no one reminds you to take the medicine.                 1                        2                     3    
18. When the schedule to take the medicine is not  
      convenient.                                                                           1                        2                     3   
19. When your normal routine gets messed up.                         1                        2                     3                     
20. When you are not sure how to take the medicine.                1                       2                     3  
21. When you are not sure what time of the day to take  
       your medicine.                                                                     1                        2                     3 
22. When you are feeling sick (you know, like having  
       a cold or the flu).                                                                 1                         2                    3  
23. When you get a refill of your old medicines and 
       some of the pills look different than usual.                         1                         2                    3 
24. When a doctor changes your medicines.                              1                         2                    3           
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Three Question Health Literacy Assessment 
 
 
 
1. How often do you have problems learning about your medical condition because of 
difficulty understanding written information? 
 
always            often          sometimes          occasionally             never 
 
2.      How often do you have someone help you read hospital materials? 
 
always            often          sometimes          occasionally             never 
 
3.      How confident are you filling out medical forms by yourself?  
  
  always            often          sometimes          occasionally             never 
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Medication Adherence Skills Workshop Evaluation Form 
 
Please circle the response that best represents what you have gained as a result of this 
program: 
 
1. Has your confidence about your ability to gain information about your medications          
increased? 
 
       
     1           2            3    4                      5 
not at all     a little    somewhat         quite a bit   a great deal 
 
 
2.  Has your understanding of the importance of following medication directions increased? 
 
       
     1           2            3    4                      5 
not at all     a little    somewhat         quite a bit   a great deal 
 
 
3.  Has your confidence in taking your medications increased? 
 
       
     1           2            3    4                      5 
not at all     a little    somewhat         quite a bit   a great deal 
 
 
 
4.  Has this training session been helpful to you? 
       
     1           2            3    4                      5 
not at all     a little    somewhat         quite a bit   a great deal 
 
 
 
Additional Comments: Please tell us anything else you would like about what you thought 
of this training session or how you might use what you learned. 
 
_____________________________________________________________________________ 
_____________________________________________________________________________ 
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